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Abstract
Dietary long chain n-3 fatty acids in fish-oil have proven efficacy in reducing 
cardiovascular risk associated with an atherogenic lipoprotein phenotype (ALP) 
and in reducing C H D  mortality. However, the acquisition of these health benefits 
is seriously limited by low habitual intakes of oily fish. Since the shorter chain 
fatty acid alpha-linolenic acid (ALA) can be converted, to a variable extent, in vivo 
to its longer chain counterparts, in theory, it should have the capacity to exert fish 
oil like effects on cardiovascular risk. To test this hypothesis, a pilot study was 
designed to assess the practical issues of delivering 16g of ALA per day to a 
group of normal healthy (n=9) volunteers. Outcomes were used in a larger study 
designed to examine the relative effects of diets enriched with ALA in flaxseed 
oil, and fish oil on plasma lipids, lipoproteins and selected haemostatic variables 
in subjects with an ALP. Normal, healthy male subjects (n=57) with an ALP were 
randomly assigned to one of three diets for 12 weeks; a diet enriched with 
flaxseed oil (high ALA n=21), a “control" diet enriched with sunflower oil (high 
linolenic acid n-17) and the "control” diet supplemented with fish oil capsules (3g 
E P A + D H A  n=19). Evidence for dietary compliance was provided by 7-day 
records of food intakes and increases in the concentration of n-3 P U F A  in 
erythrocyte membrane phospholipids. The pilot study provided valuable 
information on the delivery of ALA into the study diet, which improved accuracy 
of dietary dose, portability and stability of the oil and aided dietary compliance in 
the principal study. The flaxseed, fish oil and “control” diets achieved intake ratios 
of n-6:n-3 of 0.4, 5.2 and 30.0 respectively. There was ho overall difference in 
any measured variable between the 3 diets (6 &  12 week post diet) or between 
the flaxseed and fish-oil groups compared to control. Total plasma cholesterol 
decreased relative to baseline values, within ail 3 test diets (pre versus post-diet). 
Plasma T A G  was significantly decreased after the fish oil diet, relative to baseline 
(-23%. P<0.001). The change in plasma T A G  was inversely associated with the 
level of D H A  (022:6 n-3) in erythrocyte membrane fatty acids at 12 weeks (r2 = 
4 8 %  p=0.001). LDL subclasses showed a significant reduction towards larger, 
lighter particles after fish-oil (small, dense LDL-3 -22% p=0.003). There was no 
change in the concentrations of plasma fibrinogen, factor VII, or in the plasma 
activity of PAI-1 on any diet or endothelial function as measured by flow- 
mediated dilatation on a subset on each diet. In conclusion, the fish-oil diet 
induced predictable changes in plasma lipids and lipoproteins that are associated 
with lower C H D  risk. The flaxseed-oil diet did not reproduce these effects even in 
the presence of low intakes of dietary n-6 fatty acids.
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1 C H A P T E R  1 G E N E R A L  I N T R O D U C T I O N
1.1 Coronary Heart Disease
Coronary Heart Disease (CHD) accounted for 2 2 %  of all deaths in males under 
the age of 75 in the U K  in 2001 (Office for National Statistics 2002), 
nevertheless, death from C H D  in males has been declining, in 1971 375 per
100,000 deaths were attributable to cardiovascular disease, by 1990, that figure 
was 300. Between 1989 and 1999, there was a 4 3 %  fall in deaths from C H D  in 
males aged 45-54 years, and a 34% decrease in those aged 65 to 74 years (BHF 
2001). While advances in primary and secondary health care have undoubtedly 
contributed to this decline in C H D  mortality, C H D  morbidity figures halve changed 
little. On the other hand the prevalence of obesity in the U K  is increasing; in 
2001, 2 4 %  cent of women and 2 1 %  of men were obese (Health Survey for 
England, 2001) compared to 8 %  of women and 6 %  of men in 1980 (ONS 1980). 
This is due primarily to inappropriate diet and reductions in physical activity. An 
increase in the prevalence of Type II diabetes has also immerged almost 
certainly due to decreases in physical activity and worsening dietary intake 
(UKPDS 1988). Obesity contributes to a range of diseases including 
cardiovascular disease. The National Audit Office estimated that obesity reduces 
life expectancy on average by 9 years (NAO 2001). In diabetics, the incidence of 
C H D  risk is increased 2 to 3 fold compared with non-diabetics. In a large 
prospective study, C H D  risk in people with diabetes, but without overt CHD, was 
similar to that in non-diabetics with established C H D  (Haffner et al 1998).
The metabolic syndrome has been described as a ‘clustering’ of several risk 
factors for CHD, including central obesity, insulin resistance, dislipidaemia and 
hypertension (Table 1.1). In the UK, it has been suggested that as many as 2 5 % 
of the population show clear signs of the metabolic syndrome (Tonkin et al. 
2003). The Kuopio Ischaemic Heart Disease Risk Factor Study was a population 
based prospective study that found a 2-fold increase in C H D  and all cause 
mortality in men with the metabolic syndrome compared to those without (Lakka
7
et al 2002). These data alone suggest that C H D  risk may have already reached 
epidemic proportions in the UK.
Table 1.1: Predisposing factors for the metabolic syndrome
Diagnosis is established when S3 factors present (JAMA 2001)________________
Risk Factor Defining Level
Abdominal Obesity (Waist Circumference)
Men
Women
>102 cm (>40 inches) 
>88cm (>35 in)
TAG £1.7 mmol/l
HDL-C
Men <1.0
Women <1.3
Blood Pressure >130/>85 mmHg
Fasting Glucose >6.0 mmol/l
1.1.1 Attributable risk versus absolute risk
Until recently, most clinical investigations of diet and C H D  have been 
cholesterolcentric in their approach. Large prospective epidemiological studies 
established a continuous relationship between T C  levels and death from CHD. 
The MRFIT trial (1986) associated increasing T C  with increasing mortality, and 
found a significant reduction of first major C H D  events with dietary interventions 
to lower TC. The Framingham study found a direct relationship between TC 
levels and C H D  mortality (Anderson et al 1987). The cross-cultural seven 
countries study, found that a 0.5mmol/l increase in TC was associated with 12% 
increase in C H D  mortality (Verschuren et al 1995). Focusing only on T C  is an 
inadequate predictor of C H D  risk in a population such as the UK. Fruchart & 
Packard (1997) plotted the frequency of distribution of serum cholesterol levels in 
both the diseased and non-diseased population and found the absolute risk of 
C H D  mortality with serum cholesterol of 7.5mmol/l was about 90%, however only 
3 %  of those with C H D  had this level, making the attributable risk just 2.7%. On 
the other hand, serum cholesterol levels of 5.2mmol/l were associated with a 
C H D  risk around 20%, but 4 5 %  of those with C H D  also had this level; the 
attributable risk therefore Is greater at 9%. Figure 1.1 illustrates the overlapping 
distributions between C H D  free subjects and those with established CHD. There 
exists a “grey area” within which the TC levels do not discriminate C H D  from
8
health. In the principal dietary investigation we examined the effects of diet on a 
range of C H D  risk factors, not solely TC.
Figure 1.1: Serum cholesterol as an inadequate indicator of CHD risk (Fruchart & Packard
1997)
Cholesterol in disease free subjects ............  ■■■■■
Cltolostoro! in CHD subjects
Total So rum Cholesterol (mmoifl)
1.2 Overview of lipoprotein metabolism
The T C  value Is a representation of all the lipoproteins in the circulation that 
contain free cholesterol or cholesterol esters. Cholesterol and T A G  are 
transported around the body via lipoproteins, which are subdivided into those of 
exogenous (from the gut) and endogenous (from the liver) origin. Table 1.2 
summaries the main lipoproteins their origin, structure, role in the body and in 
C H D  risk.
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Table 1.2: Origin, principle function and role in CHD of the main lipoproteins.
Lipoprotein Origin & Structure Principal Function Risk in CHD
Chylomicrons
(CM)
Formed in epithelial 
cells in lower intestine 
after consumption of a 
meal containing fat
Transport of TAG from the 
gut to the adipose and 
muscle cells. Liver 
processes what is left.
Contributes to raised 
TAG in postprandial 
state. Remnant particles 
are proinflammatory and 
proatherogenic
Very Low 
Density 
Lipoprotein 
(VLDL)
Liver: 10% Protein, 
mainly containing TAG
Transport of TAG formed 
in liver: mainiy to adipose 
tissue
In IR and ALP may 
contribute in process of 
neutral lipid exchange in 
formation of more 
atherogenic LDL particles
Low Density
Lipoprotein
(LDL)
Mainly derived from 
delipidation of VLDL: 
Highest in CE as % of 
weight
Carry majority of 
cholesterol in the blood. 
Transport of CE to 
peripheral cells for 
membrane structure and 
hormone production
High levels >4.0mmoi are 
considered atherogenic, 
higher residency time 
increases likelihood of 
proinflammatory and 
proatherogenic effects.
High Density
Lipoprotein
(HDL)
Liver: Highest in 
density due to high 
protein/lipid ratio
Transport of CE from 
peripheral cells to the liver 
(Reverse Cholesterol 
Transport Pathway)
Considered anti­
atherogenic levels 
>1.1mmol/l desirable.
1.2.1 Triacylglycerol and C H D  risk.
The increased use of statins and fibrates continue to reduce many C H D  risk 
factors, but the media and to a certain extent health professionals seem to focus 
their attention on cholesterol as the key player in CHD. It is widely accepted that 
C H D  is associated with not only cholesterol but also a variety of other factors 
including gender, genetics, environmental and dietary factors. While there is still 
intense interest in cholesterol as an independent indicator on CHD, 
epidemiological evidence has emerged that has also identified TAG. T A G  was 
initially downgraded as risk factor for C H D  because it was statistically associated 
with other variables in particular HDL-C. The P R O C A M  study (Assman et al 
1997) suggested that a high HDL-C level is more protective than a low level of 
LDL-C, but also that for any given LDL-C level, C H D  events were higher in those 
with T A G  levels above 2.3mmol/l compared to those with <2.3mmol/l (Figure 
1.2). Meta-analysis of 46,413 man and 10,864 women showed that for every 1
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mmol/l increase in T A G  there was an increase risk of C H D  by 3 2 %  in men and 
7 6 %  in women (Hokanson and Austin 1996). The findings of the Copenhagen 
Male Study reported a clear gradient of C H D  risk with increasing T A G  levels 
(Brewer 1999). Intervention with the T C  and T A G  lowering drug Gemfibrozil by 
the Helsinki Heart Study (Tenkanen et al 1994) reported a 7 0 %  fall in the 
incidence of C H D  in those with initial fasting T A G  >2.3 mmol/l. The Framingham 
Study (Castelli 1992) also found a strong inverse relationship between T A G  and 
HDL-C. The highest incidence of C H D  occurred in the group with the lowest HDL 
and highest TAG.
Figure 1.2: The effects of increased TAG on the incidence of CHD as identified by the
PROCAM study (Assman et a l 1997).
<32 3 2-4 0 4 04 9 >4 9LDL Ct»o*estero4 mmol/l
1.3 The Atherogenic Lipoprotein Phenotype (ALP)
An ALP is a collection of abnormalities in plasma lipoproteins, which increases 
the risk of heart disease in apparently healthy individuals. An ALP is associated 
with moderately raised serum T A G  (>1.5mmol/l) with reduced HDL levels 
(<1.0mmol/l) and a predominance of small, dense LDL particles (Austin & 
Edwards 1996). The prevalence of an ALP in the free living population is not 
known, numbers are likely to parallel that of mild insulin resistance in middle 
aged males and post-menopausal women, with around 2 5 %  being affected
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(Despres & Marette 1994). It is further characterised by preponderance of 
chylomicron remnant particles, cholesterol ester enriched VLDL and prolonged 
postprandial clearance of T A G  rich lipoproteins (Griffin & Zampelas 1995). Up to 
5 0 %  of the individuals who exhibit an ALP may do sp through environmental 
factors such as poor diet and low levels of physical activity. The frequency of an 
ALP is highest in middle aged men and may be a better indicator for C H D  risk 
than LDL-C. Many more C H D  patients are found to have this trait than those with 
hypercholesterolemia alone (Superko 1996).
Insulin resistance (IR) describes a state where the ability of insulin to stimulate 
uptake and disposal of glucose in muscle is impaired. It is commonly found in 
overweight individuals and those with type-ll diabetes. Ruderman et al (1981) 
described “metabolically obese” individuals who were a normal weight, but 
exhibited IR similar to those who were obese. IR does not only effect glucose 
uptake it also affects T A G  uptake in adipose tissue and muscle. Lipoprotein 
Lipase (LPL) in adipose tissue is stimulated by insulin, and as such a decrease in 
LPL activity will affect the rate at which larger T A G  rich lipoproteins are 
dilapidated and metabolised further. The net effect of this is not only prolonged 
postprandial lipaemia, but also greater fasting T A G  levels. Raised fasting T A G  in 
IR individuals may also be caused by a reduction of peripheral blood flow 
blunting the delivery of T A G  rich lipoproteins to peripheral muscle (Summers et al 
1990). IR is also associated with raised levels of circulating free fatty acids (FFA); 
these are the major substrate for hepatic VLDL synthesis, and as such there is 
an associated rise in T A G  rich VLDL, even in the fasting state.
Prolonged postprandial lipaemia and raised fasting T A G  levels increase the 
likelihood of potentially atherogenic lipoprotein particles being formed, primarily 
through the action of neutral lipid exchange. In this manner, a reduction in 
plasma T A G  levels may confer some benefit in reducing potentially atherogenic 
structural changes occurring to lipoproteins, in particular LDL-C. Low-density 
lipoprotein can be remodelled in a manner that makes it more atherogenic, this
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process is known as neutral lipid exchange (Figure 1.3). The effects are not just 
limited to LDL, but also affect H D L  ultimately altering their size and composition. 
Changes in their heterogeneity have profound effects in terms of their 
atherogenicity and preponderance in the circulation. Prospective trials have 
shown that small LDL particles are strong predictors of future coronary events, 
similar to that of hypertension and smoking (Stampfer et al 1996, Gardner et al 
1996).
Figure 1.3: Neutral lipid exchange between TAG rich particles and LDL. (Adapted from
Griffin 2001)
The mechanisms by which LDL undergoes its structural changes are primarily through neutral lipid 
exchange. Cholesterol esters can be exchanged between VLDL and LDL in exchange for TAG (Nichols & 
Smith 1965). This results in a cholesterol ester (CE) rich VLDL and a TAG rich LDL particle. The effect of HL 
acting on the TAG rich LDL results in a small, dense cholesterol and protein rich particle or LDL-3. An 
increase in fasting TAG above 1.5 mmol/l is associated with an increase in the number of small, dense LDL 
particles in the circulation (Griffin 2001). This can be explained in part by the process of neutral lipid 
exchange. When fasting TAG levels are below 1,5mmol/l there exists an equimolar exchange of lipids and 
CE between donor particles (Packard & Shepherd 1997). When fasting TAG increases above 1.5 -1 .6  
mmo/l, this equimolar exchange is replaced by a net transfer of TAG into the LDL particle. This process 
generates TAG rich, CE poor LDL, which undergoes lipolysis by HL; resulting in a small, dense LDL
particle.
1.4 Small dense LDL and C H D  risk
LDL is a heterogeneous particle. Gradient gel electrophoresis (GGE) and more 
recently density gradient centrifugation have allowed isolation of distinct LDL
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subclasses (Griffin 1990). Heterogeneity can be caused by factors such as 
differing lipid and cholesterol content. Density gradient ultracentrifugation 
resolves 3 distinct LDL subclasses, categorised by their respective densities 
within the gradient. The largest and most buoyant “LDL-1” lies between 
1.025g/ml and 1.034g/ml, the intermediate size “LDL-2” between densities 
1.034g/ml and 1.044g/ml, and the small, dense “LDL-3” between 1.044g/ml and 
1.063g/ml. In some instances in individuals with overt hypotriacylglycerolaemic, a 
small, dense LDL particle “LDL-4” is measured. The largest LDL-1 subspecies is 
relatively T A G  rich, the intermediate size LDL-2 is less T A G  rich and has a higher 
protein content. The LDL-3 particle contains very little T A G  is protein rich and 
smaller in size than either of its progenitors. Figure 1.4 illustrates the LDL 
subclasses generated using G G E  and Density Gradient ultracentrifugation 
methods.
Figure 1.4: Density Gradient (top) and GGE (bottom) profiles illustrating distinct
subclasses within LDL
Both methods quantify subclasses on their percentage relative to the total area 
uhder the curve. The distribution shown in Figure 1.4 is consistent with the 
pattern A  phenotype as first described by Austin and co workers (1990). If over 
4 0 %  of the LDL is LDL-3, the subject is said to have a pattern “B” phenotype. 
Pattern “B” describes a preponderance of small, dense LDL particles. Pattern “A ” 
phenotype describes a low number of LDL-3 particles with most being found in
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the densities 1.019g/ml to 1.044g/ml. Unlike GGE, density gradient centrifugation 
also reveals a pattern T  phenotype (or intermediate) in which there is an almost 
equal preponderance of LDL-2 and LDL-3.
1.4.1 H D L  particle size and C H D  risk
H D L  is often described as two distinct lipoproteins: a larger HDL 2 particle 
containing free cholesterol, CE, some T A G  and a smaller H D L 3 particle, 
containing less free cholesterol, C E  and 5 0 %  as much T A G  as H D L 2 (Eisenburg 
1984). The structural changes that occur in HDL are described by Tailleux and 
Fruchart (1996). The transition between HDL 2 and H D L 3 is a continuous one, and 
as such HDL-C should be viewed as a heterogeneous group of particles (Nicoll 
et al 1980). Two subclasses can be isolated and quantified by density gradient 
ultracentrifugation. As with LDL, area under the protein curve is used to 
determine the relative percentages of each sub fraction. Changes in the 
distribution of the two subclasses can be affected by other lipoproteins.
1.5 Diet and C H D
Figure 1.5 illustrates the chemical structure of saturated, mono and n-3 and n-6 
polyunsaturated fatty acids. The prefixes n-3 and n-6 determine which family of 
polyunsaturates the fat originates from. Those with the prefix n-3 (or omega-3) 
have the first double bond on the third carbon atom from the carboxyl end. Those 
with the prefix n-6 have the first double bond on sixth carbon. While both families 
fall under the heading PUFA, they have different effects metabolically in humans, 
which are discussed later.
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Figure 1.5: The chemical structure of saturated, mono, n-3 and n-6 polyunsaturated fatty
acids
Saturated16 14 12 10 B 6 4 2
\ A A A A A M ™Palmitic acid 1Hexadeconoic acid
Monounsaturated
A A A A = A A A A c<,ohIB 16 14 12 10 9 1Oleic acid <n-9 family)cis-9-octadeconoic acid |c-9-18:1 or 18:1, n-9)
18 16 14 12 10 8 6 4 2
V W W A A A m .9 1Elaldic acidtrans-9-octadaconoic acid (t-9-18:1i
Polyunsaturated
COOH1Linoleic acid (n-6 family)cla,cis-9,12-octadocadionoicacid |c.c-9.12-18:2 Dr 10:2,n-6)
COOH
o-Linolonic acid (n-3 family)all-cis-9,12,16-octadecatrlonoic acid (c,c,c-9.12,15-18:3 or 18:3. n-3)
The work of Keys et al (1965) was of particular importance in illustrating that a 
reduction in dietary energy from saturated fat (SFA) was associated with a 
reduction in TC. Following this discovery, ways in which SFA within the diet could 
be replaced were examined. In the 1970’s and 80’s the use of margarines to 
replace butter and lard became more widespread. The use of oils from seeds 
such as sunflowers became cheaper and hence more a cost-effective way to 
make margarine and oils; as such, energy derived from saturated fatty acids 
began to fall alongside increases in PUFA. At that time, a majority of dietary 
P U F A  was n-6 in origin; the other types of PUF A  (n-3 PUFAs) derived from 
marine and plant origin were not increased. Intakes of n-3 fats, primarily from oily 
fish and some plants failed to increase or fell slightly whilst those from n-6 
continued to increase. Consequently, the ratio of n-6 P U F A  to n-3 P U F A  
increased dramatically from around 1:1 at the beginning of the 20th Century, to 
around 10:1 in the U K  in 1990 (Gregory 1990). Intakes of oily fish in the U K  are 
generally low, due to taste, cultural and financial reasons. While there is 
convincing evidence of the beneficial effects of n-3 P U F A  on CHD, particularly
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from oily fish, attention was still firmly fixed on TC. The result of this was 
continued use of n-6 P U F A  as a replacement for SFA rather than n-3 PUFA.
Over the last 30 years, the effects of altering total energy from fat and differing 
fatty acids on C H D  risk have been examined. Table 1.3 summarises some of the 
larger dietary intervention studies conducted and their outcomes in terms of 
reducing C H D  risk and the effect on TC.
Table 1.3: Summary of interventions aimed at reducing CHD risk using differing dietary 
approaches (adapted from Hu & Willett 2002).
Trial Patients (n=)
Dietary
Intervention
% 
Energy 
from fat
Duration
(Years)
Change 
in TC 
(%)
Change 
in CHD
(%)*
Low-Fat Approach
MRC (low fat) 123 Male Ml Reduce total fat 22 3 -5 +4
DART 1015 male Ml Reduce total fat 32 2 -4 -9
High Polyunsaturated Fat Approach
Finnish Mental 
Hospital Study
676 men with no 
CHD
Reduce SFA, 
increase PUFA
35 6 -15 -44t
MRC (soy oil) 206 Male Ml Reduce SFA, 
increase PUFA
39 5 -14 -25
Minnesota 
Coronary Survey
4393 men & 
4664 women
Reduce SFA, 
increase PUFA
38 1 -14 0
Increase Omega-3 Fatt;/ Acid
DART 1015 Ml Patients Fish twice week 
or fish oil 1.5g
NR 2 NR -16
GISSI 5666 Men Ml Fish oil 1g 
EPA+DHA
NR 3.5 0 -30t
Whole-Diet Approach
Lyon Diet Heart 
Study
203 Men Ml High ALA &
Mediterranean
Diet
31 3.8 0 -72t
t  p<0.05
* Change to cholesterol refers to the percentage change is serum cholesterol level in the 
treatment group compared with the control group.
NR = Not Recorded
References
MRC Low Fat (Ball et al 1965), DART Burr et al (1989), Finnish Mental Hospital Study 
(Turpeinen et al 1979), MRC Soy oil (Morris et al 1968), Minnesota Coronary Survey (Frantz et al 
1989), GISSI (Marchioli et a /2002), Lyon Heart Study (de Lorgeril e ta l 1999).
Changing the amount of fat and the type of fat consumed not only affects TC 
levels but also lipoprotein metabolism in humans. Mensink &  Katan (1992) 
predicated the effect of replacing 5 %  of carbohydrate energy with saturated,
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monounsaturated and polyunsaturated fatty acids on TAG, HDL and LDL, and 
the LDL:HDL ratio. Predicted effects are shown in Figure 1.6
Figure 1.6: Effect of substituting 5% carbohydrate energy with SFA, MUFA or PUFA on 
lipoproteins and plasma triacylglycerol (Adapted from  Mensink & Katan 1992)
■  Saturated ■  Monounsaturtaed □  Polyunsaturated
-10 ---------------------------------------
HDL-C LDL-C TAG LDL: HDL
1.5.1 Role of dietary fatty acids in C H D
Our understanding of the pathophysiological role of dietary T A G  in 
atherosclerosis has changed over the last few decades. In terms of reducing 
C H D  risk the main message advocated was to decrease the intake of saturated 
and trans-unsaturated fatty acids, primarily to reduce LDL-C concentration (AHA 
2000). The effects of altering dietary fatty acids are not limited to LDL-C, but may 
also affect HDL-C and plasma TAG. Substituting 10% total daily energy intake 
from saturated fat with polyunsaturated, monounsaturated or carbohydrate 
decreases LDL by 0.46mmol/l, 0.38mmol/l and 0.33mmol/l respectively (Mensink 
& Katan 1992). The impact on LDL-C is favourable in terms of reducing C H D  
risk, with P U F A  being the most effective, however while carbohydrate was 
associated with a decrease in LDL-C it also lowered HDL-C, effectively leaving 
the LDL-HDL ratio unchanged. The effect of P U F A  on LDL-C is much greater 
than HDL with greater reductions in the former occurring, effectively decreasing 
the LDL-HDL ratio (Mensink & Katan 1992).
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The effects of substituting dietary fats and/or carbohydrate on fasting and non­
fasting T A G  should also be considered. Substituting dietary fat for carbohydrate 
does not reduce fasting or postprandial T A G  levels (Sacks & Katan 2002) as high 
carbohydrate intakes increase endogenous T A G  production, primarily through 
VLDL secretion. Mensink & Katan (1992) predicted the effects of 3 dietary 
therapeutic approaches on TC, LDL-C, HDL-C and plasma TAG. They compared 
a typical Northern European intake with the Step 1, Step 2 diets and 
Mediterranean diet. Decreasing energy from fat to 2 0 %  (Step 2 diet) is 
associated with a 2 0 %  rise in plasma TAG, and a 2 0 %  reduction in HDL-C. On 
the other hand, keeping fat intake at 3 8 %  of total energy but decreasing SFA and 
increasing both M U F A  and PUF A  (Mediterranean Diet) is associated with no 
changes in plasma T A G  and greater reductions in both TC and LDL-C compared 
to HDL-C, clearly a more favourable outcome. Figure 1.7 summarises the 
predicted effects of the 3 diets on plasma T A G  and HDL-C.
Figure 1.7: The predicted effects of 3 dietary therapeutic approaches (Step 1: 30% fat, Step 
2: 20% fat and the Mediterranean diet: 38% fat) on plasma TAG and HDL-C compared to a 
typical Northern European intake: 38% fat.
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1.5.2 Long chain n-3 P U F A  and CHD.
The potential benefits on reducing C H D  risk by dietary n-3 PUFA, in particular 
E P A  and D H A  from fish oils was first identified by Dyberg (1975). Since then 
these effects have been studied more closely.
1.5.3 Epidemiological studies on long chain n-3 PUFA.
Epidemiological studies have shown that men who eat at least some oily fish 
have a lower incidence of C H D  mortality than those who eat none (Kris-Etherton 
et al 2002). Kromhout and co workers (1985) examined fish consumption and 20- 
year mortality from C H D  and found that as little as 35g of oily fish per day could 
reduce C H D  mortality by 50%. Holob (1988) examined the intakes of E P A  in Inuit 
Indians living in Greenland and found they averaged 4g per day; this compared 
to 0.1g per day in the U K  population at around that time (DOH 1991); there were 
striking differences between the incidence of C H D  between the Inuit and western 
society (Leaf & Weber 1988). More recently, the 30-year follow up of the Chicago 
Western Electric Study reported favourable effects of fish consumption on C H D  
mortality (Davilglus et al 1997). In 1999, Zhang and co-workers reported that fish 
consumption, across 36 countries, was associated with a reduction in C H D  risk. 
Such epidemiological evidence has led to studies examining the effects of 
consuming fish or fish oil in both primary and secondary prevention of CHD. The 
GISSI Prevenzione Study (1999) is the largest prospective intervention study to 
date examining the effects of fish oil supplementation on secondary prevention of 
CHD; there was a 2 0 %  reduction in all cause-mortality after 3.5 years of 850mg 
of EPA and D H A  per day. Previously, Singh and co-workers (1997) 
supplemented suspected Ml patients with 1.8g of EP A  and D H A  per day and 
compared them to placebo; after 1 year there was a significant decrease in 
cardiac events in the fish oil group (p<0.01). While these studies have shown 
many favourable effects on reducing C H D  risk, other studies looked more 
specifically at the mechanisms behind these effects.
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1 .5 .4 E ffe c ts  o f  d ie ta ry  f is h  o il o n  p la s m a  T A G
O n e  o f the  m ost potent e ffec ts  of fish oils is the ir ability to d e c re a s e  both fasting  
an d  postprand ia l T A G  leve ls  (H arris  &  C o n n o r 1 9 8 0 , H arris  e t a l 1 9 8 4 , D e m a c k e r  
e t a l  1 9 9 1 ). A s  little as  3g  (1 %  of e n e rg y ) can  red uce  T A G  by as  m uch  a s  3 0 %  
(H a rris  1 9 9 7 ). S uch  a  d e c re a s e  m ay  b e  asso c ia ted  w ith a  reduction in C H D  risk  
(H o k an s o n  and A ustin  1 9 9 6 ). T h e  m ech an ism s  beh ind  th e  
h ypotriacy lg lycero laem ic  properties  o f fish oils a re  m ultifactorial. O n e  o f the  m ain  
T A G  carrying lipoproteins is V L D L . D ie ts  enrich ed  w ith n -3  P U F A  a re  a sso c ia ted  
w ith  d e c re a s e s  in th e  ra te  o f V L D L  syn thesis  in th e  liver (N e s te l e t a l 1 9 8 4 ), 
possib ly  d u e  to d iversion o f fatty ac ids  fo r phospholip id  form ation . T h e  ra te  o f 
V L D L  flux from  th e  liver is fu rth er su p p ressed  by g re a te r in takes  o f n -3  P U F A  in a  
d o se  d e p e n d a n t m a n n e r (N e s te l e t  a l 1 9 8 4 , S im o ns  e t a l 1 9 8 5 ). F ish oils h av e  
b e e n  assoc ia ted  w ith  a  reduction  in p la sm a  fre e  fa tty  acids (S in g e r 1 9 9 2 ), an d  
s m a lle r V L D L  partic les. S m a lle r  V L D L  m a y  a lso  b e  d u e  to the  dow n regulation  o f  
ace ty l C o A  carb o xy lase  (S cho o n jan s  e t a l 1 9 9 6 ), resulting in d e c re a s e d  
lipogenesis , and  co n seq u en tly  low er leve ls  o f fre e  fa tty  acids  for V L D L  form ation . 
T h e  h yp ertriacy lg lycero laem ic  s ta te  induced  by a  high c arb o h yd ra te  d ie t can  b e  
reversed  by d ie ta ry  n -3  P U F A , prim arily  through its e ffec t on th e  acety l C o A  
carb o xy la se  e n zy m e  (H arris  e t a l 1 9 8 4 ). A b b e y  e t a l (1 9 9 0 ) reported  a  s ignificant 
fa ll in V L D L  w h e n  3 .8 g  o f fish oil w e re  co n su m ed  p er day . H o w ev er, a  s trong  
correla tion  (r  =  -0 .8 4 )  b e tw e en  fall in V L D L  cho lestero l an d  in c rea se  in L D L -C  
w a s  found.
1 .5 .5  E f fe c ts  o f f is h  o ils  o n  l ip o p ro te in s  a n d  lip o p ro te in  h e te ro g e n e ity .
T h e  results  o f stud ies  exam in in g  th e  e ffec ts  o f fish and fish oils on lipoproteins  
h a v e  b ee n  equ ivo ca l. S ign ifican t d e c re a s e s  (Illingw orth e t a l 1 9 8 4 ) and  
s ignificant in creases  (S u llivan  e t a l  1 9 8 5 , A b b e y  e t  a l 1 9 9 0 , H arris  1 9 9 7 ) in L D L -  
C  h a v e  b een  m eas u red  on increasing  in takes  o f E P A  and  D H A . T h e  e ffec ts  on  
H D L -C  a re  g en e ra lly  m in im al. A  m e ta -a n a lys is  conducted  by H arris  (1 9 9 6 )  
s h o w e d  a 3 %  in c rease  in H D L -C  in norm o lip id aem ic  sub jects  but little or no
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c h a n g e  in tho se  w ith ra ised  triacylg lycero i (> 2 .0 m m o l/l) . A n y  reduction in T C  
w ithout a  d e c re a s e  in H D L -C  w ould im prove  th e  H D L .T C  ratio; a n y  rise in L D L -C  
o r T C  could b e  considered  u n favo u rab le  in term s  o f reducing C H D  risk. S o m e  o f 
th e  su g g ested  reaso ns  for d iffe rences  observed  in L D L -C  a re  differing d o ses  o f  
fish  oils and  length  o f in tervention  (R ystan  &  D revon  1 9 8 9 , G o h  e t  a l 1 9 9 7 ). T h e  
e ffec ts  o f long chain  n -3  P U F A  on lipoprotein h e te ro g e n e ity  h av e  a lso  b ee n  
inves tiga ted , in particu lar th a t o f LD L and  H D L.
In c reased  in takes  o f n -3  fa tty  acids a ffec t cho lestero l e s te r  tran s fe r protein  
(C E T P ) activity. A b b e y  a n d  co-w o rkers  (1 9 9 0 )  reported  a  2 3 %  reduction  in 
C E T P  activity  on a  fish oil d ie t. S ince  C E T P  fac ilita tes  th e  e x c h a n g e  o f C E  for 
T A G  in lipoproteins, a  reduction  in activity should m an ifes t itse lf in a  n u m b er o f  
w ays: not on ly  L D L  but a lso  V L D L  and  H D L  w ould  b e  a ffec ted . T h e re  is n o w  
good e v id e n ce  tha t in th e  p re se n c e  o f m o d era te  h yp erch o leste ro lem ia  
(p red o m in an tly  ra ised  L D L  cho lestero l), LD L  partic le  s ize  is a ffected  by th e  
hypo triacy lg lycero laem ic  properties  (fasting and  postp ran d ia l) o f fish oil, ra th er 
th an  th e  long chain  P U F A  th e m se lves  (G riffin  &  Z a m p e la s  1995)1 D ecreas in g  
fasting  T A G  b e lo w  1 .5  m m o l/l m ay  b e  asso c ia ted  w ith a  reduction  in th e  n u m b er  
o f sm all, d en se  L D L  partic les  in th e  circulation (G riffin  1 9 9 4 , Griffin 2 0 0 1 ), 
fac ilita ted  by a  c h a n g es  in neutra l lipid e x c h a n g e  (F ig ure  1 .3 ).
T h e  b en e fit tha t fish oils cou ld  con fer to  th o se  w ith  m o d e ra te ly  ra ised  T A G  but 
not overt h yp ertriacy lg lycero laem ia  is a  reduction in th e  n u m b e r o f potentially  
a th e ro g e n ic  partic les  in th e  circulation. P rospective  tria ls  h a v e  show n tha t sm all 
L D L  partic les  a re  strong predictors o f fu ture  coronary  eve n ts , s im ilar to th a t o f 
h ypertension  an d  sm oking  (S ta m p fe r e t a l 1 9 9 6 , G a rd n e r e t a l 1 9 9 6 ). D esp ite  a  
possib le  in c rease  in L D L -C , th e re  is e v id e n c e  th a t la rg er L D L  (L D L -2 ) is m ore  
p re feren tia lly  c lea re d  from  circulation com pared  to s m alle r, d e n s e  L D L  thus  
reducing  th e  tim e  fra m e  in w h ich  neutra l lipid e xc h a n g e  can  ta k e  p lace  (A b b ey  e t 
a l 1 9 9 0 ). T h e  hypotriacy lg lycero laem ic  a ffec ts  o f fish oils and  assoc ia ted  e ffects  
on C E T P  in th e  tran s fe r o f cho lestero l es ters  from  H D L  to L D L  an d  V L D L , m a y
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exp la in  w h y  in c reases  in th e  H D L 2:H D L 3 sub fraction ratios a re  often o b served  
(A b b e y  e t a l 1 9 9 0 ). It is likely that H D L 2 re ta ins  its fre e  cho lestero l and  C E  and  
con seq u ently  rem ains  re la tive ly  large. T h is  e ffec t m ay  be fu rth er a cc en tu a ted  by  
th e  reduction in C E  a cc ep to r partic les, such V L D L  and  possib ly  LD L  in th e  
circulation.
1 .6  F is h  o ils  a n d  d ie t-g e n e  in te ra c t io n
M o re  recently , th e  e ffec ts  o f fish oils on a  g en e tic  level h av e  b e e n  investigated . 
K han  e t a t  (2 0 0 2 )  s h o w e d  th a t th e  a ttenuation  o f postprand ia l T ip aem ia  w a s  
assoc ia ted  w ith m a rke d  in c reases  in th e  concentration  o f lipoprotein  lipase  (L P L )  
m R N A  in ad ipo se  tissue. T h is  is a d irect e x a m p le  o f fish oils w orking  a t a  g en e tic  
leve l, o r so -ca lled  d ie t-g e n e  in teraction . M in ih an e  and  co -w o rkers  (2 0 0 0 )  s h o w ed  
th a t resp o n ses  to  fish oils d iffe r d ep en d in g  on an  ind iv idual’s apo lipoprotein  E  
po lym orph ism . In ind iv iduals carrying th e  A p o E 4  g en o typ e , cho lestero l levels  
ten d ed  to in crease , an d  h igh -density  lipoprotein cho lestero l (H D L -C ) d e c re a s e  
w h e n  s u p p lem en ted  w ith  E P A  and D H A . O n ly  n o w  is m o re  e v id e n c e  com ing to  
light on th e  e ffec ts  o f fish oils on lipids a n d  lipoproteins. D ie t-g e n e  in teraction  is 
c learly  an  a re a  tha t w a rra n ts  furth er research  but is outs ide  th e  scope o f this  
review .
1 .7  E ffe c ts  o f  f is h  o ils  Qn h a e m o s ta s is  a n d  v a s c u la r  fu n c t io n
Im p ro vem en ts  in C H D  risk a re  not lim ited to lipids and  lipoproteins. Long chain  
n -3  P U F A  a re  th e  precursors  to m etab o lica lly  active  e ico san o id s . E icosanoids  
a re  involved in m ultip le  physio logical p ro cesses , on th e  v as cu la r w a ll regulating  
en d o th e lia l function a n d  in p la te le ts , a ffecting  h aem o stas is  (T h iem e rm a n n  1 9 9 3 ). 
E icosanoids, particu larly  th o s e  derived  from  w estern  typ e  d iets  a re  form ed from  
A rac h ad o n ic  A cid  (A A ) m etab o lica lly  e lo n g a ted  from  d ie ta ry  LA. E icosanoids can  
a lso  b e  syn thes ised  from  th e  n -3  P U F A  E ico s ap en tae n o ic  acid  (E P A ) (F isc h er  
1 9 9 3 ). D yerb erg  (1 9 7 8 )  sug g ested  th a t s o m e  o f th e  an ti-a th ero g e n ic  properties  
o f n -3  P U F A  m ight be d u e  to the ir invo lvem en t in e icosano id  production. F ig u re
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1.8  illustrates the  c lassica l o m e g a -3  an d  o m e g a -6  fa tty  acid  synthesis  p a th w a ys  
and  th e  ro le o f o m e g a -3  fa tty  acid in regulating  h ea lth /d ise a se  m arkers .
Figure 1.8: Classical omega-3 and omega-6 fatty acid synthesis pathways and the role of 
omega-3 fatty acid in regulating health/disease markers.
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T h e  U K  d iet, like m uch o f th e  W e s te rn is e d  w orld , has a  g re a te r in take  o f n -6  
P U F A  than n -3  P U F A . C o nsequ en tly , m e tab o lic  conversion o f LA results  in a  
high leve l o f A A  present in p lasm a  lipids. In populations w ith a  high n -3  P U F A  
in take  such as  th e  Inuit, less  A A  is p resen t in p lasm a lipids than  th o se  w ith  a  
m o re  W e s te rn ise d  d ie t such as  th e  D a n e s  (T a b le  1 .4 ). G re a te r  leve ls  o f E P A  
in c rea se  com petition  b e tw e en  A A  fo r incorporation into cell m e m b ra n e s  and  
s u b s eq u e n t convers ion into e icosano ids .
Table 1.4: Percentage of fatty acids in lipid fractions of Inuit and Danes (adapted from
Salen e t a l 1999)
AA (20:4) EPA (20:5)
P.L. C.E. TAG P.L C.E. TAG
8.0 4.4 0.0 0.2 0.0 0.0
0.8 0.0 0.0 7.1 15.4 4.0
P .L .=  Phospholipids C .E . = C h o les tero l Esters  T A G =  Triacylg lycero l
E xam in atio n  o f th e  Inuit population  sho w ed  a  low  inc idence  o f m yo card ia l 
in farction and  a  pro longed b leed ing  tim e  (G oo dn ig h t 1 9 8 1 ). P las m a  lipids o f  th e  
Inuit w e re  found to contain  sm all a m o u n ts  o f A A  but high levels  o f E P A  d u e  to  
high in takes o f n -3  P U F A  in the  d ie t (G o o d n ig h t 1 9 8 2 ). A  shift in h ae m o sta s is  
to w ard s  im proved  e n d o th e lia l function an d  a  less p ro -in flam m ato ry  s ta te  is 
th e re fo re  m ed ia ted  through th e  fo rm atio n  o f e icosano ids  o f n -3  P U F A  origin  
(G o o d fe llo w  2 0 0 0 ) . T a b le  1 .5  s u m m arise s  th e  e ffects  o f A A  and  E P A  on the  
fo rm ation  o f prostag land ins and  leukotrienes  and  the ir e ffects  on haem o stas is .
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Table 1.5: Effect of the fatty acids AA and EPA on prostaglandin and leukotriene 
production and their subsequent effects on haemostasis.
Fatty Acid Prostaglandins Effect
AA t x a 2 TXA2 strong platelet aggregator and vasoconstrictor 
more procoaguable state
EPA t x a 2 I TXA gf TXA3 physiologically inactive, competes with TXA2 
reducing effects results in less thrombotic state
AA PGI2T PGI2 Involved in endothelial function promoting 
vasodilatory state.
EPA PGI3 T PGI3 complements the actions of PGI2 promoting a 
more vasodilatory state.
Leukotrienes
AA b4 B4 strong chemoattractor of monocytes & 
leukocytes. Pro-inflammatory.
EPA b4 1 B5 T EPA competes with 5-lipoxygenase enzyme for 
formation of B4. Small amounts of B5 compete with 
B4 for receptors. Improvement in many anti­
inflammatory effects.
T h e  P R IM E  study (S carab in  e t a l 1 9 9 8 ) sho w ed  tha t fib rinogen , fac to r V II and  
P A I-1  e xp la in ed  8 % , 9 %  and  2 6 %  o f th e  total va ria n ce  in card io vascu la r risk  
fac to rs  respective ly . F a t rich d iets  a re  a cco m p an ied  by g re a te r h yp erco ag u lab le  
s ta tes  an d  th e s e  s ee m  to b e  m e d ia ted  m o re  by longer chain  sa tu ra ted  fa ts  (M ille r  
e t a l 1 9 9 7 ). P las m a  fac to r V II activity  (facto r V ile )  is con s id ered  one  o f the  
in d ep e n d en t risk factors  fo r coron ary  a rte ry  d is ea se  and  is controlled by both  
g e n e tic  and  env iro n m en ta l factors  (S a h a  e t a l 1 9 9 4 ). F ac to r V II activity  increases  
w ith body m ass  index, trig lycerides, H D L  an d  L D L-cho les tero l (S carab in  P  e t a l 
1 9 9 8 ). N e lso n  e t a l (1 9 9 7 b ) sh o w ed  no o b servab le  c h a n g es  in b lood coagulation  
a n d  throm botic  ten d en c ie s  w h e n  a rac h ad o n ic  acid  (A A ) w a s  in creased  to 1 .5g  
p e r d a y  a b o v e  norm al in take, nor w e re  an y  statistical ch a n g es  in blood  
coag u latio n  m eas u red  follow ing th e  addition  o f 6g  o f D H A  a  d a y  for 9 0  d ays  to a  
typ ical w estern ised  d ie t (N e lso n  e t a l 1 9 9 7 a ). Long chain  n -3  P U F A  m ay  be  
a sso c ia ted  w ith  im paired  fibrinolysis  m ed ia ted  through an  in c rea se  in PA I-1  
leve ls  (M a h rab ia n  e t a l  1 9 9 0 , B oberg  e t a l 1 9 9 2 ). S p a n n a g l e t a l (1 9 9 1 )
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investigated  fish oil su p p lem enta tio n  in typ e  I d iabetics  and  h ea lth y  controls, 
observing  s ignificant in c reases  in P A I-1  in both groups. In contrast to  this, M eh ta  
e t a l (1 9 9 8 ) s u p p lem en ted  post M l patien ts  and hea lth y  vo lu n tee rs  w ith n -3  
P U F A  and m eas u red  a  2 1 %  and 2 2 %  d e c re a s e  in PA I-1  leve ls  respectively . 
W h ile  m an y  studies s h o w  h aem o stas is  is responsive  to c h a n g es  in th e  
com position o f d ie ta ry  fa ts , a  la rge  n u m b er o f th e  d iets  p rescrib ed  a re  not 
ap p ro p ria te  fo r long-term  g en e ra l d ie ta ry  advice. T a b le  1 .6  s u m m aries  the  
function o f F ac to r V II, PA I-1  an d  F ibrinogen and  the ir roles in C H D  risk.
Table 1.6: Function and role in CHD risk of Factor VII, PAI-1 and Fibrinogen.
Function Effects
Factor VII Protein involved in coagulation & 
clot formation
f  in activity associated with greater 
procoaguable state and increased CHD risk
PAI-1 Regulates the fibronlytic system 
involved in clot formation
t  levels correlated with development of 
thrombotic disease
Fibrinogen Soluble protein from which 
insoluble fibrin clot is formed
t  concentrations associated with increased 
risk of CHD and stroke.
1 .8  D ie ta ry  s o u r c e s  o f  lo n g  c h a in  n -3  P U F A  in  th e  U K  d ie t
In th e  U K , in takes  o f cod an d  can n ed  tu n a  a re  g re a te r than  o ily fish such as  
m ack ere l and  herring. A s  T a b le  1 .7  illustrates, th e  m etab o lica lly  a c tive  long chain  
n -3  P U F A s  E P A  an d  D H A  a re  m uch lo w er in cod an d  tinned  tu n a  than  o ther oily  
fish.
Table 1.7: Fatty acid compositions of fish per 100g commonly consumed in the UK diet.
FISH Total fat (g) EPA (20:5) (g) DHA (22:6) (g)
Cod 0.67 0.10 0.20
Herring 9.04 0.70 0.90
Salmon -  farmed 7.67 0.39 0.82
Tuna -  canned brine 0.50 0.04 0.07
Mackerel 13.87 0.90 1.40
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W h e re  fish oils m a y  be h ave  a  role is in th o se  individuals w h o  a re  not con s id ered  
a t risk o f C H D  a fte r routine health  screen in g . W h ile  an individual m a y  h a v e  to ta l 
cholestero l level b e low  6 .5m m o l/l th e y  m a y  a lso  h ave  m o d era te ly  ra ised  T A G  
(> 2 .3 m m o l/l) . T h e s e  va lu es  m ay  not e x c e e d  th e  action points se t by m a n y  
hospita ls  and  G P s , and  so w ou ld  not trigger in tervention. T h e  
hypotriacy lg lycero laem ic  e ffects  o f fish oils d raw s  attention  to  th e  ro le  lo w er  
circulating levels  o f T A G  m a y  h ave  on structura l ch an g es  o f L D L  and  H D L . 
T h e s e  ind iv iduals w h o  m a y  not be identified  as  “a t risk” by health  screen ing , m a y  
p o ssess  an  A L P . N o w  th a t th e  benefic ia l e ffec ts  o f e ve n  m ild in takes  o f E P A  and  
D H A  a re  know n, it ra ises  th e  question  o f w h e th e r an  in crease  in in take o f th e s e , 
throqgh consum ption  o f oily fish is fea s ib le . E ven  if the  cost, and  palatab ility  
issues could b e  ad d ressed , it ra ises co n cern s  o v e r th e  sustainab ility  o f o ily  fish  
(Institu te  o f B io logy 2 0 0 3 )  w e re  th e  population  o f th e  U K  sud d en ly  to  in c rea se  
th e ir in take . A lp h a-lin o len ic  acid  (A L A ) th e  sh o rte r chain  (1 8 :3 n -3 ) p rogen ito r o f  
E P A  and  D H A  as  a  d ie ta ry  p recursor m a y  provide  a  su itab le  d ie ta ry  a lte rn ative  to  
oily fish.
1 .9  S h o r t  c h a in  n -3  P U F A  a n d  C H D .
A L A  is p resen t in sm all quantities  in th e  hab itu a l d ie t o f m ost w estern  countries  
an d  is found  in m ost p lant based  foods including s o y a b e a n  oil (3 % ), and  
ra p e s e e d  oil (9 % ). B y fa r  th e  h ighest con cen tra tio n s  a re  found in flax se e d  oil (5 0 -  
6 0 % ). A L A  can  un d erg o  d esatura tion  an d  e long atio n  though th e  s a m e  m etab o lic  
p a th w a y  as  linolenic acid  (L A  18:2  n -6 ), an d  in d eed  shares  so m e  of the  s a m e  
e n z y m e s  as  this p a th w ay  (G ers te r 1 9 8 8 ) (F ig u re  1 .9 ) If the  in take o f A L A  could  
b e  in c rea se d , in th e  a b s e n c e  o f E P A  and  D H A  in th e  diet, could a d e q u a te  
con vers io n  o f A L A  to  its lo n g er chain  fa tty  ac id s  s h o w  s im ila r e ffec ts  to fish oil 
sup p lem en ta tio n  w ithout th e  need  fo r long chain  P U F A  consum ption?  If this w e re  
possib le , it w ould  not only b en efit th e  c o n s u m er w h o  did not like fish, but a lso  put 
less  s tra in  on a  po tentia lly  n o n -su sta in ab le  reso u rce .
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T h e  convers ion  o f A L A  to E P A  and possibly D H A  is d e p e n d e n t on a  n u m b e r o f  
factors . C u n n a n e  and  co w orkers  (1 9 9 1 )  sug g ested  th a t a  la rg e  proportion o f  
A L A  u n d erg o es  beta -o x id atio n  w h ile  m ore  recen t findings sug g est th e  e x te n t to  
w hich  A L A  is oxidised is not as  g re a t as  previously  thought (B u rg e  2 0 0 4 ) . In  
v e g a n s , w h o  con su m e no long cha in  n -3  P U F A , E P A  and D H A  a re  found in 
p la sm a  lipids convincing e v id e n c e  th a t not all A L A  u n d erg o es  B -oxidation . 
H o w ev er, th e re  is still concern  that in takes  o f A L A  in veg an s  is low, c o m p a re d  to  
LA (D a v is  &  K ris -E therton  2 0 0 3 )  d u e  to  th e  g en era lly  low  fa t in take o f this group.
H o lm an  and  co -w o rkers  (1 9 8 2 )  fed  A L A  to sub jects  w ith  low  leve ls  o f E P A  and  
D H A  in th e ir p lasm a  phospholip ids; in c reases  in E P A  and  D H A  w e re  o b served . 
O th e r factors , such as  th e  a b u n d an c e  o f E P A  and D H A  a lre a d y  in cell 
m e m b ra n e s , and  the am o u n t o f n -6  P U F A  in the  d iet m a y  a lso  a ffec t th e  
convers ion  o f A L A  to E P A  an d  D H A . T h e  la tte r is o f so m e  im p o rtan ce  as  both 18  
c arb o n  n -3  and  n -6  fa tty  acids u se  th e  s a m e  d es a tu ra se  e n z y m e  b efo re  
e lo ng atio n  to 2 0  carbons. F igure  1 .9  outlines the  m etab o lic  p ath w ays  o f A L A  and  
LA to th e ir longer chain  m etab o lites .
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Figure 1.9: Metabolic pathways of the conversion of iinoleic acid and alpha iinoienic acid
to their respective longer chain PUFA.
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T h e  d ie ta ry  n -6 :n -3  ratio  in s im p le  te rm s  d escrib es  th e  ratio o f LA  and  A A  to  
A L A , E P A  and  D H A  con su m ed . T h e  tw o  p aren t fatty  ac ids  LA an d  A L A  a re  
essen tia l fa tty  acids  in the  d iet. T h e  ratio o f n -6  P U F A  to n -3  P U F A  is in the  order  
o f 10:1 in th e  U K . T e n  tim es  th e  a m o u n t o f LA  to A L A  in the  d ie t m a y  reduce  the
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am o u n t o f A L A  e ffec tive ly  converted  to E P A . Try ing  to c o n su m e a  d ie t low  in n -6  
P U F A  and  high in n -3  P U F A  is not as  stra ightforw ard  as  it s e e m s . T a b le  1 .8  
outlines som e o f th e  oils ava ila b le  in the  U K . F la x  oil is inc luded in th e  tab le  to  
illustrate its high A L A  con ten t co m p ared  to o th er oils.
Table 1.8: Fatty acid composition of oils detailing P/S ratio and n-6:n-3 ratio.
Oil
18:0%
Stearic
18:1 % 
Oleic
18:2 % 
Linoleic
18:3%
a-iinolenic
P/S
ratio
n-6: n-3 
ratio
Canola 1.8 56.1 20.3 9.30 4.2:1 2.2:1
Rapeseed 1.6 53.8 22.1 11.1 4.9:1 2:1
Sunflower 4.5 19.5 65.7 0.0 6.4:1 No n-3
Olive 2.2 72.5 7.9 0.6 0.6:1 13:1
Corn 1.8 24.2 58.0 0.0 4.6:1 No n-3
Flax - 31.0 14.8 56.0 11:1 0.3:1
Butter 9.83 20.4 1.8 1.2 0.1:1 1.5:1
S e v e ra l ap p ro a ch e s  h a v e  b ee n  used to e x a m in e  w h a t a ffec ts  th e  convers ion  o f  
A L A  to its lo n g er cha in  m etab o lites . Firstly, increasing  th e  in take  o f A L A  a lo ne , 
w ith little c h a n g e  in o th e r d ie ta ry  factors; this w ould  e ffec tive ly  b eg in  to low er th e  
n 6:n 3  ratio  and  pro vide  m o re  A L A  for th e  A 6 -d e s a tu ra s e  e n z y m e  to  con vert  
(B o u d reau  e t a l 1 9 9 2 ). S eco n d ly , to  not on ly  in c rease  A L A  consum ption , but to  
d e c re a s e  LA  in take. T h is  w ou ld  e ffec tive ly  low er th e  d ie tary  n -6 :n -3  ratio to 1:1 o r  
b elow , reducing com petition  b y  18:2  n -6  for th e  A 6 -d e s a tu ra s e  e n z y m e  (A llm an  
e t  a l 1 9 9 5 ).
T a b le  1 .9  lists s o m e  o f th e  stud ies  conducted  using A L A  in th e  last tw o d ec ad e s . 
O u tco m es , if m e as u red , inc lude  e ffec ts  on lipids and  significant c h an g es  in E P A  
a n d /o r D H A . T h e  g en d e r, hea lth  and  n u m b ers  o f vo lun teers , d o se s  o f A L A  and  
duration  o f th e  s tud ies  v a ry  w ide ly , as  d o es  the  source  o f A L A  sup p lem enta tio n  
and  m eth o d s  o f d e te rm in in g  increases  in E P A  and  D H A . E ffects  on lipoproteins  
and  T A G  a re  eq u ivo ca l, w ith  a  g re a te r n u m b er o f s tudies show ing  no e ffect. A  
la rg er n u m b er o f s tud ies  m e as u re  s ignificant in c reases  in E P A  following  
in tervention; n o n e  listed  s h o w  a  s ignificant e ffec t on D H A .
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T o  d e te rm in e  if A L A  w a s  as  e ffec tive  as  E P A  o r D H A  a t low ering lipids flaxseed  
oil w a s  fed  a t 3 5m g /k g  p e r d ay  for 12  w e e k s  (L a y n e  e t a l 1 9 9 6 ). N o  e ffec ts  on  
lipids w e re  m easu red  in th e  A LA  subjects . For the  a v e ra g e  7 0kg  m a le , that 
rep resen ted  an in take o f 2 .4 g  o f A L A  p er day . S upp lem en tin g  w ith 3 .3 g  o f A L A  
p e r d a y  fo r 3  y ea rs  w a s  assoc ia ted  w ith s o m e  anti-th rom botic  e ffec ts  and  a  
s ignificant in crease  in E P A  in p lasm a lipids an d  p la te le ts  (R e n a u d  e t a l 1 9 8 6 ). 
In c rea se s  in d ie tary  E P A , e ve n  w hen  very  sm all, w e re  con s id ered  significant in 
th e  con tex t o f throm bosis  (R e n au d  & N o rd a y  1 9 8 3 ). U sing ra p e s e e d  oil as  a  
m o d e  o f delivery , 5 .9g  p e r d a y  o f A L A  s u p p le m e n te d  for 6  w e e k s  w a s  assoc ia ted  
w ith  a  non significant d e c re a s e  in E P A  a n d  D H A  (0 .4 %  and  0 .1 %  total fa tty  acids  
resp ective ly ) in cho lestero l esters  (V a ls ta  &  Jau h ia in en  1 9 9 5 ). T h e  n -6 :n -3  ratio  
o f the  d ie t w a s  3 :1 , and  d esp ite  an in c rease  in A L A  intake, th e  d ie t still con tained  
m o re  LA  than  A L A , prim arily  as  th e  m ain  sou rce  o f A L A  w a s  ra p e s e e d  oil. T h e  
fa ll in E P A  and  D H A  c o m p ared  to b as e lin e  w a s  m uch less th an  th a t observed  on  
the  high LA  diet, w h ich  w a s  run in p aralle l. T h is  m ay  sug g est tha t som e, lim ited  
e long atio n  o f A L A  is still tak ing  p lace . W h e n  th e  n-6: n -3  ratio  w a s  low ered  to  
0 .3:1  and  sub jects  w e re  sup p lem en ted  w ith 7 .4 g  o f A L A  p e r d a y  for 4  w e ek s , 
s ignificant in c reases  in A L A , E P A  and  D P / \  w e re  observed  (F re e s e  & M u tan en  
1 9 9 7 ). Increasing  th e  in take  o f A LA  to 9g p er d ay  in m ildly h yp erch o les te ro laem ic  
m en  w a s  assoc ia ted  w ith s ignificant in c reases  in E P A  in p la sm a  fatty  acids  
(A b b e y  e t a l 1 9 9 0 ). T h e  n -6 :n -3  ratio w a s  s im ila r to tha t o f F re e s e  & M u tan en  
(1 9 9 7 )  a t 0 .5 :1 . Increasing  th e  in take  o f A L A  from  7 .4g  to 9g  p er day , and  
m ain ta in in g  a  s im ilar n -6 :n -3  ratio did not a lte r th e  o u tcom e significantly, d esp ite  
sev era l d iffe ren ces  in s tudy  design.
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A d a m  a n d  c o -w o rk ers  (1 9 8 6 )  c o m p a re d  th e  e ffe c ts  o f in c reas in g  e n e rg y  fro m  
f la x s e e d  oil w h ils t k ee p in g  e n e rg y  fro m  L A  c o n s ta n t a t 4 % . T h e  s tu d y  to o k  
p art in a  m e ta b o lic  k itchen; all o th e r long c h a in  n -3  fa tty  ac id s  (E P A , D P A  an d  
D H A ) w e re  e xc lu d ed  fro m  th e  d ie t. O n ly  th e  1 6 %  e n e rg y  fro m  A L A  d ie t  
c a u s e d  a  s ig n ifican t in c re a s e  in p la te le t lipid A L A ; th is  w a s  a c h ie v e d  th rou g h  
3 8 .8g  o f A L A  p e r d a y  fo r  2  w e e k s . In ta k e s  o f th is  m a g n itu d e  w o u ld  no t b e  
fe a s ib le  in a  free -liv in g  p o p u la tio n .
A n  e ffe c t on  p la te le t a g g re g a tio n  to  A D P  an d  th rom bin  a fte r  6  w e e k s  w a s  
o b s e rv e d  b y  F re e s e  a t a l  (1 9 9 4 )  w h e n  c o m p a rin g  an  n -6 :n -3  ra tio  o f  2 8 :1  
(h igh  su n flo w e r o il) to  2 .8 :1  (h igh  ra p e s e e d  oil) th e  la tte r co n ta in in g  6 .8 g  o f  
A L A . H a e m o s ta tic  c h a n g e s  s im ila r to  th o s e  o f A d a m s  an d  c o -w o rk e rs  (1 9 8 6 )  
w e re  s e e n . F re e s e  an d  c o -w o rk e rs  a lso  rep o rted  a  d e c re a s e  in D H A  a n d  
E P A , th e  la tte r o f w h ic h  w a s  s ign ificant. T h e  d e c re a s e  in lo n g e r c h a in  n -3  fa tty  
ac id s  sup p o rts  th e  h yp o th es is  th a t LA  c o m p e te s  fo r e lo n g a tio n  w ith  A L A  an d  
a s  such  a  n -6 :n -3  ra tio  o f 2 .8 :1  m a y  no t b e  suffic ien tly  low  e n o u g h  to  in c re a s e  
co n vers io n  o f A L A  to  long ch a in  n -3  P U F A . In a n o th e r 6  w e e k s  s tu d y  (A llm a n -  
F arin e lli e t a l  (1 9 9 9 )  no  c h a n g e s  in a n y  h a e m o s ta tic  fa c to rs  w e re  s e e n  
fo llo w in g  1 1 .6g  o f A L A  p e r  d a y  (n 6 :n 3  ra tio  0 .8 :1 )  d es p ite  a  s ig n ifican t rise  in 
p la te le t E P A . S im ila r fin d in gs  w e re  a lso  rep orted  by Li e t  a l  (1 9 9 9 )  in 
v e g e ta r ia n  m e n . F in n e g a n  e t a l  (2 0 0 3 a )  fo u n d  no Im p ro v e m e n t in blood  
co a g u la tio n  o r fib rin o ly tic  fac to rs  a fte r  6  m o n th s  on 4 .5 g  o r 9 .5 g  o f A L A  p e r  
d ay , n e ith e r w e re  th e re  a n y  e ffe c ts  on  lip ids an d  lipopro te ins . Both d o se s  
w e re  a s s o c ia te d  w ith  s ig n ifican t in c re a s e s  in E P A  in p la te le t pho sp h o lip id s .
M a n tz io ris  e t a l  (1 9 9 4 )  c o m p a re d  n -6 :n -3  ra tios  o f 18:1 to  0 .6 :1 , an  8 -fo ld  
in c re a s e  in A L A  a n d  a  2 .5 -fo ld  in c re a s e  in E P A  in p la s m a  lipid frac tio n s  w a s  
re p o rte d  a fte r  4  w e e k s  on th e  d ie t b u t no  c h a n g e s  in lipopro te in  o r T A G  leve ls . 
T h e  incorporation  o f A L A  into p la s m a  lip ids s e e m e d  to  b e  a t th e  e x p e n s e  o f 
L A  a s  w e ll a s  o le ic  ac id  un like  A d a m s  e t  a l  (1 9 9 0 )  w h o  o b se rve d  
d is p la c e m e n t o f o le ic  ac id  only. F u rth e r  a n a ly s is  o f th e  d a ta  fo u n d  a  lin e ar  
re la tio n sh ip  b e tw e e n  A L A  in ta k e  (in  th e  p re s e n c e  o f a  re d u c ed  L A  d ie t) and  
E P A  c o n cen tra tio n s  in th e  p h o sp h o lip id s  o f p la s m a  (r= 0 .8 6 )  a n d  p la te le ts
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(M a n tz io ris  1 9 9 5 ) . T h is  re la tio n sh ip  m a y  w e ll fa c ilita te  p rac tica l d ie ta ry  
s tra te g ie s  fo r in c reas in g  E P A  c o n cen tra tio n s  in tissu es .
W h ile  th e re  is go o d  e v id e n c e  th a t th e  e lo n g a tio n  a n d  d e s a tu ra tio n  o f A L A  
ta k e s  p lace , th is  p ro ce ss  is b e liev ed  to  b e  re la tiv e ly  s lo w  (S in g e r  1 9 9 2 ) , an d  
p ro b a b ly  d e p e n d a n t o n  th e  n -6 :n -3  ra tio  (B o u d re a u  e t  a l  1 9 9 2 ) . A  tw o -w e e k  
in terven tio n  cyc le  m a y  b e  insuffic ien t to  s h o w  s ig n ifican t c h a n g e s , p articu la rly  
if th e  d ie ts  b e fo re  th e  in terven tio n  w e re  h igh in n -6  P U F A . S in g e r &  B e rg e r  
(1 9 8 6 )  fo u n d  th a t w ith  ju s t 2  w e e k s  on a  high A L A  d ie t (3 5 g  A L A  p e r  d a y ), a  
s ig n ifican t rise  in p la s m a  lipid A L A  o ccu rred , b u t no  co rres p o n d in g  in c re a s e  in 
E P A  o r d e c re a s e  in A A . W h e n  2 0 g  o f A L A  w a s  s u p p le m e n te d  fo r  2 3  d a y s  
s ig n ifican t in c re a s e s  in E P A  in p la te le ts  w e re  m e a s u re d , a s  w e ll a s  red u ced  
a g g re g a tio n  to  c o lla g e n  (A llm a n  e t  a l  1 9 9 5 ) . In ta k e s  o f th is  m a g n itu d e  o f 3 5 g  
p e r  d a y  w o u ld  no t b e  fe a s ib le  in th e  long te rm , n e v e rth e le s s  d e c re a s e s  in T C  
a n d  T A G  w e re  o b s e rv e d  su g g estin g  th e  p o ten tia l h y p o c h o le s te ro la e m ic  and  
h y p o tria c y lg ly c e ro la e m ic  e ffec ts  o f A L A  m a y  b e  in d e p e n d e n t o f its fo rm atio n  
o f E P A  (S in g e r 1 9 9 2 ) .
S tu d ie s  w ith  in c re a s e d  len g th  o f in terven tio n  m a y  p ro d u c e  m o re  e v id e n c e  fo r  
th e  ra te  a n d  a m o u n t o f  co n vers io n  o f s h o rte r ch a in  n -3  fa tty  ac id s  to  E P A  and  
D H A . P e rh a p s  th e  b e s t in d icato r o f th is  w a s  th e  3 7y e a r  F re n c h  fa rm e rs  s tu d y  
(R e n a u d  e t  a l  1 9 8 6 ) , w h e re  s ig n ifican t in c re a s e s  in E P A  w e re  m e a s u re d  w ith  
in ta k e s  o f 3 .3 g  p e r  d a y  o f A L A . A  m a jo rity  o f s tu d ies  w ith  s im ila r in tak es  o f 
A L A , b u t s h o rte r d u ra tio n  h a v e  fa ile d  to  o b s e rv e  s ig n ifica n t in c re a s e s  in E P A  
(V a ls ta  e t a l 1 9 9 5 , L a y n e  e t a l 1 9 9 6 , G o h  e t a l 1 9 9 7 , F re e s e  e t a l  1 9 9 7 ). It is 
re a s o n a b le  to  s p e c u la te  th a t th e  e x te n d e d  d u ratio n  o f th is  s tu d y  m a y  h a v e  
a ffe c te d  a d ip o s e  tis s u e  co m po s itip n , w h ich  in tu rn  a ffe c te d  th e  F A  
c o m p o s itio n  o f th e  m e ta b o lic  tra n s p o rt a n d  fu n c tio n a l poo ls. F ig u re  1 .1 0  
illustrates  th e  d y n a m ic  re la tio n sh ip  b e tw e e n  th e  d ie ta ry , tran s p o rt, functiona l 
a n d  s to ra g e  poo ls.
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Figure 1.10: The fatty acid com position o f functional pools can be affected by the 
dynamic relationship between dietary intake and subsequent storage and transport of 
fatty acids
It is im p o rtan t to re c o g n is e  th e  ro le  o f th e  vario u s  m e ta b o lic  poo ls  s h o w n  in 
F ig u re  1 .1 0 . T h e  com po s itio n  o f th e s e  poo ls  is a ffec te d  by d ie ta ry  in takes; 
w h ile  th e  F A  com po s itio n  o f tran s p o rt poo ls  such  as  T A G  a n d  C E  m a y  re flec t 
re c e n t in takes  (Ju d d  e t  a l  1 9 8 9 , M a  e t  a l  1 9 9 5 )  th e y  a re  a lso  likely to b e  
a ffe c te d  by lo n g er-te rm  d ie ta ry  in take  (L a n d s  1 9 9 5 ). W e s te rn  d ie ts  a re  
typ ica lly  h igh  in n -6  P U F A , a n d  th e re  is n o w  e v id e n c e  th a t a d ip o s e  tissu e  is 
strong ly  re la te d  to  lo n g er-te rm  fa tty  ac id  in tak e  (T jo n n e la n d  e t a l  1 9 9 3 ). In 
W e s te rn  pop u la tio n s  as  m u ch  a s  1 0  to  1 5 %  o f a d ip o s e  tiss u e  c a n  c o m p rise  o f 
LA  (W o o d  e t a l  1 9 8 7 ), thu s  a d ip o s e  tiss u e  m a y  b e  providing  a  su p p ly  o f LA  to  
th e  m e ta b o lic  tran s p o rt poo ls  during  d ie ta ry  restriction  o f LA. A  typ ica l 7 0 k g  
m a n  w ith  2 0 %  b o d y  fa t (1 4 k g ) cou ld  b e  carry ing  a s  m u ch  a s  2 k g  o f LA. 
T u rn o v e r o f th e s e  b o d y  s to res  such  a s  LA  m a y  co n tin u e  long a fte r  d ie ta ry  
restric tions  h a v e  b e e n  in s tig a ted . F u n ctio n a l pools such  as  e ry th ro cy tes  or 
p la te le ts  a re  o ften  u se d  a s  a  m e a s u re  o f o u tc o m e  o r d ie ta ry  c o m p lian c e , 
u n fo rtu n ate ly  th e  e ffe c ts  o f a d ip o s e  tiss u e  on th e  F A  com po s itio n  o f th e s e  
pools  is not o ften  co n s id ered .
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A  re ce n t p ro sp e c tiv e  tria l co n c lu d ed  th a t 1 0 -y e a r  risk o f C H D  w a s  not 
a s s o c ia te d  w ith  A L A  in take  (O o m e n  e t a l 2 0 0 1 ) . O th e r c a s e  contro l s tu d ies  
h a v e  a lso  b e e n  in co n c lu s ive  (G u a lla r  e t  a l 1 9 9 9 , P e d e rs e n  e t  a l 2 0 0 0 ) .  A  
n u m b e r o f o th e r s tu d ies  h a v e  s u g g e s te d  th a t A L A  is b e n e fic ia l to  
c a rd io v a s c u la r h ea lth  (H u  e t a l 1 9 9 9 , L o n geril e t a l  1 9 9 9 ). T h e re  h a v e  b e e n  
m a n y  s tu d ies  c o n d u cted  e x a m in in g  d iffe re n t d o se s  o f A L A , fro m  d iffe re n t  
s o u rc e s  a n d  o v e r vary in g  len gth s  o f  t im e  h o w ev e r, th e s e  a re  fa r  less  in 
n u m b e r th a n  th o s e  s tu d ies  e x a m in in g  th e  e ffe c ts  o f fish  oils o r long c h a in  n -3  
P U F A  on c a rd io v a s c u la r h ea lth .
In  m o s t c a s e s  A L A  s u p p le m e n ta tio n  d id  not a lte r  s ig n ifican tly  T C , L D L -C  o r  
T A G . In s o m e  s tu d ies  s ig n ifican t in c re a s e s  in th e  m e ta b o lic  a n d  tra n s p o rt  
po o ls  o f E P A  w a s  m e a s u re d . T h e  n u m b e rs  o f s tud ies  th a t h a v e  rep o rte d  
s ig n ifica n t in c re a s e s  in D H A  a re  v e ry  fe w . D iffe ren t s tu d ies  h a v e  u sed  
d iffe re n t tran s p o rt o r fu n c tio n a l po o ls  to  d e te rm in e  A L A  c o n vers io n  s u ch  a s  
ch o le s te ro l e s te rs , p la te le ts  an d  e ry th ro c y te s . D u ra tio n  o f  in te rven tio n  m a y  
a ffe c t th e  resu lts  d u e  to  co n fo u nd in g  fac to rs  such  a s  a d ip o s e  tiss u e  
com po s itio n ; in p a rtic u la r L A  co n ten t. T h e  g e n d e r  an d  g e n e ra l h e a lth  o f th e  
s u b je c ts  partic ip a tin g  in th e  in te rven tio n  w ill a ls o  a ffe c t th e  resu lts; s ig n ifican t 
c h a n g e s  in lip ids an d  lipopro te ins  a re  less  like ly  to  b e  m e a s u re d  in h e a lth y  
v o lu n te e rs , e v id e n c e  is a lso  e m e rg in g  th a t m a le s  an d  fe m a le s  m e ta b o lis e  
A L A  d iffe re n tly  (B u rg e  2 0 0 4 ) .
It is u n c le a r w h e th e r  A L A  m a y  b e  use fu l in te rm s  o f red uc in g  C H D  risk  in a  
p o p u la tio n  e xp re ss in g  a n  A L P . P rev io u s  s tu d ie s  h a v e  s u g g e s te d  th a t  red uc in g  
th e  n -6 :n -3  ra tio  m a y  im p ro v e  co n v ers io n  o f A L A  to E P A  a n d  D H A , if th is  can  
b e  a c h ie v e d , it is u n c le a r w h e th e r  th e  in c re a s e s  in long ch a in  n -3  P U F A  will 
b e  s u ffic ien t to  m o d ify  C H D  risk in th is  p o p u la tio n . It re m a in s  u n c le a r w h e th e r  
12  w e e k s  is su ffic ien t t im e  to  o b s e rv e  a n  e ffec t; m o s t s tu d ies  u n d e r 2  w e e k s  
fa ile d  to  s e e  in c re a s e s  in th e  c o n vers io n  o f A L A  to  lo n g er ch a in  n -3  P U F A . 
T h e  e ffe c t o f LA  in a d ip o s e  tiss u e  on  th e  c o n vers io n  o f A L A  re m a in s  u n c le a r  
e v e n  in th e  p re s e n c e  o f  restric ted  d ie ta ry  L A  in tak e . *
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O u r  h yp o th es is  is th a t in c re a s e d  in ta k e  o f A L A  a n d  d e c re a s e d  in ta k e s  o f LA  
w ill m a x im is e  th e  p o ten tia l fo r  m e ta b o lic  e lo n g a tio n  o f A L A  to  E P A  a n d  D H A  
th ro u g h  re d u c ed  c o m p e titio n  fo r th e  d e lta -6  d e s a tu ra s e  e n z y m e . T h e  e ffe c ts  
o f th e  d ie t on fas tin g  T A G , h a e m o s ta s is  a n d  v a s c u la r  fu n c tio n  w ill b e  
m e a s u re d  a lo n g s id e  c h a n g e s  in lipopro te ins  a n d  lipopro te in  h e te ro g e n e ity ;  
a n y  c h a n g e s  in C H D  risk  c a n  th e n  b e  e lu c id a te d .
1 .1 0  A im s  o f  in v e s t ig a t io n s
T h e  in ves tiga tio ns  a im e d  to  e x a m in e  th e  p ractica l feas ib ility  o f d e live rin g  
d ie ta ry  A L A  using fla x s e e d  oil w ith o u t th e  u se  o f  m a n u fa c tu re d  fo o d  item s. T o  
in c re a s e  th e  like lihood o f  e lo n g a tio n  in  v ivo  o f A L A  to  E P A  an d  D H A  th e  s tu d y  
a im e d  to  c a re fu lly  con tro l th e  d ie ta ry  in tak es  o f both  n -3  a n d  n -6  fa tty  ac id s . It 
e x a m in e d  th e  e ffe c t o f  A L A  s u p p le m e n ta tio n  on b io m a rk e rs  o f C H D  in 
in d iv id u a ls  exp re ss in g  a n  A L P  c o m p arin g  th e m  w ith  d ie ta ry  fish  oil 
s u p p le m e n ta tio n  to  d e te rm in e  if A L A  w a s  a s  e ffe c tiv e  in red uc in g  risk fac to rs  
fo r  C H D . It a im e d  to  e x a m in e  th e  issu e  o f d ie ta ry  c o m p lia n c e  a n d  s tra te g ie s  
th a t m a y  im p ro v e  it. It w a s  ta rg e te d  a t m id d le -a g e d  m a le s  a s  th e y  h a v e  b e e n  
iden tified  a s  m o re  a t risk o f  C H D  th a n  p re -m e n o p a u s a l w o m e n .
1 .1 0 .1  S tu d y  O b je c t iv e s
T h e  pilo t s tu d y  w a s  d e s ig n e d  to  look  a t issu es  surro un d in g  d e liv e ry  o f d ie ta ry  
f la x s e e d  oil to  v o lu n te e rs . Its  o b jec tive  w a s  to  id en tify  a n y  p ro b le m s  o r use fu l 
s tra te g ie s  th a t m a y  im p ro v e  th e  runn ing  a n d  c o m p lia n c e  o f th e  p rinc ipal study. 
T h e  princ ipal s tu d y  in vo lved  2  d ie ts  run in p a ra lle l w ith  a  h igh A L A  d iet; th e s e  
w e re  both  high in L A  (s u n flo w e r o il), o n e  o f w h ich  w a s  fu r th e r  s u p p le m e n te d  
w ith  3 g  o f  E P A  a n d  D H A  p e r  d a y (H a rr is  1 9 9 7 ) . T h e  la tte r  w a s  u sed  a s  a  
“con tro l” to  d e te rm in e  th e  e ffe c t o f long cha in  n -3  P U F A  in th e  s tu d y  
p o p u la tio n , in p a rtic u la r th e  e ffe c ts  on p la s m a  T A G  a n d  s m a ll, d e n s e  L D L . 
T h e  high A L A  d ie t w a s  a c h ie v e d  using fla x s e e d  oil, a n d  w a s  a lso  lo w  in 
d ie ta ry  n -6  fa ts . If  n -3  P U F A  fro m  A L A  w e re  a s  e ffe c tiv e  as  fish  o ils  in 
red u c in g  C H D  risk fac to rs , th e  e ffe c ts  o f th e  d ie t w o u ld  c o m p a re  fa v o u ra b ly  
w ith  th e  “contro l”. T h e  h igh L A  d ie t re p re s e n te d  th e  U K ’s h igh d ie ta ry  n -6  fa t
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in tak es . If  su ccessfu l th e  s tu d y  w o u ld  h igh ligh t a  s u ita b le  a lte rn a tiv e  to  o ily  
fish  a n d  fish  oils in th e  g e n e ra l po p u la tio n , b en e fitin g  not o n ly  c a rd io v a s c u la r  
h ea lth , but p o te n tia lly  a ffec tin g  a  g re a te r  proportion  o f th e  p o p u la tio n  w h o  do  
not re g u la rly  c o n s u m e  long cha in  n -3  fa tty  ac id s .
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2 C H A P T E R  2: G E N E R A L  M A T E R I A L S  A N D  M E T H O D S
All p rac tica l w o rk  d e ta ile d  in this C h a p te r , C h a p te rs  3, 4  a n d  5  w e re  c arried  
o ut by  m y se lf, e x c e p t w h e re  s ta ted  o th e rw is e .
2 .1  B lo o d  s a m p le  c o l le c t io n  a n d  s to r a g e .
B loods w e re  ta k e n  a fte r an  o vern ig h t fa s t. S u b je c ts  w e re  in stru cted  to  a b s ta in  
fro m  a lco h o l a n d  avo id  v ig orou s  e x e rc is e  2 4  hours prior to  v e n e p u n c tu re . 
B lood w a s  d ra w n  fro m  th e  a n te cu b ita l v e in  into V a c u ta in e rs  (B e c k to n -  
D ic k e n s o n ) . b y  a  q u a lified  nurse . B lood  w a s  d ra w n  in to  E D T A  (fina l 
co n c en tra tio n  1 m g /m l) fo r lipid an d  lipopro te in  an a lys is , red b lood  cell fa tty  
ac id  com p o s itio n  an d  L D L  oxidation , into  s o d iu m  c itra te  fo r th e  m e a s u re m e n t  
o f P A I-1 , F a c to r  V I I  an d  F ib rin o g en  a n d  into flu o rid e  o x a la te  fo r g lu co s e  
d e te rm in a tio n . A ll b lood, e x c e p t F a c to r  V I I  a n d  F ib rin o g en , w e re  k e p t a t  4 ° C  
fo r <  1 h o u r b e fo re  being  c en trifu g ed  a t 3 0 0 0 g  fo r 10  m ins  a t 4 ° C  (M e g a fu g e
1 .0  H e ra e u s  S e p a te c h ). T h e  rem ain in g  s a m p le s  w e re  c en trifu g ed  a t 3 0 0 0 g  fo r  
10 m in s  a t ro o m  te m p e ra tu re . A ll p la s m a  s a m p le s , e x c e p t th o s e  fo r L D L  
s u b c la ss  d e te rm in a tio n , w e re  fro ze n  to  - 1 8 ° C  w ith in  1 ho u r o f  cen trifu g a tio n  
an d  th e n  s to red  a t - 8 0 ° C  until an a ly s is . P la s m a  s a m p le s  fo r L D L  su b c lass  
d e te rm in a tio n  w e re  s to red  a t 4 °C  a n d  run w ith in  2 4  hours o f v e n e p u n c tu re .
2 .2  P r e p a r a t io n  o f  re d  b lo o d  c e lls  f o r  e r y th r o c y te  m e m b r a n e
p h o s p h o lip id  f^ t ty  a c id  a n a ly s is .
T h e  co m p o s itio n  o f e ry th ro cy tes  m e m b ra n e  fa tty  ac id s  w e re  used  a s  a  
m e a s u re  o f d ie ta ry  c o m p lian c e , a s  w e ll a s  an  ind irect m a rk e r  fo r th e  
co n v ers io n  o f s h o rte r ch a in  n -3  P U F A  to  lo n g er c h a in  n -3  P U F A . 
A p p ro x im a te ly  1 5  m is  o f red  blood c e lls  (R B C ), s e p a ra te d  fro m  p la s m a  as  
d es crib ed  a b o v e , w e re  w a s h e d  th re e  tim e s  w ith  0 .9 %  s a lin e  so lu tion  a t 4 °C .  
T w o -h u n d re d  a n d  fifty  m icro litres  o f 0 .1 %  b u ty la ted  h y d ro x y to lu en e  in 
p ro p ra n -2 -o l w a s  a d d e d  to  F A  p re v e n t o x id a tio n  a n d  s a m p le s  s to red  a t - 8 0 ° C  
until an a ly s is .
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2.3 A n a ly s is  o f  p la s m a  lip id s , l ip o p r o te in s  a n d  g lu c o s e .
P la s m a  ch o les te ro l, T A G , H D L -C , L D L -C , A p o B  a n d  g lu c o s e  w e re  all 
m e a s u re d  on th e  C o b a s  M ira  P lus  a u to a n la y s e r (R o c h e  D ia g n o s tic s  Ltd, U K ). 
A liq u o ts  o f  fro ze n  p la s m a  w e re  th a w e d  a t ro o m  te m p e ra tu re  im m e d ia te ly  prior 
to  a n a lys is .
T o ta l p la s m a  c h o le s te ro l w a s  d e te rm in e d  using th e  ch o le s te ro l e n z y m a tic  
co lo u rim etric  a s s a y  e n d p o in t m e th o d  (R a n d o x , U K ). T o ta l ch o les te ro l is 
d e te rm in e d  a fte r e n z y m a tic  hydro lys is  a n d  o x ida tio n . T h e  in d icato r  
q u in o n e im in e  is fo rm e d  a n d  m e a s u re d  a t 5 0 0 n m . P la s m a  triacy lg lycero l w a s  
d e te rm in e d  using th e  G P O -P A P  m eth o d  (R a n d o x , U K ). P la s m a  T A G  is 
d e te rm in e d  a fte r e n z y m a tic  hydro lys is  w ith  lip ases  resu lting  in th e  fo rm atio n  o f  
th e  in d icato r q u in o n e im in e  th is  is m e a s u re d  a t 5 0 0 n m  a n d  is d irectly  
p ro p o rtion a l to  th e  T A G  co n c en tra tio n . H ig h -d e n s ity  lipopro te in  cho les te ro l 
w a s  d e te rm in e d  using  th e  D ire c t H D L  ch o les te ro l e n z y m a tic  a s s a y  kit 
(R a n d o x , U K ). T h e  a s s a y  cons is ts  o f  tw o  d istinct reac tio n  s te p s , th e  firs t 
e lim in a te s  ch y lo m ic ro n s , V L D L  a n d  L D L -C  b y  ch o le s te ro l e s te ra s e , 
c h o les te ro l o x id a s e  a n d  s u b s e q u e n tly  c a ta la s e . H D L -C  is re le a s e d  by  
d e te rg e n ts  an d  th e  a b s o rp tio n  o f th e  q u in o n e im in e  d y e  p ro d u ced  is d irectly  
p ro p o rtion a l to  th e  c h o le s te ro l con ten t, w h ich  is m e a s u re d  a t 6 0 0 n m . C o ­
e ffic ien t o f varia tio n  w ith in  runs  is 1 .2 %  a n d  b e tw e e n  b a tc h e s  0 .9 % .
L o w -d e n s ity  lipopro te in  c h o les te ro l w a s  d e te rm in e d  using th e  D ire c t L D L  
c h o les te ro l e n z y m a tic  a s s a y  kit (R a n d o x , U K ). T h e  a s s a y  con sis ts  o f tw o  
d is tinct reac tion  s tep s , th e  firs t e lim in a te s  chy lo m icro n s, V L D L  a n d  H D L -C  b y  
c h o les te ro l e s te ra s e , ch o les te ro l o x id a s e  a n d  s u b s e q u e n tly  c a ta la s e . L D L -C  
is re le a s e d  b y  d e te rg e n ts  in th e  s te p  to  a n d  th e  in ten s ity  o f th e  q u in o n e im in e  
d y e  p ro d u ced  is d irec tly  p ro p o rtion a l to  th e  c h o les te ro l c o n ten t, w h ich  is 
m e a s u re d  a t 6 0 0 n m . G lu c o s e  w a s  d e te rm in e d  using th e  U n i-k it il (R o c h e ). 
T h is  is a n  e n z y m a tic  te s t w ith  h ex o k in a s e . T h e  co n c en tra tio n  o f N A D H  fo rm ed  
is d e te rm in e d  b y  m o n ito rin g  a b s o rb a n c e  a t 3 4 0 n m . C o -e ffic ie n t o f varia tion  
w ith in  runs is 0 .5 %  a n d  b e tw e e n  b a tc h e s  1 .0 % . A p o  B co n cen tra tio n  w a s
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d e te rm in e d  using  th e  a p o lip o p ro te in  B im m u n o tu rb id im etric  im m u n o a s s a y  
(R a n d o x  U K ). T h e  princ ip le  is b a s e d  o n  th e  reac tion  o f a  s a m p le  con ta in in g  
h u m a n  a p o B  a n d  a  sp ec ific  a n tis e ru m  to  form  a n  inso lub le  c o m p lex , w h ich  
c a n  b e  m e a s u re d  tu rb id im etrica lly  a t 3 4 0 n m . C o -e ffic ie n t o f varia tio n  w ith in  
runs is 1 .8 %  a n d  b e tw e e n  b a tc h e s  4 .2 % .
2.4 D eterm ination o f LDL subclasses by density  g rad ien t 
u ltracen trifuga tion .
L D L  s u b c la ss es  w e re  s e p a ra te d  a cco rd in g  to th e  m e th o d  o f G riffin  e t  a l 
(1 9 9 0 ) . 3 m ls  o f p la s m a  w a s  a d ju s te d  to  a  d en s ity  o f 1 .0 9 g /m l by  th e  add ition  
o f 0 .3 8 g  o f solid KBr. A  sa lt g ra d ie n t w a s  p re p a re d  as  sh o w n  in (F ig u re  2 .1 )  
using  a  m u lti-ch a n n e lle d  peris ta ltic  p u m p  (W a ts o n -M a rlo w , U K ).
Figure 2.1: Separation of plasma LDL subclasses by discontinuous density gradient
ultracentrifugation
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T h e  d en s ity  o f e a c h  solution  w a s  c h e c k e d  by a n  e lec tro n ic  d en s ity  m e te r  (Pan- 
S c ien tific ) b e fo re  add itio n  to  th e  g rad ien t. T h e  g ra d ien t w a s  c en trifu g ed  in a  
B e c k m a n  O p tim a  X L 1 0 0  u ltrac en trifu g e  a t 4 0 ,0 0 0  rpm  (2 0 0 ,0 0 0 g )  fo r 2 3  
h ours  a t 2 3 ° C  in a  4 0 T i sw in g  ou t ro tor (M a x  acc e le ra tio n , n o  b ra k e ) U p o n  
co m p le tio n  th e  tu b e s  w e re  p la c e d  in a  B e c k m a n  frac tio n  re c o v e ry  sys tem  
(F ig u re  2 .2 ) . M a x id e n s  (N y c o m e d , N o rw a y ) a  d e n s e  h yd ro p h o b ic  fluid  
(M a x id e n s ) d en s ity  1 .9 g /m l w a s  u s e d  to  d is p la c e  th e  g ra d ie n t b y  in troduction  
u n d e r th e  p la s m a  layer. T h e  g ra d ie n t w a s  u p w ard ly  d is p lac ed  through  a
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_  (ml) (g/ml)  Subclass
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m icro flow  ce ll by m e a n s  o f a n  infusion p um p, running a t 4 2 m l/h r, a n d  
m o n ito red  co n tin u o us ly  a t 2 8 0 n m  in a  s p e c tro p h o to m e te r (B e c k m a n  D U 6 5 0 ).
Figure 2.2: Diagram of the Beckman Fraction recovery system
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T h e  resu lting  L D L  profile  p ro v id e s  a  g ra p h ic a l re p res en ta tio n  o f th e  d iffe ren t  
L D L  su b c la ss es . E a c h  s u b c la s s ’ p e rc e n ta g e  a re a  is in teg ra ted  by d ropp ing  
p erp e n d icu la rs  to  a  fla t b as e lin e . T h e s e  p e rc e n ta g e  a re a s  a re  c o rrec te d  to  
lipoprotein  m a s s  e q u iv a le n c e  by m u ltip ly ing  b y  spec ific  extinction  co effic ien ts  
(fo r LD L-1  th is  co e ffic ien t is 2 .6 3 , fo r L D L -2  2 .9 4  a n d  fo r L D L -3  1 .9 2 )  as  
p rev io u s ly  d e te rm in e d  (G riffin  e t a l  1 9 9 0 ).
2.4.1 D eterm ination o f HDL Subclasses by dens ity  g rad ien t 
u ltracen trifuga tion
2 m ls  o f p la s m a  w a s  a d ju s te d  to  a  d en s ity  o f 1 .3 g /m l by th e  add ition  o f 0 .9 8 g  
o f K B r. T h e  a d ju s ted  p la s m a  w a s  p la c e d  a t th e  bottom  o f a  4 0 T i tu b e  
(B e c k m a n -C o u lte r). T h re e  laye rs  o f d iffering  d en s ities  w e re  a d d e d  on  top  o f 
th e  p la s m a  la y e r us ing  a  p eris ta ltic  p u m p  (W a ts o n  M arlo w ). F irstly, 2 .5 m ls  o f
1 .2 5 g /m l N a B r, th e n  6 m ls  o f 1 .1 9 g /m l N a B r. D istilled  w a te r  w a s  a d d e d  to  
m a k e  up th e  v o lu m e  to  11 m is. S a m p le s  w e re  c en trifu g ed  in a  B e c k m a n  
O p tim a  X L 1 0 0  using  a  4 0 T i s w in g -o u t b u ck e t ro tor (M a x  a cc e le ra tio n , no  
b ra k e ) a t 1 5 °C  fo r 2 0  hours  a t 4 0 ,0 0 0  R P M  (2 0 0 ,0 0 0 g ) . U p o n  co m p le tio n  th e
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tu b e s  w e re  p la ce d  in a  B ec km an  frac tio n  re co v ery  sys tem  (F ig u re  2 .2 ) . A  
d e n s e  h yd ro p h o b ic  flu id, M ax id en s  (N y c o m e d , N o rw a y ) d en s ity  1 .9 g /m l w a s  
u sed  to  d is p la c e  th e  g ra d ie n t b y  in troduction  u n d e r th e  p la s m a  la ye r. U s ing  a n  
in fusion p u m p , runn ing  a t 4 2 m l/h r, th e  g ra d ie n t w a s  d is p la c e d  th ro u g h  a  
m icro flo w  cell w h ils t b e ing  m o n ito red  co n tin u o us ly  a t 2 8 0 n m  in a  
s p e c tro p h o to m e te r (B e c k m a n  D U 6 5 0 ) . T h e  resu lting  H D L  pro file  p ro v id es  a  
g ra p h ic a l re p res en ta tio n  o f th e  d iffe re n t H D L  su b c la ss es . E a c h  s u b c la s s ’ 
p e rc e n ta g e  a re a  is in teg ra te d  by d ro p p in g  p e rp e n d ic u la rs  to  a  f la t b a s e lin e . 
T h e s e  p e rc e n ta g e s  c an  b e  ap p lied  to  th e  to ta l H D L -C  m e a s u re m e n t, to  
p ro v id e  a  re la tiv e  v a lu e  o f H D L 2 an d  H D L 3 in m m o l/l.
2 .5  D e te r m in a t io n  o f  e r y th r o c y te  m e m b r a n e  fa t ty  a c id  
p h o s p h o lip id  c o m p o s it io n
L ip ids w e re  e x tra c te d  fro m  th e  e ry th ro cy te  m e m b ra n e s  w ith  a  m ix tu re  o f 
ch loro fo rm : m e th a n o l (2 :1 ; vo l/vo l), co n ta in in g  b u ty la ted  h y d ro x y to lu en e  (0 .0 1  
%  B H T ) a s  a n  an tio x id an t, accord in g  to  th e  F o lch  m e th o d  (F o lc h  e t  a l 1 9 5 6 ) . 
F a tty  ac id  m e th y l e s te rs  w e re  p re p a re d  w ith  so d iu m  m e th o x id e  (0 .5  M  so lution  
in m e th a n o l), in c u b a te d  a t 6 0 °C  fo r 15  m in u tes , ac id ified  w ith  g lac ia l a c e tic  
ac id , a n d  fin a lly  e x tra c te d  w ith  h e x a n e . T h e  resu lting  fa tty  ac id  m eth y l e s te rs  
w e re  a n a ly s e d  w ith  a  g a s  c h ro m a to g ra p h y  (G C ) using  a  3 4 0 0  G a s  
C h ro m a to g ra p h  (V a ria n ). P A G  C a p illa ry  C o lu m n : 3 0 m  x  0 .2 5 m m  x  0 .2 5 p m  
film  th ick n es s  (S u p e lc o , Inc ) and  a  f la m e  ion iza tion  d e te c to r (2 5 0 °C ) , w ith  
h e liu m  a s  th e  c a rr ie r  g a s . T e m p e ra tu re  w a s  p ro g ra m m e d  a t 4 °C /m in  fro m  1 5 0  
to  2 2 0 ° C . T h e  fa tty  ac id  p e a k s  w e re  identified  a g a in s t a  s ta n d a rd  fa tty  ac id s  
m ix tu re  (S u p e lc o  3 7  C o m p o n e n t F A M E  M ix , S ig m a  C h e m ic a l C o . U K ) an d  run  
on th e  s a m e  co lu m n  u n d e r id en tica l cond itions. In d iv id u a l s ta n d a rd s  
(D o c o s a p e n ta e n o ic  acid: 2 2 :5 n -3 , D o c o s a te tra e n o ic  acid: 2 2 :4 n -6 )  w e re  a lso  
u se d  a s  th e s e  tw o  fa tty  a c id s  w e re  not in c lu d ed  in th e  s ta n d a rd  m ix ture . T h e  
in jectio n  v o lu m e  w a s  2  p L  and  th e  run 4 5  m in . T h e  m a x im u m  C V s  fo r  
re p e a te d  in jections  w e re  0 .4 %  fo r F A  re te n tio n  tim e  a n d  0 .3 %  fo r F A  p e a k  
A U C . R es u lts  a re  e x p re s s e d  as  p e rc e n ta g e s  o f th e  sum  o f a ll identified  p ea ks . 
T h is  w o rk  w a s  c a rrie d  o u t b y  a  c o lle a g u e  D r E ric  A h -S in g , U n ive rs ity  o f  
S u rrey .
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2 .6  C o m p a r is o n  o f  H D L  s u b c la s s e s  a s  is o la te d  b y  H D L -D G U C  a n d  
e le c t r o p h o r e t ic  s e p a r a t io n .
H D L  is s tru c tu ra lly  h e te ro g e n e o u s , such  th a t H D L  s u b c la s s e s  c an  b e  iso lated  
o n  th e  b as is  o f th e ir  lipid com po s itio n , a p o p ro te in  con ten t, th e ir  e le c tro p h o re tic  
m obility  a n d  d en s ity .
G ra d ie n t G e l E lec tro p h o re s is  is a  sen s itive  te c h n iq u e  b a s e d  on sep ara tin g  
H D L  b y  th e ir  p artic le  s iz e . A  n o n -d e n a tu rin g  p o ly a c ry la m id e  g ra d ie n t g e l is 
u sed , an d  h as  s h o w n  a t le a s t fiv e  H D L  sub c lasses : H D L 3C, H D Lsb , H D L sa , 
H D L 2a  a n d  H D L 2b. T h e  3  H D L 3 s u b c la s s e s  c an  b e  g ro u p e d  to g e th e r  a s  c an  
th e  2  H D L 2 s u b c la s s e s  to  g iv e  a  ra tio  o f H D L 2 to  H D L 3. (B la n c h e  e t a l  1 9 8 1 , 
V e z in a  e t a l 1 9 8 8 , W illia m s  e t a l 1 9 9 2 ) .
T h e re  a re  s e v e ra l u ltracen trifu g atio n  m e th o d s  fo r  m e a s u rin g  H D L : an a ly tica l, 
p re p a ra tiv e , d e n s ity  g ra d ie n t a n d  ra te  z o n a l cen trifu g a tio n . T h e  e q u ip m e n t  
req u ired  is e x p e n s iv e  a n d  p re p a ra tiv e  m e th o d s  fo r iso lating  H D L  can  b e  tim e  
con su m in g , a s  th e y  re q u ire  re p e a te d  cen trifug ation  o ften  o v e r a  period  o f  
d ay s . T h e  d e n s ity  g ra d ie n t u ltr^cen trifu gatio n  (D G U C )  m e th o d  c an  b e  
p erfo rm e d  in o n e  s te p  o v e r  2 4  hours. T h e  m e th o d  d e s c rib e d  a b o v e  w a s  used  
to  c o m p a re  th e  n e w  L ip o p rin t H D L  S y s te m  using identica l s a m p le s .
2 .6 .1  A  n e w  g e l ro d  e le c tr o p h o r e s is  s y s te m  f o r  t h e  d e te r m in a t io n  o f  
H D L  s u b c la s s e s :  H D L  L ip o p r in t  s y s te m
T h e  L ipoprin t H D L  S y s te m  (Q u a n tim e trix s  C o rp o ra tio n , U S A ) w a s  a  n e w  
te c h n iq u e  fo r s e p a ra tin g  H D L  s u b c la ss es  using p o ly a c rly a m id e  gel 
e lec tro p h o re s is  (P A G E ) . T h e  g e l is p re -c a s t a n d  c o n ta in e d  w ith in  sm all g lass  
tu b e s , a n d  a ll th e  re a g e n ts  fo r  m e th o d  a re  c o n ta in e d  w ith in  th e  s ys te m  kit.
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2.6.1.1 Method
T h e  b u ffe r sa lts  w e re  reco n stitu ted  b y  d isso lv ing  o n e  via l (2 0 g ) in 1 2 0 0 m ls  o f 
distilled  w a te r. F in a l pH  8 .2  -  8 .6 . T h e  req u ired  n u m b ers  o f tu b e s  w e re  p la ce d  
in th e  p re p a ra tio n  rack  (F ig u re  2 .3 )  w ith  th e  unfilled end  fa c e  up. A  m a x im u m  
o f 12  tu b e s  c an  b e  run a t o n e  tim e . S to ra g e  b u ffe r w a s  re m o v e d  fro m  th e  top  
o f th e  tu b e s  by g e n tle  tap p in g  onto  an  a b s o rb e n t cloth. 2 5 p l o f p la s m a  w e re  
a d d e d  to  th e  to p  o f th e  g e l, 3 0 0 p l o f th e  loading  gel w a s  la y e re d  on th e  top . 
O n c e  all s a m p le s  had  b e e n  lo a d e d , th e  to p s  o f th e  tu b e s  w e re  te m p o ra rily  
s e a le d  a n d  th e  w h o le  rack  in verted  s e v e ra l tim e s  to  e n s u re  c o m p le te  m ix ing  
o f th e  s a m p le  a n d  load ing  gel.
Figure 2.3: HDL Lipoprint loading and preparation rack.
T h e  tu b e s  w e re  p o lym erise d  by th e  ap p lica tio n  o f light. T h e  p re p a ra tio n  rack  
w a s  p la ce d  in th e  c e n tre  o f th e  p re p a ra tio n  light w ith  th e  load ing  g e l portion  o f  
th e  tu b e s  to u ch in g  th e  light tu b e . P o ly m e ris a tio n  took  3 0  m in u tes . U p on  
co m p le tio n , tu b e s  w e re  re m o v e d  a n d  p la ce d  in th e  u p p er s e g m e n t o f th e  
e lec tro p h o re s is  c h a m b e r. A  m a x im u m  o f 12  tu b e s  cou ld  b e  run a t a n y  o n e  
tim e . If less  th a n  12 s a m p le s  w e re  b e in g  run, e m p ty  s lots w e re  filled w ith  
g la ss  rods co n ta in in g  o n ly  a ir. A ll tu b e s  con ta in in g  s a m p le s  w e re  c h e c k e d  fo r  
a ir  b u b b les , w h ich  w e re  re m o v e d  b y  g e n tle  tap p in g . 1 0 0 0 m ls  o f b u ffe r solution  
w a s  a d d e d  to  th e  b o ttom  c h a m b e r, a n d  th e  rem ain in g  2 0 0 m ls  in th e  top  
c h a m b e r. T h e  a p p a ra tu s  w a s  th e n  c o n n e c te d  to  a  p o w e r sup p ly . G e ls  w e re  
run a t 3 m A  p e r tu b e  a t 3 0 0 V  fo r a p p ro x im a te ly  8 0  m in u tes . R u n n in g  tim e s
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v arie d  d ep e n d in g  on th e  n u m b er o f tu b e s  p resent, but a s  a  ru le , 
e lec tro p h o re s is  w a s  s to p p ed  w h e n  th e  a lb u m in  frac tion  w a s  a p p ro x im a te ly  
1cm  from  th e  e n d  o f th e  tu b e . T h e  tu b e s  w e re  re m o ve d  from  th e  c h a m b e r  an d  
p la ce d  b ack  in th e  p re p a ra tio n  rack . T h e  a lb u m in  front, v is ib le  a s  a  p a le  
y e llo w  b an d , w a s  m a rk e d  on th e  e x te rio r o f th e  tu b e s  w ith  a  thin  m a rk e r p en . 
Identification  o f th is  fro n t a llo w ed  a n a ly s is  o f th e  H D L  s u b c la ss es  to  b e  
p erfo rm e d  re la tiv e  to  th e  a lb um in  front. T h e  optica l d en s ity  o f th e  tu b e s  w a s  
d e te rm in e d  using a  d e n s ito m e te r (P h a rm a c ia , B io tech ). A n  im a g e  o f th e  g e ls  
in th e  p re p a ra tio n  ra c k  w a s  cap tu red  using th e  L IP C A P  c a p tu re  ap p lica tio n  
(P h a rm a c ia  B io tech ). C a p tu re  w a s  v ia  a  C C D  v id eo  c a m e ra  using w h ite  
b ackg ro u n d  light. T h e  c ap tu red  im a g e s  w e re  a n a ly s e d  using th e  Im a g in e  
M a s te r  ID  P r im e  s o ftw a re  (P h a rm a c ia  B io tech ). H D L  frac tio ns  w e re  identified  
using R f v a lu e s . T h e  V L D L  and  L D L  b an d  a t th e  top  o f th e  tu b e  w a s  la b e lled  
R f 0  a n d  th e  a lb u m in  front, a s  R f 1. H D L 2 w a s  identified  a s  h av ing  an  R f  o f  
0 .1 8  and  H D L 3 a s  an  R f o f 0 .2 7 . A  d ia g ra m  o f how  th e  gel tu b e  looks a fte r  
e lec tro p h o re s is  is s h o w n  in F ig u re  2 .4 . A  m a n u a l b as e lin e  w a s  in serted  a n d  
th e  a re a  u n d er th e  c u rv e s  o f th e  tw o  H D L  su b -frac tio n s  ca lc u la te d  by d ro p p in g  
p erp e n d icu la rs  to  th e  b as e lin e . A re a s  u n d e r th e  c u rve  w e re  e x p re s s e d  a s  
optica l d en s ity  units a n d  th e n  c o n verted  in p e rc e n ta g e s  (F ig u re  2 .5 )
Figure 2.4: Diagram of electrophoresis gel tube from HDL Lipoprint kit illustrating the 
Rf bands for HDL2 and HDL3 subfractions.
V L D L / L D L Albumin
H D L 2 H D L g
I
R f  =  0  
R f = O . I 8
Rl' = 027
R f  =  If)
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Figure 2.5: HDL profile generated from  HDL-Lipoprint System showing VLDL, HDL2 and 
HDL3 subclasses. R f values calculated from  VLDL to Albumin Front (Alb).
mm
2.7 V a lida tion  o f HDL subc lasses us ing  HDL-DGUC and the
L ip o p rin t HDL system
2.7.1 A im s
T o  c h a ra c te ris e  e lec tro p h o re tic  b an d in g  p a tte rn s  (L ipoprin t) by  d ire c t 
c o m p a ris o n  w ith  H D L  s u b c la s s e s  c o -is o la te d  by d en s ity  g ra d ie n t  
u ltracen trifu g atio n .
2.7.2 S tudy Design
A  sm all g ro u p  o f v o lu n te e rs  w e re  s e le c te d  from  w ith in  th e  u n ivers ity  s tu d en t  
p o p u la tio n  to  c o m p a re  th e  H D L  D G U C  m e th o d  w ith  th e  n e w  H D L  L ipoprint 
S y s te m . T h e  e xp ec ta tio n  w a s  th a t s im ila r v a lu e s  fo r H D L 2 a n d  H D L 3 w o u ld  b e  
fo u n d  from  e a c h  m eth o d .
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2.7.2.1 Subjects:
7  M a le  a n d  3  F e m a le  s u b je c ts  to o k  p a rt in th e  v a lid a tio n  s tu d y  e a c h  provid ing  
a  s a m p le  o f fas tin g  b lood  fo r d u p lic a te  a n a ly s is  using th e  H D L  L ipoprin t 
S y s te m , a n d  d e n s ity  g ra d ie n t u ltracen trifu g atio n .
2 .7 .3  R e s u lts :
M e a s u re m e n t o f  H D L  su b fractio n s  using th e  P A G E  m e th o d , resu lted  in lo w e r  
%  A U G  v a lu e s  fo r  H D L 3 th a n  th e  d e n s ity  g ra d ie n t m e th o d , a n d  h ig h e r %  A U C  
v a lu e s  fo r H D L 2. B oth  m e th o d s  c le a rly  identified  th e  d iffe re n c e s  in th e  
H D L 2:H D L 3 ra tio  o b s e rv e d  w h e n  c o m p a rin g  fe m a le  to  m a le  su b jec ts . M e a n  
v a lu e s  fo r A U C  fo r  H D L 2 a n d  H D L 3 fro m  both  m e th o d s  a re  s h o w n  in T a b le  2 .1
Table 2.1: mean values fo r AUC for the page and density gradient methods
[  -------- ------------- %AUC (S.D.)-—-----
NO. S e x  PAGE PAGE DGUC DGUC
HDL2 HDL3 HDL2 HDL3
n = 7  M a le  3 3 .6 ( 1 3 .0 )  6 6 .4 ( 1 3 . )  8 .5  (3 .0 )  9 2 .5 ( 3 .0 )
n = 3  F e m a le  6 1 .0 ( 4 .6 )  3 9 .0 ( 4 .6 )  3 6 .3 ( 1 5 .5 )  6 3 .7 ( 1 5 .5 )
C o rre la tio n  b e tw e e n  H D L  su b c la ss  d a ta  using P A G E  a n d  H D L -D G U C  is 
s h o w n  in T a b le  2 .2 . a n d  F ig u res  2 .6  a n d  2 .7 . A n  e x a m p le  o f a  m a le  a n d  
fe m a le  H D L  s u b c la ss  p ro file  as  g e n e ra te d  using D G U C  is s h o w n  in F ig u re  
2.8.
Table 2.2: Correlation between PAGE and DGUC methods.
C o rre la tio n h d l 2 h d l 3
P A G E  vs D G U C r= 0 .7 7 r= 0 .7 7
p < 0 .0 1 p < 0 .0 1
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Figure 2.6: -  AUC (%) values for HDL2 PAGE com pared tp HDL2 DGUC, from the same
sample.
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Figure 2.7: -  AUC (%) values for HDL3 PAGE com pared to HDL3 DGUC, from  the same
sample.
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Figure 2.8: HDL profiles generated using DGUC (Grey = Female, Red = Male)
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2 .7 .4  C o m p a r is o n  o f  H D L -D G U C  a n d  g e l ro d  e le c tr o p h o r e s is  in  th e
s e p a r a t io n  o f  H D L  s u b c la s s e s  in  3  s u b je c ts .
H D L  s u b c la s s e s  w e re  s e p a ra te d  fro m  3  su b jec ts  b y  th e  tw o  m e th o d s . B lood  
w a s  ta k e n  a t b a s e lin e  a n d  1 2  w e e k s  a n d  p la s m a  p re p a re d  a s  d e s c rib e d  in 
C h a p te r  2.
2 .7 .5  R e s u lts
B oth  m e th o d s  w e re  a b le  to  d is tingu ish  b e tw e e n  H D L 2 a n d  H D L 3 sub fractio n s . 
R e s u lts  fo r A U C  d iffe red  d e p e n d in g  on th e  m e th o d  u se d . C h a n g e s  o v e r  t im e  
w e re  d e te c te d  b y  both  m e th o d s . C o -is o la tio n  o f s a m p le s  using  th e  L ipoprin t 
s y s te m  (T a b le  2 .3 )  a n d  H D L -D G U C  (T a b le  2 .4 )  a re  sh o w n .
Table 2.3:: Results o f %AUC for H bL Lipoprint at 0 and 12 weeks
%  A U C  @  0  W e e k s %  A U C  @  12  W e e k s
S u b je c t H D L  2 H D L 3 H D L  2 H D L 3
A 21 7 9 16 8 4
B 17 8 3 15 8 5
C 2 0 8 0 2 4 7 6
Table 2.4 Results of %AUC for DGUC at 0 and 12 weeks.
%  A U C  @  0  W e e k s %  A U C  @  12  W e e k s
S u b je c t H D L  2 H D L 3 H D L  2 H D L 3
A 6 9 4 3 9 7
B 4 9 6 4 9 6
C 15 8 5 8 9 2
S u b je c ts  A  a n d  B s h o w e d  s im ila r c h a n g e s  in H D L  2 a n d  H D L 3 in both th e  
H D L -D G U C  a n d  P A G E  m e th o d s . T h is  w a s  not o b s e rv e d  w ith  sub jec t C . 
C o rre la tio n  b e tw e e n  th e  tw o  m e th o d s  w a s  n o t s ig n ifican t (p = 0 .2 8 )  r= 0 .5 3 . T h e  
re la tiv e  p e rc e n ta g e s  o f H D L 2 a n d  H D L 3 fro m  e a c h  m e th o d  w e re  co n v erte d  
into H D L  ch o le s te ro l m m o l/l e q u iv a le n ts  a n d  a re  s h o w n  in T a b le  2 .5 .
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Table 2.5: Calculation of mmol values of HDL2 and HDL3 using the HDL Lipoprint
system and HDL-DGUC methods.
Subject Total
HDL
mmol/l
Lipoprint 
HDL2 HDL3 
(mmol/l) (mmol/l)
DGUC 
HDL2 HDL3 
(mmol/l) (mmol/l)
AHDL2
(mmol/l)
AHDL3
(mmol/l)
A (wk 0) 1.07 0.23 0.84 0.06 1.01 0.17 -0.17
A(wk 12) 1.00 0.16 0.84 0.03 0.97 0.13 -0.13
B (wk 0) 0.97 0.17 0.80 0.04 0.93 0.13 -0.13
B(wk 12) 1.11 0.17 0.94 0.05 1.03 0.12 -0.12
C (wk 0) 0.85 0.17 0.68 0.13 0.72 0.04 -0.04
C (wk 12) 0.89 0.21 0.68 0.07 0.82 0.12 -0.14
T h e s e  d a ta  s h o w  th a t p la s m a  co n c en tra tio n  v a lu e s  fo r H D L 2 a n d  H D L 3 a re  
d iffe re n t w h e n  ca lc u la te d  fro m  th e  A U C  d a ta  using to ta l H D L  v a lu e s . P A G E  
resu lts  a re  g re a te r  fo r H D L 2 an d  less  fo r  H D L 3 w h e n  c o m p a re d  to  th e  H D L -  
D G U C  m e th o d .
2 .7 .6  D is c u s s io n
W h ile  both  m e th o d s  w e re  a b le  to  d istingu ish  b e tw e e n  H D L 2 an d  H D L 3 
su b frac tio n s , a n d  a lso  d e te rm in e  c h a n g e s  in com po s itio n  o v e r tim e , th e  A U C  
o f e a c h  m e th o d  d iffe red  g reatly . W h ile  th e  H D L -D G U C  m e th o d  re lie s  on  th e  
pro te in  co n ten t, th e  P A G E  m eth o d  q u an tifies  H D L  on  its lipid co n ten t. T h e  
ratio  o f  lip idrprotein  in th e  tw o  s u b c la s s e s  v a rie s , lead in g  to  d iffe re n t g ra p h ic a l 
re p re s e n ta tio n s  o f  th e  s a m e  s a m p le , d e p e n d in g  on w h ich  m e th o d  is u sed . 
H D L 2 is g e n e ra lly  T A G  rich and  p ro te in  poor, as  o p p o s ed  to  H D L 3 w h ich  is 
sm a lle r , c o n ta in s  less lipid an d  is re la tiv e ly  high in p ro te in . T h is  is re flec ted  in 
th e  resu lts  w h ic h  s h o w  h ig h e r v a lu e s  fo r  H D L 2 using P A G E  v s  H D L -D G U C ,  
a n d  s im ila r h ig h e r v a lu e s  fo r H D L 3 c o m p a rin g  H D L -D G U C  to  P A G E . D e s p ite  
th e  d iffe re n c e s , both m e th o d s  w e re  a b le  to  d is tingu ish  g e n d e r  d iffe re n c es  
b e tw e e n  su b jec ts , a s  w e ll as  q u a n tita tiv e  c h a n g e s  in H D L  su b c lass  
p o p u la tio n s . It is c le a r  th a t th e  m a th e m a tic a l con vers io n  o f A U C  fo r  e a c h  H D L  
s u b c la s s  m a y  not p ro v id e  a n  a c c u ra te  re p res en ta tio n  o f  th e  c h o les te ro l 
c o n ten t o f e a c h  H D L  su b c lass . E v e n  in th is  sm all g roup  o f s a m p le s  th e re  
a p p e a re d  to  b e  s ig n ifican t v a ria tio n  in th e  % A U C  b e tw e e n  th e  tw o  m eth o d s .
T h e  P A G E  m e th o d  p ro ved  a  re lia b le , q u ick  a n d  e ffic ien t m e th o d  w ith  th e  
a d v a n ta g e  o v e r H D L -D G U C  o f o ffe rin g  high th ro u g h -p u t o f s a m p le s  p e r  d ay . 
T h e  H D L -D G U C  m e th o d  is lim ited  to 6  s am p le s  p e r 2 4  hours p e r
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u ltracen trifu g e . T h e  re liab ility  o f th e  d a ta  w o u ld  b e  in c re a s e d  b y  a n a ly s is  o f  
la rg e r n u m b ers  o f s a m p le s .
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3 C H A P T E R  3 P I L O T  S T U D Y
3 .1  In t ro d u c t io n
P rio r to  th e  s ta rt o f th e  p rinc ipal s tu d y  a  p ilot s tu d y  w a s  d e s ig n e d  p rim arily  to  
te s t th e  feas ib ility  o f m e th o d s  fo r A L A  d e live ry  in fla x s e e d  oil in a  s m all g ro u p  
o f n o rm o lip id aem ic , h e a lth y  v o lu n tee rs . T h e  in vestigation  s e rv e d  to  p ro v id e  
ins igh t into th e  log istics o f d e live rin g  a  high d o s e  o f fla x s e e d  oil e ffe c tiv e ly  to  
fre e  living sub jec ts . It a ls o  s e rv e d  to  look a t th e  p a la tab ility  a n d  g e n e ra l  
a c c e p ta n c e  o f th e s e  fo o d s , a n d  m e th o d s  b y  w h ich  c o m p lia n c e  to  th e  d ie ta ry  
pro toco l m a y  b e  im p ro ved .
A n  ad d itio n a l a im  w a s  to  m e a s u re  th e  d ie ta ry  n 6 :n 3  ratio  a c h ie v e d  by  
in c reas in g  A L A  a n d  d e c re a s in g  n -6  P U F A  in th e  d ie t, a n d  to  e x a m in e  w h e th e r  
a  red uctio n  in th is  ratio  is a s s o c ia te d  w ith  “fish -o il” like e ffe c ts  on  C H D  risk. T o  
d e te rm in e  d ie ta ry  c o m p lia n c e  an d  a n y  in d irect c o n vers io n  o f A L A  to  E P A  a n d  
D H A , e ry th ro cy te  m e m b ra n e  p hospho lip id  fa tty  ac id  com po s itio n  w a s  
m e a s u re d . T h e  p ilo t a ls o  s e rv e d  a s  a  m e a n s  to  tra in  s tu d y  s ta ff  w ith  th e  
m a te ria ls  a n d  m e th o d s  th a t w o u ld  b e  u sed  in th e  m a in  in terven tio n  study.
3 .2  M a te r ia ls  &  M e th o d s
T h is  p ilo t s tudy  w a s  a p p ro v e d  b y  th e  e th ics  c o m m itte e  o f th e  U n ive rs ity  o f 
S u rrey , G u ild fo rd , an d  th e  R o ya l S u rre y  C o u n ty  H o sp ita l. In fo rm ed  c o n s en t  
w a s  o b ta in ed  fro m  th e  p artic ip a tin g  sub jec ts .
3 .2 .1  S u b je c ts
A  to ta l o f n ine  n o rm a l, h e a lth y  m a le  v o lu n te e rs  fro m  w ith in  th e  U n ive rs ity  o f  
S u rre y  a g e d  21 -  5 8  w e re  recru ited  a n d  u n d erto o k  a  4  w e e k , fre e  living  
d ie ta ry  in terven tio n . S u b je c ts  w e re  recru ited  throu g h  a d v e rtis e m e n ts  p la ce d  
w ith in  th e  un ivers ity , a n d  s e v e ra l o f th e  s ta ff involved  w ith  th e  s tu d y  a lso  to o k  
p art. D e s p ite  a tte m p ts  to  in c re a s e  th e  s iz e  o f th e  s tu d y  g ro u p  n o  m o re  th a n  9  
v o lu n te e rs  cou ld  b e  recru ited .
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3.2.2 The study diet
T h e  in te rven tio n  con s is ted  o f o n e  d ie t b a s e d  on 3 0 m is  o f fla x s e e d  oil p e r d a y  
a g a in s t a  b ac kg ro u n d  o f low  d ie ta ry  n -6  P U F A  in take . T h e  a im  w a s  to  a c h ie v e  
a  d ie ta ry  n 6 :n 3  ratio  o f < 1 . It w a s  d e c id e d  to  d o  th is  w ith  16g  o f A L A  p e r d ay . 
T h is  in tak e  w a s  c o n s id ered  la rg e  e n o u g h  to h a v e  a  p o ten tia l e ffe c t on E P A  
fo rm atio n  (M a tz io r is  e t  a l  1 9 9 4 , A llm a n  e t  a l 1 9 9 5 , Li e t  a l 1 9 9 9 )  but still b e  
m a n a g e a b le  b y  v o lu n te e rs  as  a  d ie ta ry  s u p p le m e n t. A ll s u b je c ts  fo llo w ed  th is  
d ie t fo r 4  w e e k s . S u b je c ts  w e re  p ro v ided  w ith  cold p re s s e d  f la x s e e d  oil (F lo ra , 
d is tribu ted  b y  S a v a n t)  in 5 0 0 m l b o ttles  a n d  w ritten  in fo rm atio n  in th e  fo rm  o f  
rec ip e s  a n d  tips  on  h o w  to  u se  th e  f la x  oil an d  flax  oil con ta in in g  p roducts.
S u b je c ts  w e re  in stru cted  to  u se  c o m b in e  o r m ix  th e  oil w ith  e v e ry d a y  fo o d s  o r  
to  ta k e  th e  oil d irec tly  on  a  spo o n  w ith  m e a ls . T o  s im p lify  th e  d o s e  o f A L A  an d  
to  a id  c o m p lia n c e , in tak es  o f flax  oil w e re  d e te rm in e d  using  a  unit sys tem . 
O n e  unit w a s  e q u iv a le n t to  3 .8 g  o f  A L A  o r 6rn ls  o f f la x  oil. In add itio n  to  this, 
fla x s e e d  oil e n r ic h e d  b u tte r (2:1  b u tte r:flax  oil ra tio ) a n d  m a y o n n a is e  (3:1  low  
fa t m a y o n n a is e :fla x  oil ra tio ) w a s  m a d e  a n d  g iven  to  su b jec ts  to  u se  w h e n e v e r  
poss ib le . T h e  unit s y s te m  a lso  a p p lied  to  th e s e  p roducts . S u b je c ts  w e re  
in s tru cted  to  fo llo w  a  lo w  n -6  P U F A  d ie t, a n d  to  fa c ilita te  th is  w e re  p rovided  
w ith  ra p e s e e d  oil (G o ld e n fie ld s , C arg ill F o o d s ) fo r cooking  a n d  frying. T h e re  
w e re  c le a r  instructions  no t to  b a k e , co o k  o r fry  w ith  th e  f la x  oil o r f la x  oil 
pro d u cts  d u e  to  th e  oil oxid is ing  a b o v e  7 0 °C . O n e  ta b le s p o o n  o f ra p e s e e d  oil 
w a s  e q u iv a le n t to  0 .5  units. S u b je c ts  w e re  a lso  instructed  to  avo id  o ily fish  
a n d  fish  oil s u p p le m e n ts  a n d  to  fo llo w  a s  n e a r  th e ir  n o rm a l d ie t  a s  p o ss ib le  
o u ts id e  o f  th e s e  restric tions . T h e  a im  w a s  to  c o n s u m e  8  un its  p e r  d ay . A ll th e  
pro d u cts  s u p p lied  to  th e  sub jec ts , a n d  th e ir  re s p e c tiv e  unit v a lu e s  a re  sho w n  
in T a b le  3 .1 .
Table 3.1: Unit System for determining ALA intake in differing food products.
Food Am ount Unit Value
Flaxseed Oil 6 mis 1.0
Enriched Mayonnaise 1 Tablespoon 1.0
Rapeseed Oil 1 Tablespoon 0.5
Enriched Butter Cube 1 cube 1.0
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3.2.3 Dietary Analysis
T w o  7 -d a y  food  d ia ries  w e re  c o m p le ted , a n d  d ie ta ry  in takes  b e fo re  a n d  during  
th e  s tu d y  a n a ly s e d  using th e  d ie ta ry  a n a ly s is  so ftw are  D ie tp la n  5  (F o re s tfie ld  
S o ftw a re  Ltd) In ta k e s  o f m a cro n u trien ts  a n d  d ie ta ry  n -6  a n d  n -3  fa ts  w e re  
c a lc u la te d . D a ta  input w a s  carried  ou t b y  J e n n y  H u nn ise t.
3 .2 .4  M e a s u r e m e n t  o f  lip id s , l ip o p r o te in s  a n d  a n th r o p o m e tr ie s
B lood  s am p le s  w e re  ta k e n  a t th e  s ta rt o f th e  s tu d y  (0  w e e k s ), m id -p o in t (2  
w e e k s ) an d  a t th e  e n d  (4  w e e k s ). B lood  w a s  ta k e n  a n d  p re p a re d  a s  d e s c rib e d  
in C h a p te r  2  an d  a n a ly s e d  fo r T A G , T C , H D L -C  and  g lu co s e  as  d e s c rib e d  in 
c h a p te r  2 . L D L -C  w a s  c a lc u la te d  using  th e  F re id w a ld  e q u a tio n  (F re id w a ld  e t  
a l  1 9 7 2 ) . L o w -d e n s ity  lipopro tein  s u b c la s s e s  w e re  s e p a ra te d  by d e n s ity  
g ra d ie n t u ltracen trifu g atio n  as  d e s crib ed  in c h a p te r  2  a t  b a s e lin e  a n d  4  w e e k s  
p o st d ie t.
3 .2 .5  A n a ly s is  o f  e r y th r o c y te  m e m b r a n e  p h o s p h o lip id  fa t ty  a c id s
T h is  w a s  d e te rm in e d  using g as  c h ro m a to g ra p h y  as  p rev io u s ly  d es crib ed  in 
c h a p te r  2  an d  a n a lys is  p erfo rm e d  b y  C a ro lin e  E m ery .
3 .2 .6  S ta t is t ic s
S ta tis tica l an a ly s is  w a s  p e rfo rm e d  using  S P S S  vers io n  10 . T h e  s ta tis tica l 
s ig n ifica n c e  o f d iffe re n c e s  in b a s e lin e , m id -p o in t an d  e n d -p o in t p la s m a  
b io ch e m is try  a n d  w e ig h ts  w e re  te s te d  b y  A N O V A  w ith  re p e a te d  m e a s u re s  
o v e r tim e . P re  v e rs u s  p o st s tu d y  d iffe re n c e s  w e re  d e te rm in e d  b y  p a ired  
s tu d e n t t-tes t.
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/N o  su b jec ts  rep orted  a n y  s id e  e ffec ts  w h e n  tak in g  th e  oil. It w a s  e a s ily  a d d e d  
in to  th e  d ie t, a lth o u g h  m o re  fre q u e n tly  by  ad d in g  it to  d rinks  o r tak in g  it w ith  
food  a s  o p p o s ed  to  incorporating  it in to  th e  foo d  m atrix . O n e  s u b je c t w a s  ap \e  
to  d e te c t th e  oil e v e n  w h e n  b le n d e d  w ith  o th e r fo o d s  to  m a s k  th e  flav o u r, but 
g e n e ra lly  p a la tab ility  w a s  g o o d , a n d  su b jec ts  fou n d  th e  rec ip e s  in c lu d ed  in th e  
w ritten  in fo rm ation  usefu l. S u b je c ts  fo u n d  it d ifficult to  ju d g e  q u an tities  
a c c u ra te ly  w h e n  using th e  oil a lo n e  a n d  d e s p ite  th e  add itio n a l u s e  o f  e n rich e d  
pro d u cts , s o m e  su b jec ts  rep o rted  d ifficu lty  in a ch iev in g  th e  d e s ire d  n u m b e r o f  
units  p e r  d ay . T h e  unit s y s te m  itse lf w a s  a lso  c o n s id ered  a  p o o r id e a . M a n y  
s u b jec ts  fo u n d  th e  b u tte r c u b e s  to o  la rg e  to  u se  in o n e  sitting a n d  e x p re s s e d  
p ro b lem s  using th e m  a s  th e y  n e e d e d  to  b e  k e p t fro z e n  until 2 0  m in u tes  b e fo re  
u se . A  s im ila r p ro b lem  o ccu rred  w ith  th e  m a y o n n a is e  w ith  s u b je c ts  rap id ly  
b ec o m in g  fru s tra ted  w ith  th e  m o n o to n y  o f this  m o d e  o f d e livery .
A  m a jo rity  o f su b jec ts  e x p re s s e d  d ifficu lty  in ad h e rin g  to  th e  s tu d y  d ie ta ry  
pro to co l w h e n  e a tin g  out, a n d  s u g g e s te d  th a t m o re  c o m p re h e n s iv e  a d v ic e  b e  
g iv e n  b e fo re  e m b a rk in g  o n  th e  p rinc ipal in terven tio n . S u b je c ts  a lso  reco rd ed  
o th e r w a y s  o f incorporating  th e  oil in to  th e  d iet; th e  m o st c o m m o n  m e th o d  w a s  
to  in c lu d e  th e  oil in a  m ilk s h a k e  drink.
3 .3 .1  D if fe r e n c e s  b e tw e e n  th e  n u tr i t io n a l c o m p o s it io n  o f  b a s e l in e  
a n d  s tu d y  d ie ts
A  c o m p a ris o n  b e tw e e n  b a s e lin e  a n d  s tu d y  d ie ts  re v e a le d  a n  in c re a s e  in 
e n e rg y  fro m  fa t (p = 0 .0 1 )  a n d  a  d e c re a s e  in e n e rg y  fro m  c a rb o h y d ra te  
(p = 0 .0 1 ) . E n e rg y  d erive d  fro m  P U F A  in c rea se d  from  6 .9 %  to ta l e n e rg y  to
1 1 .5 %  (p = 0 .0 0 3 ) . A  d e c re a s e  in th e  n -6 :n -3  ra tio  w a s  fro m  1 6 .2  in th e  h ab itual 
d ie t, to  0 .3 5  in th e  d ie ta ry  in te rven tio n  (p = 0 .0 2 )  w a s  m e a s u re d . T h e  m e a n  
in ta k e  o f A L A  p e r d a y  w a s  2 3 .1g (± 4 .1 g ) , th is  w a s  e q u a l to  6 .2  units. T h e  
o rig in a l a im  o f 8  units w a s  n o t a c h ie v e d  fo r re as o n s  s ta te d  a b o v e . V a ria b ility  
in th e  in tak e  o f A L A  c a m e  fro m  o th e r fo o d s  co n ta in in g  A L A  a n d  d iffe re n c e s  in
3.3 R E S U L T S
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su b jec ts  c o m p lia n c e  to  th e  d ie t. A  s u m m a ry  o f hab itu a l a n d  s tu d y  d ie ts  is 
sh o w n  in T a b le  3 .2 .
Table 3.2: Habitual and study diet information from the pilot study.
Total Energy/ %  Energy H a b itu a l D ie t (S .D .) S tu d y  D ie t (S .D .)
Total Energy (M J) 9 .5  (2 .2 ) 11.1 (2 .0 )
Protein 15.4  (1 .0 ) 14.0  (2 .4 )
Fat 3 3 .9 (4 .1 ) 39.1 (4 .9 )**
Carbohydrate 4 0 .9  (6 .0 ) 35 .7  (6 .0 )**
SFA 10.9  (2 .4 ) 1 1 .4 (2 .9 )
M U FA 11.1 (1 .0 ) 1 0 .9 (1 .8 )
P U FA 6 .9  (0 .9 ) 11.5  (2 .9 )***
n6:n3 ratio 16.2  (16 .8) 0 .35  (0 .1 )*
Dietary Unit equivalents 6 .2
* p = 0.02 * * p ~ 0 .0 1  *** p “  0.003 (Paired t-test)
T h e re  w e re  no s ig n ifican t d iffe re n c e s  m e a s u re d  in p la s m a  T A G , C h o les te ro l, 
H D L -C h o ie s te ro l, L D L -C h o le s te ro l o r G lu c o s e  a t a n y  in te rven tio n  t im e  po in t 
(T a b le  3 .3 ) .
Table 3.3: Biochemical parameters and weights of aii subjects at weeks 0,2 and 4.
W e e k  0 (S .D .) W e e k  2  (S .D .) W e e k  4  (S .D .)
T A G  mmol/l 1 .4 2 (0 .5 8 ) 1 .2 4 (0 .3 3 ) 1 .37  (0 .23)
Cholesterol mmol/l 4 .91 (0 .9 9 ) 4 .73  (0 .82) 4 .7 7 (0 .8 0 )
H D L mmol/l 1 .1 7 (0 .3 1 ) 1.20  (0.38) 1 .1 6 (0 .3 3 )
LDL mmol/l 3 .09  (0 .8 6 ) 2 .96  (0.75) 2 .98  (0 .88)
G lucose mmol/l 5 .52  (0 .3 5 ) 5 .52  (0 .31) 5 .49  (0 .29 )
W eight (kg) 7 7 .0  (6 .1 ) 77 .2  (5.8) 7 6 .7  (5.8)
T h e  c h a n g e s  in e ry th ro c y te  m e m b ra n e  fa tty  acid  p h o sp h o lip id s  w e re  re la ted  
to  c h a n g e s  in d ie ta ry  in take . T h e  p e rc e n ta g e  o f A L A  in e ry th ro cy te  m e m b ra n e  
fa tty  ac id  phosp h o lip id s  in c re a s e d  fro m  0 .4 %  to ta l fa tty  a c id s  to  1 .3 %  
(p = 0 .0 2 ) . T h e re  w a s  a lso  a n  in c re a s e  in E P A  fro m  1 .1 %  to  2 .1 %  by w e e k  4  
(p = 0 .0 0 4 ) . O n  th e  o th e r h an d , D H A  d e c re a s e d  fro m  4 .9 %  to  3 .4 %  (p = 0 .0 0 4 ) . 
T h e  com po s itio n  o f e ry th ro c y te  m e m b ra n e  fa tty  ac id  p h o sp h o lip id s  a t w e e k  0  
a n d  w e e k  4  is sh o w n  in T a b le  3 .4 .
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Table 3.4: Fatty acids in erythrocyte membrane phospholipids at week 0 and week 4.
% W e e k  0 
(S .D .)
% W e e k  4  
(S .D .)
A%
Palmitic Acid 16:0 2 6 .0 (1 .7 8 ) 27.2  (6.0 ) 4.6%
Stearic Acid 18:0 10.1 (1.6) 11.8 (4.2) 16.8%
Oleic Acid 18:1 n-9 3.2 (6.4) 5 .7 (1 0 .2 ) 78.1%
Linoleic Acid 18:2 n-6 14.8 (1.9) 14.4 (2.3) -2 .7%
Alpha-Linolenic Acid 18:3 n-3 0.4  (0 .29) 1 .3 (0 .9 7 )* 225 .0%
Arachadonic Acid 20:4  n-6 1 3 .8 (4 .7 ) 1 1 .5 (5 .0 ) -16 .7%
EPA  20:5 n-3 1.1 (0 .64) 2.1 (1 .14)** 90.9%
D H A  22:6  n-3 4 .9  (1.4) 3.4 (1 .94)** -30 .6%
* p  =  0 . 0 2  ** p  = < 0 . 0 1
C o m p a ris o n  o f p e rc e n ta g e  c h a n g e  in d ie ta ry  in take  o f fa ts  b e tw e e n  b a s e lin e  
an d  in terven tio n  w ith  c h a n g e s  in e ry th ro cy te  m e m b ra n e  p hospho lip id  fa tty  
acid  com po s itio n  is sh o w n  in F ig u re  3 .1 .
Figure 3.1: Percentage change in dietary intake between baseline and intervention of 
fats and observed changes in erythrocyte fatty acid membrane composition.
□  Diet BRBC i
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T h e  m e a n  p e rc e n ta g e  o f e a c h  L D L  s u b c lass  a t b a s e lin e  and  4  w e e k s  a re  
sh o w n  in T a b le  3 .5 .
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Table 3.5: Mean distribution of LDL subclasses at week 0 and week 4.
Distribution o f LDL Week 0 Week 4
subclasses Mean (SD) Mean (SD)
% LDL 1 19(9.9) 22 (17.4)
% LDL 2 56 (12.2) 57 (7.8)
% LDL 3 25 (17.4) 21 (7.3)
A t b a s e lin e  8  ou t o f th e  9  su b jec ts  e x h ib ite d  a  p attern  A  p h e n o ty p e . O n e  
s u b je c t (s u b je c t 6 )  exh ib ited  a  p a tte rn  B p h en o typ e . O v e ra ll no  s ig n ifican t  
c h a n g e s  w e re  o b se rve d  in L D L  s u b c la s s  p ro files . F ig u re  3 .2  illustrates  all th e  
L D L  s u b c la s s  p ro files  p re  d ie ta ry  in terven tio n  (b lu e ) a n d  p o st d ie ta ry  
in te rven tio n  (re d ). S u b je c t 6  d e m o n s tra te d  a  shift fro m  th e  “h ig h -risk” p a tte rn  
B p h e n o ty p e  to  p a tte rn  A .
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3.4 Discussion
T h e  p ilo t s tu d y  s u c c e e d e d  it its in itial a im s  to  te s t th e  fea s ib ility  o f rou tes  o f  
d e liv e ry  in p rovid ing  A L A  in co m b in a tio n  w ith  a  d ie t lo w  in n -6  P U F A  d ie t  
V e rb a l fe e d b a c k  fro m  all th e  su b jec ts  w h o  to o k  p art led  to  c h a n g e s  th a t m a y  
im p ro v e  c o m p lia n c e  in th e  p rinc ipal s tudy. T h e  add ition  o f A L A  to  foo d s  a fte r  
coo k in g  o r a s  p a rt o f th e  in g re d ien ts  p ro v ided  a n  e ffe c tiv e  ro u te  o f  d e live rin g  
th e  oil. T h e  u s e  o f w ritten  in fo rm atio n  a n d  rec ip es  a id e d  c o m p lia n c e  as  
v e rb a lly  rep o rted  b y  su b jec ts  a n d  a s  s h o w n  by in c re a s e s  in e ry th ro cy te  
m e m b ra n e  F A  A L A . S e v e ra l su b jec ts  s u g g e s ted  th a t h av in g  th e  oil p a c k a g e d  
in kno w n  q u an tities  w o u ld  a id  a c c u ra te  d e live ry , a n d  a lso  p ro v id e  g re a te r  
flex ib ility  w h e n  e a tin g  o u ts id e  o f th e  h o m e  a s  such  m o re  w ritten  in fo rm atio n  
on e a tin g  ou t w a s  a d d e d  in to  th e  p rinc ipal s tu d y  a lo ng  w ith  a b a n d o n in g  th e  
unit sys te m , w h ich  w a s  not w e ll liked, fo r p re -p a c k a g e d  oils  in kno w n  d o ses .
T h e  m o s t s u ccessfu l m e a n s  o f d e liv e ry  w a s  using th e  oil d irectly , e ith e r  
ad d in g  it to  fo o d  a fte r  it h ad  b e e n  c o o k ed , o r using it a s  p a rt o f a  cold d ish  
such  a s  a  s a la d  d ress ih g . T h e  id e a  o f incorporating  th e  oil in to  m ilks h ak es  
w a s  not in itia lly  c o n s id e re d  in th e  pilot, but w a s  a d d e d  to  m e th o d s  o f d e live ry  
fo r  th e  p rinc ipal s tu d y  a fte r  q m a jo rity  o f  sub jec ts  found  it u se fu l.
T h e  tw o fo ld  in c re a s e  in A L A  m e a s u re d  in e ry th ro cy te  m e m b ra n e  
p h o sp h o lip id s  p ro v id es  e v id e n c e  fo r e ffe c tiv e  ab so rp tio n  a n d  incorporation . 
T h e  in c re a s e s  in th e  a b u n d a n c e  o f A L A  in e ry th ro cy te  m e m b ra n e  
p h o sp h o lip id s  in th o s e  s u b jec ts  tak in g  th e  fla x  oil d ie t cou ld  b e  u sed  a s  a n  
in d icato r o f c o m p lia n c e  to  th e  d ie t. T h e  fa ilu re  to  m e a s u re  a n y  in c re a s e s  in 
D H A  a re  c o n s is te n t w ith  th e  find ings  o f o th e r s tu d ies  (T a b le  1 .9 ). H o w e v e r, 
th e  in terven tio n  p erio d  o f th is  pilot w a s  o n ly  4  w e e k s , w h e re a s  th e  principal 
stu d y  w o u ld  last 12. It is im p o rtan t to  n o te  th a t th e  m e a n  life sp an  o f a n  
e ry th ro cy te  is 1 2 0  d a y s  (4  m o n th s ), a n d  th a t re lia n ce  on  th is  o v e r a  2 8 -d a y  
p eriod  m a y  no t p ro v id e  a n  a c c u ra te  ind ication  o f d ie ta ry  c o m p lia n c e  a n d  A L A  
co n vers io n  to  its lo n g e r ch a in  p roducts . T h e  e ffec ts  o f th e  m e ta b o lic  tran sp o rt  
a n d  s to ra g e  poo ls  o f F A  d iscu ssed  in C h a p te r  1 shou ld  a ls o  b e  co n s id ered .
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In c re a s e s  In th e  e ry th ro cy te  fa tty  ac id s  A L A , a n d  E P A , bu t d e c re a s e  in D H A  
m a y  b e  th e  re su lt o f  insuffic ient m e ta b o lic  e lo n g a tio n , ra th e r th a n  insuffic ien t  
A L A  fro m  th e  d iet. T h e  u se  o f th e  7  d a y  foo d  d ia ries  s u p p o rted  th is  by  
sho w in g  a  d e c re a s e  in th e  d ie ta ry  n -6 :n -3  ra tio  fro m  1 6 .2  in th e  h ab itu a l d ie t to  
0 .3 5  in th e  s tu d y  d ie t. C h a n g e s  in th e  co m p o s itio n  o f e ry th ro cy te  fa tty  acid  
m e m b ra n e s  p ro v id ed  a  v a lu a b le  ins igh t in to  incorporation  a n d  m e ta b o lic  
e lo n g a tio n  o f A L A . T h e  a b s e n c e  o f a n y  c h a n g e s  in d ie ta ry  s a tu ra te s  an d  
m o n o u n s a tu ra te d  fa ts  s u g g e s t th a t c h a n g e s  o b se rve d  in m e m b ra n e  fa tty  
ac id s  a re  a s  a  resu lt o f  substitu tion  fo llow ing  th e  a lte ra tio n  o f o th e r d ie ta ry  
fa tty  ac id s , m o s t n o ta b ly  A L A . F o r e x a m p le , o le ic  ac id  in c re a s e d  b y  7 8 %  
fo llow ing  a  2 %  reduction  in M U F A  d ie ta ry  in take , w h e re a s  LA  re m a in e d  
v irtu a lly  u n c h a n g e d .
T h e  s ig n ifica n t in c re a s e  in E P A  in th e  a b s e n c e  o f a n y  d ie ta ry  so u rces  
s u g g e s ts  th a t e lo n g a tio n  o f  A L A  h as  o cc u rre d . H o w ever* th e re  is no e v id e n c e  
o f co n tin u ed  e lo n g a tio n  as  d e m o n s tra te d  b y  th e  3 1 %  d e c re a s e  in D H A . T h e s e  
d a ta  m a y  s u g g e s t th a t d e c re a s e s  in A A  an d  D H A  in th e  e ry th ro cy te  
m e m b ra n e  p h o sp h o lip id s  h a v e  b e e n  re p la c e d  to  s o m e  e x te n t b y  o le ic  ac id .
D e s p ite  s o m e  e x te n s iv e  c h a n g e s  in d ie ta ry  com po s itio n , th e re  w e re  no  
s ig n ifican t in c re a s e s  in to ta l e n e rg y  in tak e . T h e  s ig n ifican t rise  in to ta l e n e rg y  
fro m  fa t  (+ 5 % )  w a s  to  a  certa in  e x te n t c o m p e n s a te d  fo r b y  a  reduction  in 
o ve ra ll e n e rg y  fro m  c a rb o h y d ra te  ( -4 .8 % ). T h e re  w e re  v e ry  s m a ll non­
s ig n ifican t c h a n g e s  in th e  to ta l e n e rg y  fro m  S F A  an d  M U F A , bu t a s  e x p e c te d  
a  s ig n ifican t rise  in to ta l e n e rg y  fro m  P U F A . T h e re  w e re  n o  c h a n g e s  in o vera ll 
w e ig h t. It is u n c le a r  h o w  su b jec ts  m a in ta in e d  e n e rg y  b a la n c e  (d e m o n s tra te d  
by w e ig h t m a in te n a n c e ) w h e n  no s p e c ific  a d v ic e  w a s  g iv en  o th e r th a n  th a t  
s ta te d  e a rlie r .
T h e re  w e re  no  s ig n ifican t c h a n g e s  in L D L  s u b c la s s e s  m e a s u re d  o v e r th e  4  
w e e k  p erio d . T h is  is like ly  to  b e  d u e  to  8  ou t o f 9  su b jec ts  b e ing  
n o rm o lip id a em ic . T h e y  p re s e n te d  w ith  P a tte rn  A  p h en o typ es  a t th e  s tart o f th e  
study. H a d  A L A  e x e rte d  fish  oil like  e ffe c ts  on L D L  s u b c la ss  d istribution , it
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w o u ld  h a v e  b e e n  d ifficu lt to  m e a s u re  in s u b jec ts  a lre a d y  exh ib itin g  th e  p a tte rn  
A  p h en o typ e . S u b je c t 6 , w h o  b e g a n  th e  s tu d y  as  p a tte rn  B (F ig u re  3 .7 ) ,  
sh ifted  to w ard s  p a tte rn  A  b y  w e e k  4 , th is  w a s  re p re s e n te d  by a  d e c re a s e  fro m  
7 7 %  L D L -3  a t b a s e lin e , to  3 1 %  L D l - 3  a t  th e  e n d . T h is  w a s  a c c o m p a n ie d  b y  a  
d e c re a s e  in T A G  fro m  2 .8 9  m m o l/l a t th e  c o m m e n c e m e n t o f  th e  s tu d y , to  1 .6 4  
m m o l/l a t  th e  e n d . It is not p o ss ib le  to  co n c lu d e  if th e  e ffe c ts  o b s e rv e d  in th e  
p ilo t s tu d y  w o u ld  o c c u r in o th er h yp e rtriac y lg lyc e ro lae m ic  su b jec ts . T h e  
p rin c ip le  s tu d y  p o p u la tio n  h o w ev e r, w o u ld  con s is t o f d is lip id a em ic  sub jec ts .
3 .5  C o n c lu s io n
O v e ra ll, th e  n u m b ers  in v es tig a ted  w e re  to o  s m all to  d e te rm in e  s ta tis tica lly  th e  
e ffe c ts  o f th e  d ie t on a n y  o f th e  p a ra m e te rs  m e a s u re d . W h a t  it did a c h ie v e  
w a s  v a lu a b le  ins ights  in to  th e  log istical a n d  p ractica l issu es  surro un d in g  th e  
d e liv e ry  o f d ie ta ry  A L A  fo r  th e  p rinc ipal s tudy. It p ro v id ed  e v id e n c e  fo r  
incorporation  o f A L A  into  e ry th ro cy te s , a n d  h o w  th is  m a y  p o te n tia lly  b e  usefu l 
a s  a n  ind icator o f d ie ta ry  c o m p lia n c e . T h e  s tu d y  a lso  p ro v id ed  s o m e  e v id e n c e  
fo r  m e ta b o lic  e lo n g a tio n  o f  A L A  to  E P A .
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4  C H A P T E R  4 : T H E  IM P O R T A N C E  O F  A L P H A -
L IN O L E N IC  A C ID  A S  A  S O U R C E  O F  N -3  P U F A : 
A S S E S S M E N T  O F  D IE T A R Y  C O M P L IA N C E .
4 .1  In t r o d u c t io n
T h e  n e e d  fo r go o d  d ie ta ry  c o m p lia n c e  in a  d ie ta ry  in terven tio n  s tu d y  is 
e s s e n tia l. It is m a d e  m o re  d ifficu lt in free -liv in g  s tu d ies , w h e re  in tak es  c a n n o t  
b e  re g u la te d  a s  a c c u ra te ly  as  th e y  c a n  in a  m e ta b o lic  k itchen . T h e s e  s tu d ies  
a re  n e v e rth e le s s  im p o rtan t, a s  th e y  a re  m o re  re p re s e n ta tiv e  o f th e  ty p e s  o f  
b eh a v io u rs  th a t w o u ld  b e  w itn e s s e d  shou ld  such  d ie ta ry  a d v ic e  b e  g iven  to  
th e  po p u la tio n  in g e n e ra l. E n h a n c in g  d ie ta ry  c o m p lia n c e  is a n  im p o rtan t 
c o n s id era tio n  w h e n  d ev is in g  a  fre e -liv in g  d ie ta ry  in terven tio n  s tu d y . B arn ard  
e t a l (1 9 9 5 )  identified  a  n u m b e r o f  fac to rs  w h ich  e n h a n c e  d ie ta ry  c o m p lia n c e , 
including involving fa m ily  m e m b e rs , e n c o u ra g in g  foo d  m on ito rin g , providing  
instruction  on cooking , nutrition a n d  m e a l p lan s . L ew is  e t  a l  (1 9 9 0 )  a lso  fou n d  
th a t a d h e re n c e  on  less  p a la ta b le  d ie ts  cou ld  b e  e n h a n c e d  w ith  w ritten  
in fo rm atio n  on h o w  to  m a k e  th e m  ta s te  b e tte r. P rov id in g  s p e c ific  fo o d s  to  
ind iv id u als  a lso  im p ro ves  d ie ta ry  c o m p lia n c e  (J e ffe ry  e t  a l 1 9 9 3 ) . G o rb a ch  
a n d  c o -w o rk e rs  (1 9 9 0 )  s u g g e s te d  th a t m o tiva tio n  to  c h a n g e  w a s  a n  im p o rtan t 
fac to r, th is  is re le v a n t a s  a  n u m b e r o f s tu d ie s  ta rg e t p o p u la tio n s  w h o  a re  
a w a re  o f th e ir  risk fac to rs  o r d ia g n o s e s . T h e  m o s t c o m m o n  fac to rs  w h ich  
d e c re a s e  d ie ta ry  c o m p lia n c e  a re  th a t p e o p le  e n jo y  th e  foo d  th e y  a re  curren tly  
e a tin g  a n d /o r  th e y  a lre a d y  th in k  th e ir  d ie ts  a re  h ea lth y  (C o n tu g n a  e t  a l  1 9 9 2 ). 
W h ile  th is  m a y  b e  a n  im p o rtan t c o n s id era tio n  in lo n g -te rm  d ie ta ry  a d v ic e , it is 
less  like ly  to  a ffe c t th o s e  w h o  h a v e  v o lu n te e re d  to  ta k e  p art in a  s tu d y  o f  
kn o w n  d u ratio n  a n d  w h o  a re  c o n s id ered  to  b e  m o tiva ted .
4 .2  M e th o d s
T o  d e te rm in e  h ab itu a l a n d  s tu d y  d ie ta ry  in takes , v a lid a ted  (B in g h a m  e t a l 
1 9 9 7 ) 7  d a y  foo d  d ia rie s  w e re  u sed . B a s e d  on th e  find ing o f o th e r s tu d ies  an d  
on th e  e x p e r ie n c e  o f o th e r in ves tig a to rs  w h o  h a v e  p rev io u s ly  w o rk e d  on  
d ie ta ry  in terven tio n  s tu d ies , a  list o f  fac to rs  w h ich  m a y  im p ro v e  o r re d u c e  
d ie ta ry  c o m p lia n c e  w e re  c o n s id e re d  (T a b le  4 .1 ) .
65
Table 4.1: Factors that may positively or adversely affect compliance
Factors which aid compliance Factors which may reduce compliance
Good information & education Time frame (3 month intervention)
Dietary supplements that are simple to use Palatability
Time required each day to comply Quality of life (such as eating out)
Support during intervention (written & verbal) Side effects of supplementation
F ro m  th e s e , p ractica l a n d  e d u c a tio n a l s tra te g ie s  to  e n h a n c e  c o m p lia n c e  w e re  
d e v is e d . T h e s e  w e re  c a te g o ris e d  into e d u c a tio n  an d  in fo rm atio n , and  into  
p rac tica l a n d  d ie ta ry  s tra te g ie s .
4 .3  E d u c a t io n  &  In fo r m a t io n  S t r a te g ie s
V o lu n te e rs  w e re  p ro v id ed  w ith  in fo rm atio n  in 4  w a y s . Firstly, a n  o p e n  e ve n in g  
w a s  o rg a n is e d  w h e re  th e  in ves tig a to rs  in vo lved  e x p la in e d  th e  b as ic  con cep ts  
o f th e  study; th is  in c lu d ed  p artn e rs  w h o  fo r m a n y  w e re  co n s id ered  
in s tru m e n ta l in m a in ta in in g  c o m p lia n c e  a t h o m e , p rim arily  a s  th e y  w e re  
h e a v ily  invo lved  in foo d  p re p a ra tio n . S e co n d ly , an d  to  e n h a n c e  th e  la tte r  
point, w ritten  in fo rm atio n  w a s  g iv en  to  a ll v o lu n tee rs  (s e e  A p p e n d ix  3 ). T h is  
not o n ly  d e s crib ed  th e  ra tio n a le  fo r  th e  s tudy, but a lso  g a v e  c le a r  a d v ic e  on  
m ain ta in in g  lo w  in tak es  o f n -6  P U F A  a n d  fish  o ils  fo r th e  d u ra tio n  o f  th e  study. 
T h e  w ritten  a d v ic e  not o n ly  in c lu d ed  in fo rm atio n  on w h a t not to  e a t, but a lso  
s u ita b le  a lte rn a tiv es . W a y s  in w h ich  to  u s e  th e  oils and  m a rg a rin e s  p ro vided  
w e re  a lso  in c lu d ed . T h e  th ird  m e th o d  w a s  an  ind iv idual c o n su lta tio n  w ith  a  
S ta te  R e g is te re d  D ie titian . T h is  w a s  c o n d u c te d  o n  a  o n e -2 -o n e  b as is  w ith  th e  
v o lu n tee r. It in vo lved  a  d e ta ile d  d ie t h is tory  to  identify  foo d s  w h ich  m a y  not 
h a v e  b e e n  reco rd ed  in th e  7  d a y  h ab itu a l d ie t d ia ry  an d  a d v ic e  m o re  spec ific  
to  th a t ind iv idual on h o w  to  m a in ta in  a  lo w  in tak e  o f d ie ta ry  n -6  P U F A  an d  fish  
oils e xc lu d in g  th o s e  p ro v id e d  b y  th e  s tu d y . T h e  fourth  m e th o d  w a s  th rou g h  
v e rb a l co m m u n ica tio n . C o n ta c t te le p h o n e  n u m b ers , including o u t o f hours, 
w e re  p ro v id ed  a n d  v o lu n te e rs  a c tiv e ly  e n c o u ra g e d  to  c o n tac t s tu d y  p erso n n e l 
sho u ld  th e y  h a v e  a n y  q u e rie s  a b o u t c e rta in  fo o d s . V o lu n te e rs  w e re  a lso  
e n c o u ra g e d  to  a s k  q u es tio n s  d uring  re g u la r  re -s u p p ly  o f  s u p p le m e n ts , during
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acq u is ition  o f b lood s a m p le s  o r  if partic ip a tin g  in add itio n a l in ves tiga tio ns  
runn ing  a lo n g s id e  th e  m a in  in terven tio n .
4 .4  D ie ta r y  a n d  P r a c t ic a l S t r a te g ie s
D e live rin g  th e  oils into th e  d ie t w a s  d ifficult. F la x s e e d  oil is in h eren tly  u n s tab le  
a n d  c a n n o t b e  h e a te d  a s  it o x id ises  (C h e n  e t  a l  1 9 9 4 ). It is a lso  u n s tab le  a t  
room  te m p e ra tu re  fo r long p eriods . T h is  p re s e n te d  s o m e  p ro b lem s  in te rm s  of 
d e live ry . W h ile  th e  p ilot s tu d y  h as  issu ed  e a c h  v o lu n te e r w ith  a  bottle  o f  
fla x s e e d  oil a n d  instructed  th e m  on  h o w  to  m e a s u re  it out, using  th is  m eth o d  
fo r th e  m a in  in terven tio n  w a s  c o n s id e re d  im p ractica l fo r m a n y  re a s o n s . Firstly, 
th e re  m a y  b e  v o lu n te e r  e rro rs  in m e a s u rin g  th e  correc t d o s e  o f oil, s ec o n d ly  
in a p p ro p ria te  s to ra g e  m a y  a ffe c t fa tty  ac id  s tab ility  and  as  such  restric t th e  
“portab ility” o f th e  oil during  th e  d ay . F la x s e e d  oil s to red  in a  bo ttle  is s e a le d  
u n d e r n itrogen  w h e n  p a c k a g e d , bu t o n c e  o p e n e d  e v e n  if s to red  co rrec tly  is 
still s u b je c t to  oxidation .
T o  o v e rc o m e  th e s e  p ro b lem s  surro un d in g  d o se , s tab ility  a n d  portab ility  th e  oil 
w a s  p a c k a g e d  in light proof, n itro g en  filled  foil lined p ac ke ts  in ind iv idual 
d o se s . T h is  a p p ro a ch  w o u ld  im p ro v e  c o m p lia n c e  in a  n u m b e r o f w ays; by  
a llo w in g  th e  oil to  b e  u sed  o u ts id e  o f th e  h o m e , reducing  th e  t im e  n e e d e d  to  
m e a s u re  ou t th e  c o rrec t d o s e , en s u rin g  th e  d e liv e ry  o f a  kn o w n  a m o u n t  
(d o s e ) o f oil a n d  p o te n tia lly  red u c in g  o x id a tiv e  c h a n g e s  in th e  oil w h ich  m a y  
a ffe c t p a la tab ility  a n d  e fficacy .
W h ile  th e  su n flo w e r oil d id  not n e e d  to  b e  s u b je c te d  to  such  rig o ro u s  s to ra g e  
cond itio n s  it w a s  p a c k a g e d  in th e  s a m e  w a y  a s  th e  fla x s e e d  oil fo r  re as o n s  o f  
portab ility  an d  e a s e  o f u se . A s  th e  p a c ka g in g  w a s  th e  s a m e , a p a rt from  a  
s in g le  le tte r co d e , it re m o v e d  th e  p ro b lem  o f sub jec ts  d ed u c in g  w h ich  d ie ta ry  
s u p p le m e n t th e y  w e re  on.
A  m a jo rity  o f th e  v o lu n te e r ’s h ab itu a l d ie ta ry  n -6  P U F A  w a s  d erive d  fro m  oil 
a n d  m a rg a rin e . A s  such , th e  s tu d y  a lso  p ro vided  re p la c e m e n ts  fo r  cooking  
oils a n d  m a rg a rin e s  d uring  th e  in te rven tio n  p erio d . T h is  p o te n tia lly  w o u ld
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im p ro v e  d ie ta ry  c o m p lia n c e  b y  p rovid ing  a  sp e c ific  product, ra th e r  th a n  a  list 
o f s u ita b le  m a rg a rin e s  a n d  o ils  to  use .
4 .5  A s s e s s in g  d ie ta r y  c o m p lia n c e
A  n u m b e r o f s tra te g ie s  w e re  c re a te d  to  a s s e s s  d ie ta ry  c o m p lia n c e . A  m a jo rity  
o f th e s e  w e re  fro m  in fo rm atio n  p ro v id ed  b y  th e  v o lu n tee rs  th e m s e lv e s , e ith e r  
v e rb a lly  o r in a  w ritten  fo rm a t (T a b le  4 .2 ) .
Table 4.2: Strategies used to determ ine com pliance by volunteers
S tra te g ie s  u sed  to  d e te rm in e  d ie ta ry  a n d  s tu d y  protoco l c o m p lia n c e  
Food diaries (7 days) x3
Debriefing during re-supply of supplements or during blood sample acquisition 
Questionnaires sent out upon completion of the study 
Counting returns of oil sachets and fish oil capsules
Erythrocyte membrane fatty acid analysis_________________________________________________
T h e  n u m b e r o f s a c h e ts  o f oil req u ired  by e a c h  v o lu n te e r to  c o m p le te  th e ir  
in terven tio n  p eriod  w a s  c a lc u la te d . A s  th e  s ac h e ts  req u ired  s to ra g e  in a  
fre e z e r  until u sed , v o lu n te e rs  w o u ld  re g u la rly  a tten d  th e  in ves tig a tio n  un it to  
a c q u ire  m o re  su p p lies . A  reco rd  o f  th e  n u m b e r o f s a c h e ts  o f  oil o r fish  oil 
c a p s u le s  d is p e n s e d  w a s  re co rd e d  a n d  a ll v o lu n tee rs  a s k e d  to  re tu rn  an y th ing  
le ft o v e r  w h e n  th e y  c o m p le te d  th e  study.
4 .6  V o lu n te e r s  a s s e s s m e n t  o f  th e ir  c o m p lia n c e
T o  d e te rm in e  v o lu n te e r im p ress io n s  o f th e  s tudy, an d  to  a s c e rta in  h o w  w e ll 
th e y  th o u g h t th e y  co m p lied  a n o n y m o u s  q u es tio n n a ire s  w e re  s e n t o u t to  all 
p artic ip an ts . Q u e s tio n s  c o v e re d  im p re ss io n s  o f th e  s tudy, d ie ta ry  a n d  p ractica l 
c o m p lia n c e  a n d  th e  o p p o rtu n ity  fo r  in d iv id u a l c o m m en ts . T h e  q u e s tio n n a ire s  
a lso  p ro v id ed  ins igh t into th e  e ffe c tiv e n e s s  o f th e  s tra te g ie s  d e v e lo p e d  to  aid  
c o m p lia n c e  in this p artic u la r study.
4 .7  R e s u lts
4 .7 .1  Q u e s t io n n a ir e s
5 5  q u e s tio n n a ire s  w e re  s e n t o u t to  v o lu n te e rs  (A p p e n d ix  1 ) a n d  17  w e re  
re tu rn e d  c o m p le te d  (3 1 % ). T h e  resu lts  a re  s u m m a ris e d  in T a b le s  4 .3  to  4 .8
6 8
M ain ta in in g  a  lo w  d ie ta ry  in ta k e  o f n -6  P U F A  a n d  fish  oil during  th e  
in terven tio n  w a s  e s s e n tia l. 3 0 %  fo u n d  it h ard  o r v e ry  h ard  to  e lim in a te  foo d s  
identified  a s  being  high in th e s e  during  th e  in terven tio n . C o m p lia n c e  w ith  
m e etin g  th e  req u ired  d o s e s  o f oils w a s  a lso  v e ry  im portant; 2 9 %  o f th o se  
tak in g  fish  oil c ap s u le s  sa id  th e y  fo rg o t to  ta k e  th e m  fre q u e n tly  a n d  2 4 %  sa id  
th e y  fo rg o t to  ta k e  th e  oil s a c h e ts  o cc as io n a lly . N o n e  o f th e  v o lu n tee rs  
rep o rted  c o m p le te  c o m p lia n c e  w ith  re s p e c t to  s ac h e ts  o r c ap su les .
It is re a s o n a b le  to  a s s u m e  th a t a  d e c re a s e  in c o m p lia n c e  m a y  b e  a s s o c ia te d  
w ith  in c reas in g  d ifficu lty  c o n s e q u e n tly  w h e n  a s k e d  h o w  e a s y  it w a s  to  ta k e  th e  
s a c h e ts  o f oil, fish  oil c a p s u le s  a n d  m a rg a rin e s  a ll v o lu n tee rs  s ta te d  th e  la tte r  
tw o  w e re  a v e ra g e  o r e a s y  to  use , o n ly  3 6 %  th o u g h t th e  s a c h e ts  w e re  an  
e ffe c tiv e  m o d e  o f d e live ry . U s ing  th e  s a c h e ts  o f oil in d rinks  w a s  fav o u red  
m o re  th a n  in corpo ra tin g  th e m  into  foo d .
F e e d b a c k  on  th e  u se  o f food  d ia rie s  w a s  a lso  m ixed . 5 6 %  fo u n d  th e m  hard  or 
v e ry  h ard  to  c o m p le te , w ith  3 3 %  filling th e m  in re tro s p ec tive ly  th e  fo llow ing  
d ay . M o s t v o lu n te e rs  th o u g h t th e y  w e re  a n  a c c u ra te  re flec tio n  o f  th e ir  d ie ta ry  
in take .
T h e  u s e  o f an  o p en  e v e n in g  w a s  re p o rte d  a s  b e ing  usefu l b y  9 3 % , a n d  8 1 %  
sta te d  th e y  w o u ld  ta k e  p art in a n o th e r in te rven tio n  s tu d y  (F ig u re  4 .1 ) .  D e s p ite  
e xp re ss in g  s o m e  d ifficu lties  w ith  th e  foo d  d ia rie s  a n d  m o d e s  o f s u p p le m e n t  
d e live ry , o n ly  1 2 %  s ta te d  th e  s tu d y  w a s  h ard  o r v e ry  h ard  to  c o m p le te . 1 2 %  
s ta te d  th e y  h ad  m a d e  lifesty le  c h a n g e s  p rio r to  th e  c o m m e n c e m e n t o f th e  
study, b a s e d  s im p ly  on th e  fa c t th e y  h ad  m e t th e  en try  c rite ria  a n d  had  b ee n  
g iv en  a c c e s s  to  th e ir  b lood  s c re e n in g  resu lts .
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The very nature of a free-living study is that there will be considerable individual 
variability. This variability can manifest itself in a number of ways: lack of 
understanding, poor compliance and inaccurate recording and processing of 
dietary intakes.
Issues around “lack of understanding” can be reduced but not eliminated by good 
verba! and written communication. The socio-economic group of the volunteer 
may also have an impact on their ability to follow dietary advice (Reid et al 1984). 
The principal study provided a broad framework of support for those taking part 
and their partners if appropriate. It was felt that no additional practical measures 
could have been implemented to improve understanding in the group studied.
Poor compliance due to lack of interest or difficulty in complying with the study 
diet may be reduced with good written and verbal support (Masley 1998). In as 
far as was possible those volunteers that were having difficulties were 
encouraged to contact the study investigators. Daytime and out of hours contacts 
were available. Good, clear information on the duration and nature of the study 
were made available as part of an open day prior to commencing the study, it 
was considered that in an adult population of this nature, this information would 
enable them to decide whether 3 months was too long for them to comply with 
the diet Poor compliance due to lack of interest or practical difficulties may have 
resulted in failure to take the required dose of supplements in parallel with a low 
n-6 PUFA diet. The method of counting returns was used, but this did not take 
into account losses or damage to supplements. Some volunteers failed to return 
supplements they had remaining at the end of the study. The use of the 
margarines and oil for cooking was not limited for use by volunteers and so were 
frequently used by the rest of the family; this made it impossible to determine 
intakes based on the numbers of returns and made the study more reliant on the 
data presented in the food diaries.
4.8 Discussion
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Completion of the food diaries by volunteers is another potential source of 
inaccuracy. The quality of the food diaries ranged between volunteers in terms of 
the accuracy with which they recorded intakes, 10 food diaries across all 3 diets 
were not completed. As discussed some were completed retrospectively, which 
may decrease accurate recall of that day, or previous day’s, dietary intake. The 
quality of the diaries also varied widely with some recording more detailed 
information than others, making over or under reporting a possibility. Seven-day 
food diaries are considered the most closely associated with weighed food intake 
when compared to other forms of dietary assessments (Bingham et al 1994). 
With respect to this study, it was felt that compliance may have been reduced if 
volunteers were required to weigh every item they consumed for 3 months.
Other discrepancies to the data collected from the food diaries were added by 
operator error. Three people were involved in entering the foods recorded into 
the computer program for analysis. Discrepancies were minimised by using 
standard portion sizes for foods where no amount was specified in the diary, 
however the literature is limited in the number of foods listed and some entries 
required an educated guess from the operators. One operator was a qualified 
dietitian and the remaining two student dietitians. Discrepancies between the 
output of the dietary analysis program were exacerbated by incomplete 
nutritional data on some foods, particularly fatty acid composition. While the 
MAFF fatty acid data was included in the software, this was limited to a certain 
number of foods. As such, data on the intakes of dietary ALA, LA, EPA, DPA and 
DHA may be falsely low. The variability of the dietary data collected is likely to be 
high, with errors from volunteers, operators of the software, and omissions in the 
nutritional data of foods. As such, conclusions based on dietary intakes should 
be considered carefully when interpreting the results and their effects in terms of 
CHD risk presented in Chapter 5.
4.8.1 Over and under reporting of dietary intake
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4.8.2 Outcome o f post d ie tary com pliance questionnaires.
The use of the questionnaire to obtain feedback from subjects who had 
completed the study provided valuable insight into compliance to the written and 
verbal instructions given as well as any difficulties they had following the diet. It 
also provided insight into possible changes that may facilitate future dietary 
interventions. Although the present study was conducted with free-living 
individuals, there were constraints on participants with regard to their dietary 
intake. This had obvious consequences when eating out, for example. Apart from 
written information, the diets were designed to be as “user friendly” as possible, 
packaging the oil in portioned sachets and replacing subjects usual cooking oil 
and margarine. Responses from the questionnaire indicate that the method of 
delivering the oil in sachets was not as well received as the investigators 
predicted with 65% stating it was a hard or very hard way of delivering the oil. 
Equally, taking the oil in drinks was favoured over using in or on food. Freese 
and Mutanen (1997) used capsules as a means of delivering flax oil, and 71% of 
those on the present study taking fish oil capsules rated them as easy or very 
easy to take every day. Likewise, the margarine as a means of delivery was well 
received with 76% of respondents stating it was easy or very easy to use. This 
suggests that capsules and margarines may be a better way of delivering 
flaxseed oil in terms of compliance, particularly if dietary intervention is in free 
living populations and over a long period of time. Despite the unpopularity of the 
sachets as a means of delivery, only 12% of those asked stated that the study 
was hard to complete overall.
The use of food diaries is a necessity in dietary intervention studies. In this case 
a 7-day diary was used to ascertain habitual and then dietary intervention 
intakes. Fifty-six percent of those asked found competing the diaries hard or very 
hard, with a third completing the diaries the day after they had eaten and a 
further third reporting they “occasionally” completed the diaries the following day. 
This undoubtedly would have some effect on accuracy, increasing the chances of
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a subject forgetting or recalling inaccurate portion sizes. There seems to be little 
that can be done to change this, as the importance of not completing the diaries 
retrospectively was emphasised both verbally and in written materials. Those 
volunteers who had made lifestyle changes following the initial screening session 
stated it was because they had been given access to their screening results. 
Future studies may benefit from non-disclosure to those selected to participate in 
the study, until all investigations have been completed. Those not selected to 
take part would not require such safeguards. The large number of subjects who 
stated they would take part in a future investigation suggests that some of the 
criticisms expressed in the 3-month intervention period were not prohibitively 
difficult. It is noteworthy that 24% had retuned to their GP for further health 
checks and 53% stated their diet had not returned to normal upon completion of 
the study. This must be considered if other dietary intervention studies are to 
use the same subjects in future investigations. The use of an open evening pre 
and post intervention was considered by 93% to be useful. The opportunity to 
meet staff and investigators “behind the scenes” and to have academic staff 
explain the origins of the research and what it hopes to demonstrate were 
considered very helpful. This means of communicating information to subjects 
and partners brought volunteers together and allowed them and their partners to 
ask questions in both a formal and informal manner. The role of partners in 
motivating volunteers was not investigated by the questionnaire, but in retrospect 
may be beneficial should such a questionnaire be used again.
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5 CHAPTER 5 PRINCIPLE STUDY: THE IMPORTANCE OF
ALPHA-LINOLENIC ACID AS A SOURCE OF N-3 PUFA: 
INFLUENCE ON RISK FACTORS OF CARDIOVASCULAR 
DISEASE
5.1 Introduction
It is now well established that long chain n-3 polyunsaturated fatty acids offer 
protection against CHD (Burr et al 1989, Connor et al 1997, GISSI 1999). Most of 
these fatty acids are of marine origin, and in order to achieve intakes that confer 
protection, oily fish or fish products need to be consumed. There is much 
resistance to consumption of oily fish within populations for a variety of reasons 
including taste, cultural, financial or dietary restrictions. The fatty acid alpha- 
linolenic acid (ALA) 18:3 n-3 is the shorter chain pre-curser to the longer chain n- 
3 PUFA. As humans possess the ability to elongate these shorter chain n-3 fats 
(Gerst H 1988) it follows that if sufficient ALA were consumed, conversion to the 
longer chain n-3 PUFA might occur and potentially offer the same benefits as fish 
oils. As previously discussed, prospective and case control trials have shown 
some, little or no benefit associated with consumption of ALA. Other studies have 
shown conversion to longer chain n-3 PUFA and others have failed to measure 
this.
This study aim was to measure the effect of dietary supplementation of ALA on a 
sub-set of an all male, free-living group exhibiting an ALP within the context of 
the FSA’s objectives, which were to seek suitable dietary alternatives to long 
chain n-3 PUFA. Dietary long chain n-3 PUFA have been associated with 
favourable changes in CHD risk factors, primarily through decreases in TAG, 
reductions in the numbers of small, dense LDL particles in the circulation and 
small increases in HDL-C. In order to further reduce CHD risk in the UK 
population, ALA the shorter chain pre-curser to EPA and DHA could potentially 
be very useful. Alpha-linolenic acid is one of the most abundant fatty acids in the 
natural world. Within the present study, if adequate conversion of ALA to EPA
77
and DHA could be achieved, potentially beneficial effects in terms of reversing an 
ALP might occur.
Three high PUFA diets were tested each with different PUFA compositions. The 
high short chain n-3 PUFA diet was achieved through ALA supplementation from 
flaxseed oil, the high n-6 PUFA diet was achieved through sunflower oil and the 
high fish oil diet through sunflower and fish oil capsule supplementation. The aim 
of the ALA enriched diet was to increase the intake of ALA and decrease the 
intake of LA in order to reduce the dietary n-6:n-3 ratio below 1.0. It was 
postulated that higher intakes of ALA against a lower intake of LA may result in 
greater conversion of the shorter n-3 PUFA to longer chain n-3 PUFA via the 
delta-6-desaturase enzyme. This enzyme is essential to both ALA and LA for 
elongation, its affinity for ALA being greater than LA. The aims of the high n-6 fat 
diet were reflect the habitual dietary n-6 intakes within the UK but also to achieve 
similar intakes of PUFA to that of the flax oil diet; as a result energy derived from 
total fat and PUFA would be similar. The two diets would differ only in the ratio’s 
of n-6 and n-3 fatty acids. The aim of the sunflower and fish oil diet was to act as 
a control. It was anticipated that those subjects allocated the fish oil diet would be 
associated with improvements in some indicators of CHD risk such as TAG and 
LDL heterogeneity. Lack of significant changes using longer chain n-3 PUFA may 
indicate that the use of shorter chain n-3 PUFA from flax oil to promote “fish oil” 
like effects may not be feasible in the population investigated in the present 
study.
5.2 Methods
5.2.1 Recruitm ent and Screening
This pilot study was approved by the ethics committee of the University of 
Surrey, Guildford, and the Royal Surrey County Hospital. Informed consent was 
obtained from the participating subjects. Volunteers were recruited through local 
GP practices, via the media, or the University’s intranet and internet sites.
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Researchers from the study, contacted local GP practices via letter (Appendix 2) 
and e-mail. Presentations were also offered to those who wished to learn more 
about the study’s aims and objectives. Potential volunteers were then identified 
by the GPs using computerised biochemistry records, or anonymously by study 
personnel following data from the local hospital’s biochemistry department. 
These individuals were then contacted by the GP informing them of the study 
and if they chose to take part all they had to do was return a slip in a pre-paid 
envelope to the researchers. Until this time, the identities of those initially 
selected were only known to the GP, thus maintaining GP-Patient confidentiality. 
The initial selection criteria for identification of potential volunteers as described 
to the GPs are detailed in Table 5.1.
Table 5.1: Initial selection criteria for potential volunteers.
Volunteers must not be on any lipid lowering medication or have history of heart disease
Volunteers must be non-smokers
Volunteers must not be suffering from diabetes
Recent fasting triglyceride levels below 1.5mmol/l
Recent total serum cholesterol level <6.5mmol/l
if available, recent HDL cholesterol levels <1.1 mmol/l________________________________________
Once volunteers had agreed to take part, they were invited to provide a blood 
sample. Blood samples were taken by the study’s nurse either at their local GP 
practices, or at the university’s investigation unit. Fasting lipids and glucose were 
then checked, and if withjn the initial selection criteria, were further analysed to 
determine LDL subclass phenotype. If the volunteer’s lipids and LDL phenotype 
met the entry criteria (Table 5.2), they were then formally invited to take part in 
the study by letter. Any volunteers who fell below the criteria were given a record 
of their blood results and an explanation of why they were unsuitable for the 
study by letter. GPs were asked to contact volunteers whose blood results 
appeared abnormal, after the results were made available. These volunteers 
were not invited to take part in the study.
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Table 5.2: Entry criteria for the study after screening blood samples.
Fasting triglyceride >1.5mmol/l 
Total plasma cholesterol £6.5mmol/i 
HDL cholesterol <1.1 mmol/l 
Fasting Glucose <6.5mmol/l 
LDL-3 subclass >40%
BMI < 30 kgm'2__________________________________________________________________________
Potential volunteers were also invited to take part in the study following press 
releases. Articles appeared in the local newspaper and on local BBC radio 
(Southern Counties Radio). This method resulted in a large number of queries by 
phone, letter and e-mail. Those that met the initial inclusion criteria (excluding 
blood results) were then invited to attend the investigation unit at the university to 
have screening blood samples taken. The GPs of those volunteers who had 
abnormal results were contacted, and the individuals urged to make an 
appointment to see them to discuss their results. Those who met the inclusion 
criteria for lipids had their LDL subclass phenotype determined, only subjects 
with LDL-3 >40% were eligible to take part in the study. Three dietary cohorts 
took part (Table 5.3) the first cohort was recruited entirely from local GP’s, the 
second from the media, and the third from both sources and also from within the 
university. All those who were selected were invited to attend an open evening 
along with their partners. Study investigators presented a summary of the current 
literature, and explained why the study was being conducted.
5.2.2 S tudy Design
Table 5.3 summarises the 3 dietary intervention periods and number of subjects 
run within each cohort.
Table 5.3: Numbers of volunteers completing each diet.
Diet/
' Cohort
Numbers within each cohort 
Cohort A Cohort B Cohort C
Oct-Dec Apr-Jul May-Sept 
1999 2000 2001
Total Volunteers 
who completed 
each diet (%)
X (Flax-Oil) ' 4 9 8 21 (37%)
Y (Sunflower Oil) 6 6 5 17 (30%)
Z (Fish oil + Sunflower 
Oil)
Total Each Cohort
6
16 (28%)
7
22 (37%)
6
19 (33%)
19(33% )
80
The study was a randomised single, blind study with three parallel diets. It was 
assumed that the recruitment population was reasonably homogenous in terms 
of their habitual dietary intake prior to commencing the study, as such there was 
no run-in diet prior to starting the intervention. Volunteers were randomly 
assigned to their treatment diets and everyone instructed to follow a low n-6 
PUFA diet during the intervention. To enable them to achieve this written 
information and practical advice was provided, as well as individual direction from 
a State Registered Dietitian more specific to their lifestyle. The investigators 
substituted the volunteer’s usual cooking oil with vegetable oil (Sainsbury’s 100% 
rapeseed oil) to cook and fry with. Volunteers on the sunflower oil and the fish oil 
diets received unmarked margarine high in monounsaturated fats and low in n-6 
fat (Mono, St-lvel). Volunteers on the flax oil diet received the same margarine, 
with a higher content of alpha-linolenic acid included by the manufacturers 
(additional 1.7g per 100g of spread). Seventeen mis of flaxseed oil or sunflower 
oil were packaged in nitrogen filled, lightproof aluminium lined sachets (Gravely 
Packaging Cambs, UK). Each sachet was labelled with a single letter code 
depending on the oil it contained. No other markings were present. Sachets 
labelled Y and Z contained sunflower oil. Sachets marked X, contained flax oil. 
All sachets were kept frozen at-18°C until used by the volunteer. Each volunteer 
was instructed to consume 2 sachets per day, and use only the margarine and 
cooking oil provided. Volunteers supplemented with fish oil consumed the same 
as those on the sunflower oil diet with the addition of 6 x 1g Pikasol (Pronova, 
Biocare) capsules per day. These provided 1.7g and 1.4g of EPA and DHA per 
day respectively. Recipes and instructions provided to volunteers can be found in 
Appendix 3. The nutritional content of the margarines, oils and fish oil capsules 
used are shown in Table 5.4.
5.2.3 Diet design
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Table 5.4: Nutritional content of the margarines, oils and fish oil capsules supplied to
volunteers.
Nutrients Flaxseed Rapeseed Sunflower Mono Altered Pikasol
per100g Oil Oil Oil Mono
Energy (MJ) 3.78 3.78 3.78 . 2.84 3.02 ' 3.78
Fat (g) 99.9 100 99.9 75 80 100
SFA(g) 6.6 6.7 12 11.5 11.5 -
MUFA (g) 31.5 6P 20.5 35 35 -
PUFA (g) 57.5 30 63.3 14.7 19.7 60.3
Total n-6 (g) 14.8 9.6 63.2 - - -
Total n-3 (g) 57.5 19.6 0.1 - - 60.3
C18:2 (g) 14.8 19.6 63.2 1.0 1.0 -
C18:3 (g) 57.5 9.6 0.1 3.4 5.1 -
C20:5 (g) - - - - - 27.9
C22:4 (g) - - •- - - 3.7
C22:6 (g) - - - - - 22.3
5.2.4 Determ ining d ie tary intakes
To determine habitual intake, volunteers completed a 7-day food diary prior to 
starting the study. They were asked to complete a further 7-day food diary at 
week 6 and at week 10 for dietary analysis. Intakes were determined using the 
dietary analysis program Dietplan 5 (Forestfield Software Ltd).
5.2.5 B lood samples and anthropom etric measurements
Baseline (0 weeks), midpoint (6 weeks), and 12 week blood samples were taken 
and prepared as described in Chapter 2.
Blood pressure was taken supine, prior to venepuncture by the study nurse. 
Body composition was determined by Bio-Impedance Analysis (BIA) using the 
Bodystat 1500 (Bodystat Ltd, UK). Subjects were instructed to empty their 
bladder and remove any metallic objects from their person before analysis 
began. The Bodystat machine was calibrated using a known resistance standard 
every morning before measurements began. Subjects were provided with 
breakfast after venepuncture. Investigators used this time to provide volunteers 
with supplies to take home and also to consult with them on any problems they 
may be experiencing in adhering to the diet.
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All subjects were provided with e-mail and telephone numbers (including out of 
hours) should they run into any problems during the course of the intervention. At 
the start of the study they were given recipe booklets on how to use the oil, 
information on eating away from home and a weight diary. Subjects were 
instructed to weigh themselves once a week and to notify study personnel if they 
had gained or lost more than 1.5kg.
5.3 D eterm ination o f h aem o sta tic  variab les
Batches of blood samples, stored at -80°C  until the end of each cohort, were 
transported to the M R C  Medical Epidemiology &  Medical Care Unit in London, for 
analysis of Factor VII, fibrinogeh and PAI-1 by methods previously described by 
(Meade e t  al 1993, Miller e t  al 1996).
5.4 Endothelial dysfunction  m easu rem en ts  by flow m ediated  dilation
Ultrasound measurements were conducted by a trained radiologist at the Royal 
Surrey County Hospital and by Dr M  Griffin at the University of Surrey. Blood flow 
and arterial diameter were measured non-invasively using high-resolution 
ultrasound (Celemajer e t  a l 1992). Arterial diameter was measured from 2- 
demensional images with a 7.0Mhz liner array transducer and a standard 128XPi 
10 System. Subjects had fasted for at least 2 hours and were rested supine for 
15 minutes before measurements were taken. Scans were measured at rest and 
during cuff-induced, reactive hyperaemia (endothelium ‘NO-dependent’ dilatation, 
then again at rest and after sublingual G T N  (300pg) (endothelium independent 
dilation). A  blood pressure cuff was inflated to 2 0 0 m m H g  for 5 mins before being 
released. Readings were taken at rest and then 30, 90 and 180 seconds after 
cuff release and 3.5 and 5 mins after administration of GTN. Recovery time 
between measurements was 5 minutes. Arterial blood flow was measured by 
pulsed Doppler signal at a 70° angle to the artery. Vessel diameter was 
measured at 6 different sites in the same segment of vessel by ultrasonographer
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that was blinded to the study groups. Comparisons were made between baseline 
and the mean post cuff or post G T N  measurements and expressed as 
percentage change.
5.5 S ta tistica l T ests
Analysis was performed using S P S S  11.0 for Macintosh. The group was studied 
for covariates to check the homogeneity of baseline values. Differences within 
each dietary group were analysed using paired student t-tests. Differences 
between the 3 dietary groups were analysed using A N OVA, plus post hoc tests 
for “paired” differences. Univariate associations between continuous variables 
were determined by correlation and simple linear regression. P-values were 
considered significant at less than the 5 %  level.
5.6 R esu lts
5.6.1 Dietary A nalysis of Habitual and  S tudy  Diets
There were no significant differences in the habitual dietary intakes of 
macronutrients and energy in ail three groups at baseline. The fish oil group had 
a marginally higher intake of total energy per day compared to the control group 
but this was not significant. Nutritional data for all three diets are shown in Table 
5.5. All three study diets differed in relation to percentage energy derived from n- 
3 P U F A  (Figure 5.1). An increase in the percentage energy from M U F A  in the 
flax oil group (p<0.001) compared to the sunflower and the fish oil groups was 
observed. Intakes of n-6 P U F A  were lower in the flax group (p<0.001) compared 
to both the fish oil and sunflower oil groups (Figure 5.1). All three dietary groups 
differed significantly in their n6:n3 ratios (p<0.001) (Figure 5.1), whilst intakes of 
S F A  were similar.
8 4
In the flax oil group there was an increase in energy derived from M U F A  
(p<0.001) occurred compared to baseline. There was also an increase in energy 
from and intake of n-3 P U F A  (p<0.001). The n6:n3 ratio decreased from 8.7±5.3 
to 0.5±0.2 on the study diet (p<0.001). Intakes of n-6 P U F A  did not change 
significantly.
In the sunflower oil group there was an increase in the percentage energy 
derived from fat (p<0.01) occurred compared to the habitual diet. Saturated fat 
intake decreased from 14.5±3.4% energy to 11.3±2.4% on the study diet 
(p<0.001), whilst intakes of n-3 P U F A  (p<0.05) and n-6 P U F A  (p<0.001) 
increased. The n6:n3 ratio increased from 10.0±4.2 to 26.4±19.8 (p<0.05).
In the fish oil plus sunflower oil group the percentage energy derived from protein 
fell slightly but was still significant (p<0.01). Energy from S F A  decreased 
(p<0.01) and intakes of n-6 P U F A  (p<0.001) and n-3 P U F A  (p<0.001) increased. 
There was a decrease in the n6:n3 ratio (p<0.05). Energy derived from alcohol 
decreased from 8.6±5.7% to 6.2 ±4.5% (p<0.01).
5 . 6 . 2  H a b i t u a l  v e r s u s  s t u d y  d i e t  c o m p o s i t i o n
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Table 5.5: intakes of Macronutrients on Habitual and Study diets
Flaxseed Oil Piet (DIET X)
Habitual Diet Study Diet
Energy MJ per day 9.9 (1.9 10.8 (2.7)
%  Energy from Fat 37.7 (6.9) 42.8 (6.4)
%  Energy from Carbohydrate 41.9 (7.3) 37.5 (6.6)
%  Energy from Protein 16.5 (2.9) 15.2 (3.0)
%  Energy from SFA 13.4 (3.4) 11.8(1.9)
%  Energy from M U F A 13.0(2.1) 17.8 (2.7) ***
n-3 g/d 1.2 (2.3) 19.0 (1.4)***
%  Energy from n-3 PUFA 0.7 (1.3) 6.9 (1.4)***
n-6 g/d 6.0 (5.4) 8.6 (3.4)
%  Energy from n-6 PUFA 2.4 (2.1) 3.1 (1.2)
n6:n3 PUFA ratio 8.7 (5.3) 0 5 (0 2) ***
%  Energy from Alcohol 5.1 (4.2) 5.4 (4.7)
Sunflower Oil Diet (DIET Y)
Habitual Diet Study Diet
Energy MJ per day 10.1 (1.2) 10.1 (2.1)
%  Energy from Fat 36.8 (5.6) 41.3(5.9)**
%  Energy from Carbohydrate 42.8 (7.3) 39.6 (6.4)
%  Energy from Protein 14.6 (1.8) 14.8 (2.7)
%  Energy from SFA 14.5 (3.4) 11.3 (2.4)***
%  Energy from M U F A 12.3 (2.2) 12.8(2.1)
n-3 g/d 0.7 (0.4) 1.4 (0.8)*
%  Energy from n-3 PUFA 0.3 (0.2) 0.5 (0.3)*
n-6 g/d 7.2 (6.3) 24.2 (5.7)***
%  Energy from n-6 PUFA 2.8 (5.6) 9.1 (1.7)***
n6:n3 PUFA ratio 10.0 (4.2) 26.4 (19.8)*
%  Energy from Alcohol 6.8 (6.7) 5.4 (5.4)
Fish Oil + Sunflower Oil Diet
(DIETZ)
Habitual Diet Study Diet
Energy M  J per day 11.2 (1.8) 10.7 (1.6)
%  Energy from Fat 36.9 (5.7) 40.8 (7.6)
% Energy from Carbohydrate 39.9 (6.3) 37.7 (6.9)
%  Energy from Protein 15.6 (1.8) 14.7 (2.2)**
%  Energy from SFA 14.0 (3.5) 11.1 (2.6)**
%  Energy from M U F A 12.7 (1.5) 12.6 (1.7)
n-3 g/d 0.6 (0.4) 4.7 (0.9)***
%  Energy from n-3 PUFA 0.2 (0.1) 1.6 (0.2)***
n-6 g/d 5.7 (3.9) 24.0 (2.9)***
%  Energy from n-6 PUFA 1.9 (1.4) 8.5 (1.6)***
n6:n3 PUFA ratio 9.2 (5.0) 5.2 (0.8)*
%  Energy from Alcohol 8.6 (5.7) 6.2 (4.5)**
(SD) Standard Deviation *p<0.05 **p<0.01 ***p<0.001 (compared to habitual die
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5.6.3 E ry th rocy te  m em b ran e  p h o sp h o lip id  fatty  ac id  co m p o sitio n
Erythrocyte membrane fatty acid composition for all three diets, at all three 
time points are shown in Figure 5.2. There were no significant differences 
between the 3 diet groups in the abundance of any of the fatty acids 
measured at baseline. A  decrease (pre vs post diet) in palmitic acid on the 
flax oil diet (-13%, p=0.04) and the fish oil diet (-15%, p=0.02) was measured. 
Oleic acid decreased at week 12 on the flax oil diet (-14%, p=0.02) and the 
fish oil diet (-23%, p<0.001) compared to baseline respectively. The 
abundance of LA decreased on the flax oil diet when compared to the control 
diet (p<0.01). The abundance of A L A  (pre vs post diet) increased in the flax oil 
group (p<0.0001), this increase was significant at week 6 (p<0.001) and 12 
(p<0.001) when compared to the fish oil and sunflower oil diets. Increases in 
E P A  (pre vs post diet) on the flax oil diet (+153%, p=0.01) and the fish oil diet 
(+124%, p<0.01) were also measured as were increases in D P A  (pre vs post 
diet) on the flax oil diet (+26%, p<0.05) and the fish oil diet (+64%, p<0.01). At 
week 6 the abundance of E P A  on the flax and fish oil diets was greater than 
the sunflower oil diet (p=0.01). By week 12, this was between the fish oil and 
sunflower oil diets only (p<0.01). The abundance D H A  increased on the fish 
oil diet (pre vs post) (+60%, p<0.01); this remained significantly higher than 
those measured on the flax and control diets at week 6 (p<0.001) and 12 
(p<0.001). A  positive (p=0.01, r=0.64) correlation was observed between the 
change in n-3 P U F A  intake and the change in the abundance of 18:3 n-3 in 
erythrocyte membrane phospholipids (habitual versus study diets) (Figure
5.3).
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Figure 5.2: Erythrocyte membrane phospholipid fatty acids: relative abundance (SD) at 
baseline (0 weeks), 6 and 12 weeks in all three dietary treatment groups.
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Figure 5.3: Flax oil group: change in percentage of n-3 PUFA intake (habitual vs study 
diet) against the abundance of 18:3 n-3 in erythrocyte membrane phospholipids
(baseline vs 12 weeks) r=0.69, p<0.001
1400.0
2000 4000 6000 8000 10000
%A n3 intake (habitual vs study diet)
5.6.4 Lipids, g lu c o se , lip o p ro te in s , h aem o sta tic , LDL an d  HDL 
s u b c la s s e s .
5.6.4.1 P lasm a  g lu c o se  an d  p la sm a  ap o lip o p ro te in  B
There were no significant changes in fasting plasma glucose levels either 
within or between any of the groups at any time point. Similarly, there were no 
significant differences at any time point between ail three dietary groups in the 
concentration of plasma apolipoprotein B. (Table 5.6).
5.6.4.2 P la sm a  L ip o p ro te in s
There were no significant differences between dietary groups in lipids, 
glucose, lipoproteins, LDL and H D L  subclasses or haemostatic values at 
baseline. The fish oil group had marginally higher but non-significant levels of 
T A G  (+16%) and total serum cholesterol (+9%) compared to the control group 
at baseline (Figure 5.4).
Changes in TC, LDL-C, T A G  and H D L  at baseline, 6 and 12 weeks are shown 
in Figure 5.4. There were no significant differences in LDL-C between any diet
9 0
group at 6 and 12 weeks. There was a non-significant decrease in LDL 
cholesterol within all groups compared to their respective baselines (Figure
4.3) flax (-9%), control (-8%) and fish (-5%). This fall was consistent over the 
intervention period. There were no significant differences in HDL-C between 
groups at baseline and at 6 weeks. There was a consistent but non-significant 
decrease in HDL-C at 12 weeks relative to baseline on the flax (-15%) and 
sunflower oil (-6%) diets, and a small increase in HDL-C on the fish oil diet. 
There were no significant differences in the TC:HDL-C ratio between the three 
dietary groups at 6 or 12 weeks. Changes within each group at 6 and 12 
weeks were also not significantly different from baseline. There was a 
significant decrease (p<0.001) in the TC:HDL-C ratio in the fish group (Table 
5.6) at 12 weeks compared to baseline.
There were no significant differences in total plasma cholesterol between any 
dietary group at 6 and 12 weeks. There was however, a consistent, but non­
significant fall in total serum cholesterol within all groups (Figure 3) compared 
to their respective baseline values (pre vs post diet) flax (-12%), control (-- 
11%) and fish (-8%).
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Total plasma T A G  in the control group increased by 1 5 %  at week 6 and had 
failed to return to baseline by week 12. There was a consistent decrease in T A G  
in the flax group compared to baseline (-11% by week 6 and - 1 8 %  at week 12) 
However, these changes were not significant when compared to the fish and 
control diets. There was a pronounced and statistically significant reduction in 
T A G  on fish oil (p<0.001), which was apparent by week 6 and was still evident at 
week 12 (Figure 5.4). Changes in T A G  compared to baseline are shown in 
percentages in Figure 5.5
Figure 5.5: Changes in TAG expressed as percentages compared to baseline on all three
diets at weeks 6 and 12
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5.6.4.4 L ipoprotein S u b c la s se s
Plasma T A G  and small dense LDL-3 showed a positive relationship (p<0.015, 
r=0.32) in all subjects at baseline (Figure 5.6). A  negative (p=0.02, n=-0.33) 
correlation was measured between plasma T A G  and % LDL-1 in all subjects at 
baseline.
|B6 weeks ■  12 weeks ]
15.2%
-30.0%
Flax Sunflower Fish
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Figure 5.6: Fasting TAG versus % LDL-3 in all subjects at baseline (p=0.015, r=0.32 r2=0.10)
°/o LDL-3
No significant changes in the distribution of LDL subclasses between groups at 
any time point (Figure 5.7) were measured. Small, dense LDL 3 decreased within 
each dietary group with the fish oil group and sunflower oil group decreasing by 
1 6 %  at 12 weeks. The flax group had decreased by 12% at 12 weeks. An 
increase in %  LDL 1 was measured in the fish oil group (p<0.05), it was apparent 
at 6 and 12 weeks. A  reduction in the preponderance of LDL 3 in the fish oil 
group compared to baseline levels at week 6 (p<0.01) and week 12 (p<0.01) was 
measured. A  positive correlation at baseline between T A G  and LDL-3 (r=+0.6 
p<0.05) and T A G  and LDL-1 + LDL-2 (r=-0.6 p<0.05) was measured in the flax 
group, however this relationship was not observed at any other time point. A  
positive correlation between change in T A G  and LDL-3 (pre vs post diet) 
(r=+0.51 p<0.05) and a negative correlation between LDL-1 + LDL-2 (r=-0.52 
p<0.05) was measured on the fish oil diet.
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Figure 5.7: Percentage change in LDL subclasses from baseline at 6 & 12 weeks 
*p<0.05 **p<0.01 (compared to baseline)
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No significant changes were observed in H D L 2 or H D L 3 particles in the flax group 
when expressed as percentages (pre vs post diet). Both the control and the fish 
oil groups showed an increase in H D L 2 and decrease in H D L 3 particles (p<0.05) 
compared to baseline at week 12 (Figure 5.8). W h e n  subclasses were expressed 
in terms of cholesterol content (HDL2-C and H D L 3-C), the changes were not 
significant. In the fish and control diets H D L 2-C tended to increase and H D L 3-C 
decrease, whereas the flax diet an opposite change was observed.
Figure 5.8: HDL subclasses at baseline and 12 weeks 
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5.6.4.5 A nthropom etric  find ings
Anthropometric measurements are shown in Table 5.6. There were no significant 
differences between any dietary group at baseline or any significant changes in 
weight, blood pressure or percentage body fat between groups at weeks 6 and
12.
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S . 6 . 4 . 6  H a e m o s t a t i c  v a r i a b l e s
The concentration of plasma/serum Factor VII, fibrinogen and PAI-1 were not 
significantly different between intervention groups at baseline, nor were any 
significant changes measured between or within diets at 6 and 12 weeks (Figure 
5.9).
5.6.5 E ffects o f ery th ro cy te  DHA on  p lasm a TAG and  TC:HDL ratio
A  positive correlation (p<0.001, r=0.69) was measured in the fish oil group 
between the change in plasma T A G  (pre vs post diet) and the abundance of D H A  
in erythrocyte membrane phospholipids (Figure 5.10).
5.6.6 Effects o f d ie tary  in takes on v a sc u la r  function (E ndothelial
D ysfunction) by flow m ediated  dilatory (FMD) u ltraso u n d
Flow-mediated dilation was measured before and after dietary intervention in a 
small subset of subjects (Figure 5.11). Cuff-induced reactive hyperaemia (NO- 
dependent) and G T N  (endothelium independent) produced mean increases of 
2 %  and 5 %  in arterial diameter respectively in the fish group and decreases of 
4 %  and 3 %  in the flax group. There were no significant changes on any of the 
three diets (pre versus post).
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Figure 5.9: Haemostatic results at baseline, week 6 and week 12 for the flax, sunflower and
fish oil diets
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Figure 5.10: Absolute change in plasma TAG in the fish oil group (pre-post diet) verus 
abundance of DHA in erythrocyte membrane phospholipids r = 0.69 (r2 = 0.48) p<0.001
1 00
Figure 5.11: Vascular endothelial function measured by flow-mediated dilation at baseline
and 12 weeks.
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W h e n  examining ail the baseline data, irrespective of diet allocation, there was a 
significant correlation (p<0.001, r=0.53) between the TC:HDL-C ratio and the 
abundance of D H A  in erythrocyte membrane phospholipids. The percentage 
abundance of D H A  explained 2 8 %  of the variation in the TC:HDL-C ratio. (Figure
5.12).
Figure 5.12: Relationship in all subjects at baseline between the abundance of DHA in 
erythrocyte membrane phospholipids and the TC:HDL-C ratio r=0.53 (r*=0.28) p<0.001
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5 . 7  D i s c u s s i o n
The aim of this study was to examine whether increasing the dietary intake of 
A L A  and reducing the n6:n3 ratio would promote fish oil like changes in 
cardiovascular risk factors and modify features of the ALP.
While potentially favourable changes were observed on all three test diets with 
respect to C H D  risk, these were most notable on the fish oil diet. The study 
provided valuable practical information into means of increasing and delivering 
A L A  in the diet, against a background of low n-6 P U F A  intake.
5.7.1 Habitual and  s tu d y  d ie tary  in takes.
The habitual intakes of macronutrients in all three dietary groups was average for 
the U K  population. The dietary ratio of n6 P U F A  to n3 P U F A  was lower at 9:1 
compared to the U K  average of 10:1 (Gregory 1990). Intakes of energy, protein, 
carbohydrate, alcohol and saturated fats were not significantly different on the 
study diets. Increases in energy from fat, and decreases in energy from 
carbohydrates and saturates occurred within all three diets; therefore it seems 
reasonable to speculate that the effects on endpoint measures, if any, would be 
similar for each group. Consequently, any changes in the variables measured 
m a y  be more closely associated with MUFA, n-3 and n-6 P U F A  intakes.
Energy derived from fat increased on all three diets, but only significantly within 
the sunflower oil diet (pre vs post). S o m e  of the favourable effects on lipids and 
lipoproteins, usually attributed to reductions in total fat and/or S F A  may therefore 
be attributed to changes in the type rather th^n the absolute amount of fat. The 
intake of carbohydrate, protein and saturates were not significantly different 
between the study diets. This is important, as increasing energy from 
carbohydrate m a y  be associated with the phenomenon of carbohydrate-induced
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hypertriglyceridaemia (Harris 1984, Abbasi e t  al 2000). The cholesterol lowering 
properties of P U F A  or M U F A  (Mutanen 1997, Hodson e t  al 2001) when replacing 
S F A  should also be considered.
S F A  intakes on the intervention diets were not significantly different between 
groups at baseline, the decrease within groups was significant in both fish and 
sunflower diets when compared to baseline. These reductions may have 
contributed to the decrease in T C  observed on these diets (Gylling &  Miettinen 
2001, Hodson e t  al 2001). This is difficult to substantiate as all 3 diets resulted in 
decreases in cholesterol, with fish oil diet being the least affected.
The flax oil diet had a significantly higher intake of M U F A  (p<0.001) than the fish 
and sunflower diets, due primarily to the higher M U F A  content of flax oil (31%), 
compared to sunflower oil (20%). A  higher M U F A  content supplied to the flax oil 
group diet from the margarine (additional 5g per 100g) would have made an 
additional contribution to this. The increase in M U F A  would have been difficult to 
compensate for without adjusting the fatty acid content of the fish and sunflower 
oil diets and thus potentially increasing further the energy from fat in these 
groups. Historically, it was thought that M U F A  was neutral in terms of its effects 
on lipids (Keys e t  al 1957). However, more recently similar effects on serum 
cholesterol to those achieved with P U F A  have been reported (Ginsberg 1990). 
Berry e t  al (1991) reported a 1 0 %  decrease in T C  after 12 weeks on a high 
M U F A  diet; a significant reduction in fasting T A G  was also reported. Wardiaw &  
Snook (1990) noted a similar hypotriacylglycerolaemic effect when S F A  was 
replaced with M U F A  or n-6 PUFA.
Intakes of n-6 P U F A  on the sunflower and fish oil diets changed significantly with 
two and three-fold increases respectively. This makes it difficult to establish 
whether the decrease in T C  and LDL-C were due to changes in S F A  intake or n- 
6 P U F A  intake. Increases in energy from n-6 P U F A  were similar in the sunflower 
group when compared to the fish group, and saturates fell similarly. The greatest
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decrease in T C  was in the flax group, which did not alter its intake of n-6 P U F A  
relative to baseline, though the latter was significantly lower than the fish and 
control groups during the dietary phases (p<0.001). This might suggest that the 
hypocholesterolaemic effect of A L A  is independent of n-6 PUFA. This supports 
other evidence that dietary A L A  can reduce serum lipids by the same extent as 
LA (Chan e t a l 1991, Harris 1997).
The overall intake of n-3 P U F A  in the flax group, predominantly from ALA, was 
significantly higher than both the fish and sunflower diets. Other studies have 
reported no change in total serum cholesterol on enriched A L A  diets (Kelly e t  a l 
1993, Layne e t  al 1996), mild reductions (Abbey e t  al 1990, Freese and Mutanen 
1997, Chan e t  al 1991, Cunnane e t  al 1995) or significant decreases 
(Bierenbaum e t  al 1993, Valsta e t  al 1995). This variety of responses may be 
explained in part by studies using different sources of A L A  such as rapeseed oil, 
flaxseed oil and ground flaxseeds. The quantities consumed and length of 
intervention should also be considered. The use of whole flaxseeds as a means 
of delivering A L A  was investigated on 15 volunteers with mild hyperlipidaemia by 
Bierenbaum e t  al (1993). Over 3 months, intakes of 4.6g of A L A  per day were 
achieved through 3 slices of flaxseed containing bread and 15g of ground 
flaxseed. Significant reductions in T C  and LDL-C were seen, with a non­
significant reduction in TAG. The study demonstrates the potential 
hypocholesterolaemic effects of flaxseed, but is confounded by the contribution 
of 15.5g of fibre per day from the seed component. The use of flaxseed oil, as 
opposed to flax seeds avoids the potentially confounding hypocholesterolaemic 
effect of fibre (Knopp e t  a l 1999). This was the main reason why flaxseed oil was 
used in the present study over the use of seeds.
In a number of earlier studies investigating the effects of A L A  on lipids, baseline 
values of TC, LDL-C and T A G  were within healthy ranges. This raises the 
possibility that rendering further reductions by dietary manipulation in such 
individuals might be difficult. The use of flaxseed within the current investigation
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was aimed specifically at reducing risk factors in those individuals expressing an 
ALP, a condition associated with moderately raised T A G  and TC. In the present 
study T C  was greater at baseline than those reported by Layne e t  al (1996), 
Nydahl e t  al (1994), Valsta e t  al (1996) and Mantzioris e t  al (1994) and values for 
T A G  at baseline greater than those of Abbey e t  al (1990) and Bierenbaum e t  al 
(1993). In an almost identical study design to Layne e t  a i (1996) Goh e t  al (1997) 
provided A L A  (35mg/kg per day) against a high (0.65) P/S ratio and a low (0.44) 
P/S ratio, but in non-insulin dependant diabetics. While in the present study, 
subjects were not diabetic, fasting T A G  and T C  levels in the Goh e t  al (1997) 
study were similar to our own at «2.2mmol/l and «5.8mmol/l respectively. The 
study failed to show any significant effects on TAG, T C  or LDL-C. An increase in 
E P A  and a significant increase in A L A  in lipoprotein cholesterol ester fractions 
was seen. A  fish oil supplemented diet was run in parallel with the high A L A  diet 
(35mg/kg E P A + D H A  per day). Significant reductions in fasting T A G  and 
increases in E P A  and D H A  in lipoprotein cholesterol ester fractions were seen, 
though total cholesterol and LDL-C were not affected.
5.7.2 Influence o f d ie tary  n-3 PUFA on b iom arkers o f CHD.
While intakes of n-3 P U F A  were not separated into ALA, E P A  and DHA, sources 
of dietary E P A  and D H A  were negligible due to a total restriction on fish and fish 
oil products on all diets, the only source of E P A  and D H A  was from the fish oil 
capsules. In the flax diet, the average intake was 19g of n-3 PUFA, of which 
flaxseed oil contributed 17.2g of ALA. The remaining A L A  was from rapeseed oil 
and the margarine. The control diet was used to determine the contribution of 
A L A  from the margarine and rapeseed oil. As the margarine was identical to that 
used by the fish oil group, and a known dose of 3g E P A  + D H A  was supplied, the 
contribution of A L A  within the fish oil group was not significantly different to that 
of the sunflower group (1.7g and 1,4g per day respectively). The increases in n-3 
P U F A  in the flaxseed oil diet and the fish oil diet, when compared to the control 
diet were from different n-3 fatty acids. Since intakes of n-6 P U F A  did not differ
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significantly from baseline in the flax group, this might suggest that the effect of 
diet may have been attributable to changes in M U F A  or A L A  intake.
Intakes of n-6 P U F A  on the sunflower and fish oil diets during the intervention 
were similar; but significantly greater when compared to their respective habitual 
intakes. Intakes of A L A  were similar between the fish and sunflower oil diets. 
However, n-3 P U F A  intake on the fish oil diet was higher due to additional E P A  
and DHA. The hypotriacylglycerolaemic effects of the fish oil diet, when 
compared to control, are therefore likely to be attributed to the increase in E P A  
and D H A  rather than the total n-3 P U F A  intake.
The results of the present study suggested that A L A  was slightly more effective 
at lowering T C  and LDL-C than LA. It also suggests that when S F A  are 
substituted with LA additional E P A  and D H A  from fish oil may have opposing 
actions on LDL-C blunting the hypocholesterolaemic effect of LA.
5.7.3 E ffects of d ietary  intake on e ry th rocy te  m em brane fatty  acid 
com position
The effective incorporation of A L A  into erythrocytes on the flax diet was rapid and 
statistically significant at 6 weeks, doubling the relative abundance of A L A  within 
the cell membrane phospholipids. This provided good evidence for compliance 
and absorption of A L A  from the diet. Equally the fish oil diet was associated with 
increases of 124% and 6 0 %  in E P A  and D H A  respectively. There were no 
changes in the relative abundance of LA within any of the diets, nor were there 
any statistical changes in relative abundance of any fatty acids on the control 
(high sunflower) diet. The increases in E P A  and D H A  in erythrocytes observed 
on the fish oil diet, were largely at the expense of palmitic (16:0) and oleic (18:1n- 
9) acids. A  similar decrease in palmitic and oleic acid was observed on the flax 
oil diet, being replaced by A L A  as well as E P A  and DPA. It is interesting that 
despite a significant increase in M U F A  intake on the flax diet, erythrocyte oleic 
acid content fell significantly. Williams e t  al (1999) found a significant increase in 
M U F A  in plasma phospholipid fatty acids following supplementation. This may
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suggest that compliance with M U F A  enriched diets cannot necessarily be 
determined by erythrocyte fatty acid content alone, not at least in the presence of 
increased n-3 fats, which seem to be preferentially incorporated into erythrocyte 
membrane fatty acids.
There was convincing evidence for the conversion of A L A  to E P A  and D P A  on 
the flax diet. Intake of E P A  on the fish oil diet would have been 1.7g per day 
compared to zero on the flaxseed oil diet. Despite this difference in intake, the 
increase in the erythrocyte membrane fatty acid E P A  on the flax diet was greater 
than that of the fish oil diet: 153% versus 124% at week 12 respectively. 
Significant increases in D P A  were also seen in both the fish and flax oil diets, 
despite no D P A  being present in the flax diet and only 22mg per day in the fish 
oil. While this would suggest further elongation of E P A  in the flax group from 
20:5n-3 to 22:5n-3, it is difficult to determine the direction in which D P A  was 
formed in the fish oil diet. A  6 0 %  increase in D H A  was observed on the fisji oil 
diet only. Other studies have shown increases in E P A  when only preformed D H A  
is fed (Nelson e t  al 1997b, Mori e t  al 2000, Grimsgaard e t  al 1997), this m a y  be 
caused by E P A  “backing up” or accumulating conversion to D H A  is not 
necessary. W h e n  E P A  was fed to volunteers (4g/d) significant increases in E P A  
were measured in plasma phospholipids but no increase in D H A  was detected 
(Mori e t  al 1999). Although conversion of E P A  to D H A  occurs, it would seem that 
conversion towards shorter chain rather than longer chain fatty acids can also 
take place.
5.7.4 Differential e ffects  of dietary  EPA and  DHA on p lasm a lipids and  
lipopro teins
Studies examining the separate effects of D H A  and E P A  are becoming more 
common. In the present study, the fish oil group consumed both E P A  and DHA. 
Mori e t  al (2000) found that both E P A  and D H A  reduced TAG, but that D H A  was 
more effective though not significantly. Grimsgaard e t  al (1997) reported similar 
findings. In the present study, T A G  fell in both the fish and flax oil diets, but the
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effect (pre-post diet) was greater, and only significant in the fish oil diet. 
Interestingly, the positive association between the abundance of D H A  in 
erythrocytes and the TC:HDL-C ratio would suggest that greater levels of D H A  in 
erythrocyte membrane phospholipids may be associated with increased risk of 
CHD. One explanation for this finding may be that D H A  is the fatty acid 
responsible for increases in LDL-C that have been reported during fish oil 
feeding. S o m e  of the hypercholesterolaemic effects of long chain n-3 P U F A  may 
be masked by the high n-6 P U F A  background diet. However, if such a 
relationship existed between D H A  and T C  (LDL-C) it m a y  still be detectable. In 
accord with Mori e t  a l (2000) both diets were associated with enrichment in long 
chain n-3 fats, but only D H A  was increased in the fish oil diet. In the present 
study no correlation between E P A  and T A G  was found on the flax oil diet. 
However, in the fish oil group a significant correlation was found between the 
change in T A G  (pre-post diet) and the abundance of D H A  at 12 weeks (Figure
5.12). No significant correlations were found on the flax oil diet between the 
erythrocyte fatty acid content of A L A  or E P A  and change in TAG. This may 
suggest that the T A G  lowering effect of the fish oil diet was a result of D H A  rather 
than EPA. The inefficiency of the conversion of A L A  to D H A  and the enrichment 
of red blood cell membranes with E P A  but not D H A  on the flaxseed-oil diet is 
consistent with the idea that the level of D H A  in cell membranes and lipoproteins 
is a more important determinant of fish-oil-induced changes in blood lipids and 
lipoproteins than EPA.
5.7.5 Dietary e ffec ts  on  lipids, lipopro teins and  lipoprotein  
he terogeneity .
As discussed in Chapter 1, the T A G  lowering effects of long chain n-3 P U F A  are 
well documented. In the present study, the decrease in the concentration of 
plasma T A G  on the fish oil diet (-34%) was in the order of magnitude observed in 
other studies supplementing with long chain n-3 P U F A  (Contacos 1993, Mori e t  
a l 2000, Leigh-Firbank e t  a l 2001). A  mean absolute reduction in plasma T A G  of
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0.6mmol/l was seen in the present study after 6g per day of E P A  and D H A  
supplementation. Hokanson and Austin (1996) found that a 1 mmol/l reduction in 
fasting T A G  was associated with a 3 2 %  reduction in C H D  risk in men. 
Consequently, reductions in T A G  measured in the fish oil group in the present 
study should be considered clinically significant. It is unlikely, however, that the 
magnitude of plasma T A G  reduction achieved with fish oil capsules could be 
achieved though dietary means only, the large quantities of oily fish that would 
have to be consumed would make it impractical. While significant reductions in 
plasma T A G  were measured in the fish oil group, the diet did not reduce plasma 
T A G  below 1.5mmol/l. The relevance of the 1.5mmol threshold in modifying the 
distribution of LDL subclasses was discussed in Chapter 1, but may offer some 
insight into why the fish oil diet, even with its potent T A G  lowering effects, was 
unable to modify the A L P  of this group (Griffin e t  a l 1994).
The effects on T C  and LDL-C following fish oil supplementation are still 
equivocal, variable responses to fish oil feeding have been measured in different 
lipid phenotypes. In the current study, fish oil supplementation was associated 
with a reduction (NS) in T C  and LDL-C. The subjects in this group were not 
hypercholesterolaemic and although Nestel (1990) suggested that in 
normolipidaemic subjects changes in T C  tended to be small and often of no 
clinical importance, it is questionable whether in the present study, the 7 %  
reduction in T C  following fish oil supplementation should be labelled “clinically 
unimportant”; as a 1 0 %  reduction in T C  is associated with a 1 5 %  reduction in 
C H D  mortality (Gould e t  al 1998). Phillipson e t  al (1985) showed that the effects 
of fish oils on lowering T C  were more pronounced in subjects with raised T A G  
primarily though a reduction in VLDL-C and IDL-C. None of the dietary groups in 
the present study were hypertriacylglycerolaemic. While reductions in T C  in 
response to fish oils have been reported, increases in LDL-C, possibly through 
increased conversion of V L D L  (Huff &  Telford 1989) or competition between 
V LDL and LDL for the LDL receptor (Gianturco &  Bradley 1991) have also 
occurred. The present study not only observed reductions in T C  but also LDL-C
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after fish oil supplementation. Shifts in the distribution of LDL subclasses from 
LDL-3 towards the more receptor active LDL-2 particle in the present study m a y  
explain some of the reductions observed following fish oil supplementation.
In the present study, consuming 34mls of flaxseed oil per day resulted in a 2 1 %  
decrease in plasma T A G  by week 12, an effect not observed consuming an 
identical amount of sunflower oil. The effects of linoleic acid on fasting T A G  have 
been reported as being inconsistent (Grundy &  Denke 1990), high LA intakes 
may reduce hepatic synthesis of V L D L  TAG, or be a better substrate for LPL. In 
the present study the absolute change in plasma T A G  on the A L A  diet was - 
0.4mmoi/l, this was not statistically significant but may be clinically relevant with 
respect to C H D  risk (Hokanson and Austin 1996). In comparison, both flax and 
sunflower oil diets were associated with reductions in T C  and LDL-C with the 
A L A  diet being more effective. The effect on T C  of increasing A L A  in the diet was 
of a similar magnitude to adding 25g of soy (Setchell &  Cassidy 1999) or 2-3g of 
plant stanols to the diet per day (Gylling &  Miettinen 1999). The A L A  diet, like 
the fish oil diet, failed'to modify the A L P  but did produce changes in the 
concentration of plasma lipids. Overall the study was underpowered to be able to 
demonstrate significant changes. The power value for the sample size used was
0.38, and 0.41 for T A G  and T C  respectively.
Enrichment of erythrocyte membrane fatty acids with D H A  correlated with 
changes in plasma T A G  in the fish oil group, no such correlation could be 
determined with any fatty acid in the flax group. It is difficult to determine the 
reason behind the reduction in fasting T A G  in the flax group. Valsta and co 
workers (1995) fed 5.9g of A L A  per day as rapeseed oil and observed a 1 9 %  
decrease in plasmaTAG. Freese and co-workers (1997) fed the same amount 
but observed no changes in plasma TAG. Length of intervention did not differ 
markedly at 6 weeks and 4 weeks respectively. Our findings are similar to those 
of other studies that have shown no significant effect on fasting plasma T A G
111
when substituting LA with A L A  (Abbey e t  al 1990, Mantzioris e t  a l 1994, Pang e t  
al 1998).
Prospective trials (Stamfer e t  al 1996) have shown that small, dense LDL is 
associated with a increased risk of Ml, while case control studies (Austin e t  al 
1988) have shown small dense LDL to be predictive of future coronary events. A  
reduction in circulating levels of small, dense LDL may be achieved through a 
concomitant reduction in T A G  (Griffin e t  al 1992, G a w  e t  al 1994). Of particular 
relevance is the 1.5mmol/l threshold for TAG, beyond which the preponderance 
of small dense LDL (LDL-3) increases (Griffin e ta l 1994).
The T A G  lowering efficacy of n-3 fatty acids may not be as effective as drugs, but 
is associated with a reduction in cardiovascular risk through a variety of 
mechanisms (Nestel 1990, Harris 1989). The fish oil diet on the present study 
was associated with significant reductions in T A G  (pre versus post) and a 
reduction in the number of LDL-3 particles. Reductions in LDL-3 are a result of 
shifts towards larger, less dense LDL particles (Griffin 2001). This is of 
importance in the present study as ail volunteers expressed an ALP, and thus 
had > 4 0 %  LDL-3 at baseline. While decreases in LDL-3 were measured on all 
three diets, only the decrease on the fish oil diet was significant. None of the 
diets was able to reduce T A G  below 1.5mmol/l which may account for the 
preponderance of LDL-3 remaining above 4 0 %  (pattern B phenotype) (Griffin e t  
al 1994). The greatest reduction in LDL-3 occurred in the fish oil group, which 
also exhibited the greatest reduction in TAG, this relationship was not present in 
the flax and sunflower oil diets. In the flax group an 18% reduction in T A G  was 
associated with a 12 %  reduction in LDL-3, in the sunflower oil diet, a 4 %  
increase in T A G  was associated with a 1 6 %  reduction in LDL-3.
Three desirable effects were observed in the fish oil group: a decrease in TAG, a 
reduction in T C  and LDL-C and a significant reduction in LDL-3. The cholesterol 
response to fish oil feeding suggests an overriding effect of dietary LA in the
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background diet, essentially superimposing a high long chain n-3 P U F A  diet onto 
a high n-6 P U F A  diet. Linoleic acid is still commonly recommended in the dietary 
management of hypercholesterolemia (Ascherio e t  al 1996) and in the current 
study was one of the main replacements of S F A  on the test diets.
5.8 Effects o f d ie t on  h aem o sta tic  fac to rs .
There were no significant effects observed in PAI-1, Factor Vllc% or fibrinogen in 
the present study. While evidence exists that suggests both positive and negative 
effects of diet on haemostatic variables, it should be noted that all three dietary 
groups presented with values within the normal reference ranges for each of the 
variables measured. The anti thrombotic effects of fish oils are mediated in part 
through decreased platelet aggregation and reduction in plasma fibrinogen 
(Hostmark e t  al 1998, Mutanen e t  al 2001). Fibrinogen levels generally increase 
with age, smoking and LDL-C, but are decreased by physical activity, alcohol 
intake and HDL-cholesterol levels (Scarabin P e t  al 1998). The current study 
showed no changes in fibrinogen as a result of diet. Allman-Farinelli e t  al (1999) 
investigated differing ratios of ALA:LA on coagulation and fibrinolysis. A  ratio of 
1:1.1 produced a three-fold increase of E P A  in platelets, but no effects on 
haemostasis. In the present study a 2.5 fold increase in E P A  in erythrocyte 
membrane phospholipids was seen, the mean A L A  intake was 3.5g per day 
(Allman-Farinelli e t  a l 1999) as opposed to 18g per day on the present study. 
Fatty acid composition of platelets was not measured on the present study so a 
direct comparison cannot be made.
Olle e t  al (1998) reported significant increases in PAI-1 after fish oil feeding, an 
effect considered undesirable, but in agreement with Mahrabian e t  a l (1990) and 
Boberg e t  al (1992) who postulate that impaired fibrinolysis is mediated through 
an increase in PAI-1 levels. While there is evidence that fish oils may increase 
PAI-1 levels, Mehta e t  al (1998) reported a significant correlation between 
decreases in T A G  and decreases in P A M .  Higher circulating levels of PAI-1
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have also been shown to be associated with body mass index (Mehta et ai 
1987), but unlike Factor VIIc, are also elevated by alcohol intake and smoking 
(Scarabin e t  al 1998). While ail volunteers on the present study were non- 
smokers, it is worth noting that the energy derived from alcohol in the fish oil 
group fell significantly during the dietary intervention (p<0.01) it therefore seems 
reasonable to speculate that any increases in PAI-1 levels in response to fish oil 
feeding in present study may have been counter-acted upon by the 
hypotriacylglycerolaemic effects of the diet and decreases in alcohol 
consumption.
Leigh-Firbank e t  al (2002) showed a significant correlation between reduction in 
fasting T A G  and the increase of E P A  in platelets after feeding similar amounts of 
E P A  and D H A  as the present study. While there were similarities in intakes of 
fish oils, the present study diet was run against a background of increased n-6 
P U F A  and their study was not. Leigh-Firbank e t  al (2002) also determined 
enrichment in platelets, whereas the present study used erythrocytes. This aside, 
the present study supports much of the literature with regard to responses of 
T A G  to D H A  but not EPA. Nelson e t  al (1997b) supplemented volunteer’s diets 
with D H A  only, (6g/d) and found no significant changes in haemostatic variables. 
Interestingly a 7-fold increase in platelet E P A  was observed, despite E P A  being 
absent from the diet.
Physical activity is associated with a reduction in PAI-1 levels (Mehta e t  al 1988, 
Scarabin e t  al 1998). In the case of the current intervention, no record of physical 
activity was kept. The effects of dietary fats on haemostasis remain equivocal, it 
should be considered that some of the beneficial effects observed may be a 
result of these fats on other variables such as T A G  and lipoproteins. Other 
factors such as physical activity and alcohol intake, which are difficult to control in 
free-living studies, may also be affecting the results.
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6  C H A PT E R  6  G E N ER A L  D ISC U SSIO N
The Food Standards Agency stated in 2000 that: “to contribute to the 
improvement of the health of the U K  population it is important to encourage and 
facilitate the adoption by the population of a healthy balanced diet”. Poor diet is a 
risk factor for a number of diseases, and in particular cardiovascular disease and 
some cancers. The incidence of these diseases is highest among socially and 
economically deprived groups. Because diet is only one of a number of risk 
factors for these diseases it is not possible to establish outcome measures in 
terms of reduced incidence of morbidity or mortality. However, if all other risk 
factors remain unchanged w e  would expect improvements in diets td be reflected 
over the long term in reduced rates of cardiovascular disease and cancer. In the 
Government’s white paper Saving Lives: Our Healthier Nation, clear targets have 
been set to reduce deaths from C H D  by 4 0 %  by the year 2010 (DOH, 1999).
The main aims of the dietary interventions conducted in the pilot, dietary 
compliance and principal studies (Chapters 3 4 and 5) were to test the 
hypothesis that short chain n-3 P U F A  could promote improvements in 
cardiovascular risk factors similar to that produced by longer chain n-3 P U F A  in 
fish oils (Connor e t  al 1997, GISSI 1999). The fatty acid alpha-linolenic acid 
(ALA) can be converted into longer chain n-3 P U F A  in vivo (Gerst, 1998), and 
thereby, potentially exert the same effects as fish oils on C H D  risk. The 
experimental diets in both the pilot and principal studies achieved a dietary n-6:n- 
3 ratios <1.0, the purpose of the former was to look more at the practical 
feasibility of supplementing A L A  in a free living population, rather than the effects 
of the diet on C H D  risk. Most notably the principal study differed from the pilot in 
subject numbers, duration and volunteers who were expressing a dyslipidaemia 
or ALP. This group was chosen as the most appropriate target population for 
testing the effects of dietary A L A  for the following reasons: it is at increased risk 
of C H D  (Austin e t  a l 1990), has a relatively high prevalence in the general
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population and expresses coronary risk factors that are known to be responsive 
to fish-oil feeding (Minihane e t  al 2000).
In the principal study, 12 weeks of a diet enriched with A L A  did not reproduce the 
characteristic effects of fish-oils on blood lipids, haemostatic risk factors or tests 
of vascular function reported in previous studies (Phillipson e t  al 1985, Schmidt 
e t  a l 1990, Mori e t  a l 1999). Moreover, even the effects produced by the fish-oil 
diet, the purpose of which was to serve as ‘positive control’ were inconsistent 
with that previously shown in this group (Minihane e t  al, 2000). In explanation for 
these findings, it is conceivable that the usually pronounced effects of fish-oils on 
an A L P  and haemostatic variables were in some way obscured by combining the 
fish-oil supplement with a high intake of n-6 PUFA. Alternatively, any lack of 
dietary response could be ascribed to the relative normality of the study 
volunteers with respect to their baseline characteristics as compared to a more 
clinically defined group i.e. that expressing values outside the physiological 
reference range. It remains difficult to ascertain whether the reductions in total 
cholesterol observed on the fish oil diet were in response to increases in n-3 and 
n-6 P U F A  and/or through the more ‘permissive’ effects produced by the 
replacement of S F A  in the habitual diet. The fact that plasma T A G  was not 
reduced below the value of 1.5mmol in any dietary group m a y  explain, in part, 
why there was the lack of response in the ALP, or more specifically, a decrease 
in the abundance of small, dense LDL-3 below 40%, since this level of plasma 
T A G  represents a critical threshold for changes in these variables (Griffin e t  al 
1994, Griffin 2001). It is now well known that genotypic variation influences the 
response to dietary components. This is particularly relevant with respect to the 
variable effects of dietary n-3 P U F A  on lipid metabolism. Several c o m m o n  
polymorphisms have been implicated as modifiers of the response to dietary long 
chain n-3 PUFA, the most well known of which is the apo E polymorphism 
(Minihane e t  al, 2000, Khan e t  al, 2002). However, whilst data on the impact of 
this polymorphism on the response to the shorter chain A L A  is limited,
1 1 6
unfortunately the address of nutrient-gene interactions lay beyond the scope of 
the present study.
While all study volunteers selected for the principal intervention were positive on 
screening for the expression of an ALP, examination of their habitual diet 
revealed a ratio for dietary n-6:n-3 P U F A  that was marginally lower than the 
national average. This posed the question as to how much more “modifiable” the 
C H D  risk factors in these subjects would be through further dietary manipulation? 
All study volunteers were recruited from a population in and around the Guildford 
area. Surrey is well known to be one of the more affluent areas in the south of 
England, and as such is associated with a lower incidence of C H D  (Coronary 
Heart Disease National Service Framework, 2000). Based on the F S A  National 
Diet and Nutrition Survey (2001) the habitual diet of all the subjects was slightly 
higher than the U K  average in energy derived from total fat, saturated fat and 
monounsaturated fat and lower in n-3 and n-6 PUFA. This might suggest that 
there was a degree of selection bias in the recruitment with respect to diet, that 
is, that the trial selected Individuals whose diets were higher in fat and lower in n- 
3 P U F A  than the U K  mean pre-disposing this group to increased C H D  risk. Mean 
body mass index (BMI) for all subjects was 28.5 kg/m2 (data not shown); values 
above 25 kg/m2, are considered to be overweight. Total and LDL-cholesterol are 
positively associated with increases in BMI, whereas HDL-Cholesterol is 
inversely associated (Schroder e t  a l 2003).
The superimposition of a high intake of n-6 P U F A  on the fish oil supplemented 
diet m a y  well have confounded the inclusion of fish-oil diet as a positive control
i.e. a diet that would produce marked and predictable changes in the outcome 
measures of risk. In contrast, the A L A  enriched diet was not enriched with n-6 
P U F A  in order to achieve a n-6:n-3 ratio <1.0. In retrospect, a fourth diet, 
supplemented with fish oil but with low in n-6 P U F A  may have provided a more 
satisfactory comparison of short versus long chain n-3 P U F A  without the 
additional influence of n-6 PUFA, the effects of which were clearly in evidence
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from its cholesterol-lowering action. Alternatively, the high n-6 P U F A  could have 
been removed from the fish oil diet altogether to leave just three diets as before.
The single greatest confounding factor in all human dietary intervention studies is 
dietary compliance. This is extremely difficult to assess in any reliable way in a 
free-living study group. Although the dietary questionnaires gave some insight 
into this area, the number returned was low. Food diaries provided information on 
both habitual and study dietary intakes, but the quality of information recorded 
varied greatly between subjects. There was also an interval of 10 weeks when no 
information was documented, and it is conceivable that other foods containing n- 
6 P U F A  or E P A  and D H A  could have been consumed during this period. In 
addition to this, the nutritional data currently available on the fatty acid contents 
of foods in the U K  is still limited. This would tend to undermine the accuracy of 
the dietary analysis for intakes of ALA, LA, E P A  and D H A  and also affect the 
reliability of the calculated ratios of dietary n-6 to n-3 PUFA.
The manner in which most subjects took the oil should also be examined, as 
effectively it became two boluses of 17mls of oil twice a day. While subjects were 
encouraged to use the oil by adding it to food after cooking, a majority took it in a 
milkshake. This could be considered more of a supplement or even 
pharmacological in nature and it does not represent the manner in which A L A  
would be consumed if introduced into foods. In this case, intakes would range 
over the day depending on the type of products available. Future studies may 
wish to add flax to foods that can be consumed cold such as pasta salads or 
desserts, not only to spreads and oils. In this way potentially beneficial intakes of 
A L A  could be achieved over the course of the day and integrated as part of the 
food matrix rather than as one or two doses.
The overall implications of these studies in terms of the modification of 
cardiovascular risk in the general population are difficult to interpret. Decreases 
in plasma cholesterol and T A G  were seen in the flax oil group, and though
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insufficient to reverse the expression of an ALP, may still be linked, by 
extrapolation with C H D  mortality data, to decreased C H D  risk (Hokanson &  
Austin 1996, Gould e t  al 1998). While some studies have suggested that A L A  (n- 
3 PUFA) is as effective as LA (n-6 PUFA) in reducing C H D  risk (Chan e t  al 
1991), the LA test diet was associated with no changes in TAG. The potentially 
favourable but non-significant changes in blood lipids in the flax group might 
indicate that a greater number of subjects would have produced more statistically 
significant results (Type II error). As changes in T A G  are relatively large when 
using fish oils at the doses used in the present study, it is reasonable to assume 
the study was sufficiently powered with regard to the fish oil supplemented group. 
At the time of the study design there was limited information on the effect of A L A  
on TAG. Harris (1997) stated that as little as 3g offish oils may reduce serum 
T A G  by up to 30%. It was postulated that should dietary A L A  be as potent at 
reducing T A G  as fish oils, a similar reduction in T A G  may be observed. A  
reduction in T A G  was seen on the A L A  supplemented group, and the 
retrospective power calculation suggests that this reduction m a y  have been 
significant but that a greater number of subjects would have be required to 
determine if this was the case (figure 6.1). In order achieve a power of 0.8 and 
detect a 2 5 %  decrease in T A G  or T C  between dietary groups using A N O V A ,  a 
sample size of 50 per group (n=150) would have been required (Figure 6.1)
Figure 6.1: Power values to detect a medium size difference in TAG, between the three 
treatment groups.
F-Tost (ANOVA), Global, Groups: 3
Power (1-beta) Alpha: 0.0500 Effect size T: 0.2680
Total sample size
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Diet forms the cornerstone in aii primary preventative strategies for reducing 
C H D  mortality and morbidity, particularly in those who are at high and 
intermediate risk (~20% absolute risk). Many of these people will be 
asymptomatic for C H D  but harbour sub-clinical atherosclerosis that is 
undetectable at a population level (>20% of the U K  population). The principal 
intervention study aimed to identify and intervene in a group of free-living 
volunteers that could be classified within this vulnerable group, that is, men 
expressing silent, sub-clinical risk factors for C H D  that are amenable to dietary 
modification. The findings of the present study indicate that A L A  is not as 
effective as E P A  and D H A  in reducing lipid-mediated risk in this particular 
experimental model. Nevertheless, it was equally efficacious in lowering total and 
LDL cholesterol as the high LA / n-6 P U F A  diet. While the study was inconclusive 
with respect to the effects of dietary A L A  on markers of haemostasis and 
vascular function, it was significantly underpowered to examine the latter.
Supplementation with fish oils, especially DHA, may help prevent arrhythmias 
and sudden cardiac death in healthy m e n  (Hagstrup e t  al 1999). The evidence 
that A L A  promotes enrichment of cell membranes with E P A  may suggest greater 
attention to dietary A L A  and markers of inflammation and cardiac arrhythmia. 
(Segal-lsaacson &  Wylie-Rosett 1999). As with the hypotriacylglycerolaemic 
effects of fish oils, more research is needed to determine the combined and 
independent effects of E P A  and D H A  on cardiac arrhythmias.
Increased knowledge of the effects of dietary fatty acids on metabolic risk factors 
for C H D  in vulnerable groups underlies the formulation of dietary guidelines for 
the reduction of C H D  risk in the population at large. However, the practical 
implementation of dietary change based on this knowledge remains the greatest 
challenge of all. The use of functional foods is becoming more widespread and 
m a y  offer a means of producing subtle changes in the food chain required to 
deliver potentially beneficial nutrients to the population as a whole. Unfortunately
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food policy and what is actually achieved in practice is driven largely by business 
and not science. Hence, the successful implementation of any scientific outcome 
will not only depend on communication and co-operation with government but 
also with profiteering food manufactures and retailers.
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Appendix 1
Principal Investigation 
Volunteer Questionnaire
ALP OIL QUESTIONNAIRE 
T h is  q u e s tio n n a ire  is d e s ig n e d  to  h e lp  us d e te rm in e  h o w  you  fou n d  p artic ip a tin g  
in th e  s tudy. It w ill h e lp  us im prove  c o m p lia n c e  issues  and  p ro v id e  us w ith  
in fo rm atio n  on  w a y s  in w h ich  to  im p ro ve  fu tu re  d ie ta ry  in terven tio n  in ves tig a tio n s . 
T h e  q u e s tio n n a ire  is a n o n y m o u s  and  yo u  w ill no t b e  c o n tac ted  reg ard in g  y o u r  
a n s w e rs , so p le a s e  b e  as  h o n es t as  p o ss ib le  w h e n  co m pletin g  th e m .
Q u e s tio n s  a sk in g  yo u  to  ra te  som eth in g  b e tw e e n  1 an d  5 a re  d es ig n ed  so th a t 1 
is th e  lo w e s t rating a n d  5  is th e  h ighest.
T h e  o n ly  in fo rm atio n  w e  req u ire  fro m  you  b e fo re  you  s ta rt th e  q u e s tio n n a ire  is 
w h e th e r  yo u  w e re  tak in g  th e  c ap su les  a s  w e ll a s  th e  s a c h e ts  o f oil.
T h a n k  yo u  in a d v a n c e  fo r  y o u r c o -o p era tio n ..
1. W e r e  yo u  on  th e  fish oil d ie t?  Y e s  [ ] N o  [ ]
1 a . (if  y e s ) h o w  e a s y  did you  find it to  ta k e  th e  c ap su les  
e v e ry  d a y ?
(1 very easy, 2 easy, 3 average, 4, hard 5, very hard) S c o re  j j
2 . H o w  e a s y  w a s  th e  study, o vera ll to  c o m p le te ?
(1 very easy, 2 easy, 3 average, 4, hard $, very hard) S c o re  j
3 . D id  y o u  find th e  1st 6  w e e k s  e a s ie r  th a n  th e  2 nd? Y e s  [ ] N o  [ ]
4 . H o w  e a s y  did yo u  find it to  u se  th e  s a c h e ts  in foo d s?
(1 very easy, 2 easy, 3 average, 4, hard 5, very hard) S c o re  [ ]
5. H o w  e a s y  did y o u  find it to  u se  th e  s a c h e ts  in drinks?
(1 very easy, 2 easy, 3 average, 4, hard 5, very hard) S c o re  f 1
6 . H o w  o ften  did  yo u  fo rg e t to ta k e  y o u r c ap su les ?  
(1 never, 2 rarely, 3 occasionally, 4, lots 5, all the time)
7 . H o w  o ften  did you  fo rg e t to  ta k e  y o u r s a c h e ts ?  
(1 never, 2 rarely, 3 occasionally, 4, lots 5, all the time)
8. H o w  d ifficu lt d id you  find it to cu t o u t th e  foo d s  
in d ica ted  by th e  s tudy  p erso n n e l?
(1 very easy, 2 easy, 3 average, 4, hard 5, very hard)
S c o re  [ ]
S c o re  [ ]
S c o re  [ ]
9 . H o w  w o u ld  y o u  ra te  com pletin g  th e  food  d ia ries?
(1 very easy, 2 easy, 3 average, 4, hard 5, very hard) S c o re  ! ]
ALP OIL QUESTIONNAIRE
10 . H o w  o ften  w o u ld  yo u  e n te r  foo d s  into th e  d ia ry  
th e  d a y  a fte r  y o u  had  a c tu a lly  e a te n  th e m ?
(1 never, 2 rarely, 3 occasionally, 4, lots 5, all the time) S c o re  j j
1 1 . H o w  usefu l w a s  co n tin u o us  s u p p o rt fro m  study  
p erso n n e l in h e lp in g  y o u  c o m p le te  th e  study?
(1 not useful, 2 of some use, 3 useful, 4, very useful 5, indispensable)* S c o re  i j
12 . D id you  w e ig h  y o u rs e lf e v e ry  w e e k ?  Y e s  [ ] N o  [ ]
13 . H o w  e a s y  did y o u  find it to  u se  th e  m a rg a rin e  p ro v id ed ?
(1 very easy, 2 easy, 3 average, 4, hard 5, very hard) S c o re  ( ]
1 4 . H o w  p a la ta b le  w a s  th e  m a rg a rin e ?
(1 not at all, 2 just, 3 palatable, 4, fairly palatable 5, delicious) S c o re  [ 1
1 5 . H o w  w o u ld  y o u  ra te  th e  s a c h e ts  as  a  m e a n s  o f p a c ka g in g
a n d  d e live rin g  th e  oil (1 to  5 )?  S c o re  [ ]
16 . H o w  often  did y o u  e a t  so m eth in g  yo u  kno w  you  shou ld  
not h a v e  e a te n  w h ils t on th e  s tudy?
(1 never, 2 less than once a month, 3 less than once a week,
4, once a week, 5 more than once a week) S c o re  [ ]
1 7 . D id  yo u  m a k e  a n y  d ie t o r lifesty le  c h a n g e s  b e tw e e n
y o u r s c re en in g  b lood  te s t an d  th e  s ta rt o f th e  s tu d y?  Y e s  [ ] N o  [ j
18 . If  th e  a n s w e r to  Q . 17  w a s  y e s , w a s  th a t as a  d irect
c o n s e q u e n c e  o f  th e s e  resu lts?  Y e s  [ ] N o  [ ]
19 . . H o w  in s tru m e n ta l w a s  a  p a rtn e r o r sp o u s e  in yo u r  
decis io n  to  p a rtic ip a te  in this s tudy?
(1 HI A, 2 none, 3 some, 4, a lot 5, their idea) S c o re  ; j
2 0 . If  you a tte n d e d , did y o u  find th e  in troduction  e ven in g  
a t th e  U n ive rs ity  usefu l in a llay in g  a n y  u n certa in ties  
reg ard in g  y o u r partic ip a tio n  in th e  s tudy?  Y e s  [ ] N o  [ ]
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2 1 . H a s  se le c tio n  fo r this s tu d y  p ro m p ted  y o u  to v isit y o u r
G .P . fo r a n y  h ea lth  ch e ck s ?  Y e s  [ ] N o  [ ]
2 2 . D id  yo u  find  th e  b lood  tak in g  an  in c o n v e n ie n c e ?  Y e s  [ ] N o  [ ]
2 3 . H a s  yo u r d ie t re tu rn ed  to  n orm al s in c e  com ple tin g
th e  s tu d y?  Y e s  [ ] N o  [ ]
2 4 . D id  yo u  e v e r  e x p e r ie n c e  a n y  u n p le a s a n t s ide  e ffec ts
fro m  th e  oil o r  s a c h e ts  o th e r th a n  th o s e  m e n tio n e d ?  Y e s  [ ] N o  [ ]
2 5 . H o w  a c c u ra te  d o  you  th in k  yo u r foo d  d ia ry  w a s  c o m p a re d  
to  y o u r a c tu a l d ie t  o v e r th e  w e e k  it w a s  c o m p le ted ?
(1 <25%, 2 26-50%, 3 51-75%, 4, 75-99% 5, 100%) S c o re  [ ]
2 6 . O v e ra ll h o w  c o m p lia n t w o u ld  yo u  s a y  y o u  w e re  to  all th e  
instructions an d  a d v ic e  g iven  to  you  w h ils t on th e  s tudy?
(1 not at ail, 2 a little, 3 often, 4, most of the time 5,100% ) S c o re  [ ]
2 7 . O v e ra ll w a s  th e  s tu d y  m o re  o r less  d ifficu lt to
c o m p le te  th a n  y o u  th o u g h t?  M o re  [ ] L es s  [ ] S a m e  [ ]
2 8 . W o u ld  you  c o n s id e r p artic ipating  in a n o th e r
in te rven tio n  s tu d y  in th e  n e a r fu tu re ?  Y e s  [ ] N o  [ ]
2 9 . Is th e re  a n y  in fo rm atio n  yo u  fe lt w a s  m issing  in re la tio n  to  
th e  s tu d y  th a t y o u  w o u ld  h a v e  b e n e fite d  from
h ad  you  b e e n  m a d e  a w a re  a t th e  s ta rt?  Y e s  [ ] N o  [ ]
3 0 . if you  a n s w e re d  y e s , p le a s e  d e s c rib e  w h a t you  fe lt w a s  m issing  below .
T h a n k  y o u  fo r  t a k in g  t im e  to  c o m p le te  th is  q u e s t io n n a ir e .  P le a s e  re tu rn  it  in
th e  p re p a id  e n v e lo p e  s u p p lie d .
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T h e  Im p o r ta n c e  o f  a -L in o Ie n ic  A c id  (a - L A )  a s  a  S o u r c e  o f  L o n g -C h a in  n -3  
P o ly u n s a tu r a te d  F a t ty  A c id s  (P U F A )  a n d  its  In f lu e n c e  o n  R is k  F a c to r s  o f
C a r d io v a s c u la r  D is e a s e .
T h e  C e n tre  fo r  N u tritio n  &  F o o d  S a fe ty  a t  th e  U n iv e rs ity  o f S u rre y  &  R o y a l S u rre y  
C o u n ty  H o s p ita l Is c u rre n tly  s e e k in g  v o lu n te e rs  fo r  a  d ie ta ry  in te rven tio n  s tu d y . T h e  
s tu d y  is d e s ig n e d  to  e x a m in e  th e  e ffe c ts  o f  d ie ta ry  n -3  p o ly u n s a tu ra te d  fa tty  a c id s  
(e s s e n tia lly  f is h -o ils  a n d  a -lin o le n ic  ac id  fro m  f la x s e e d  oil) on c a rd io v a s c u la r  risk  
fa c to rs  in 6 0  h e a lth y , m a le  v o lu n te e rs  w ith  m o d e ra te ly  ra is e d  s e ru m  tr ig ly c e r id e s  
(> 1 .5 m m o l/l) .  P le a s e  fin d  e n c lo s e d  fu r th e r  d e ta ils  o f  th e  s tu d y  in th e  fo rm  o f  a  
V o lu n te e r  In fo rm a tio n  S h e e t  a n d  S tu d y  S u m m a ry . W e  h o p e  to  recru it th e s e  p a tie n ts  
th rou g h  lo cal g e n e ra l p ra c tice s  a n d  w rite  to  e n q u ire  o f  y o u r w illin g n ess  to  p artic ip a te .
T h e  s tu d y  w o u ld  in v o lv e  yo u  se le c tin g  s u ita b le  c a n d id a te s  fro m  y o u r d a ta b a s e . Y o u  
w o u ld  e ith e r  th e n  s u p p ly  us w ith  th e ir  n a m e s  a n d  a d d re s s e s  an d  a  le tte r s ta ting  y o u r  
in v o lv e m e n t in th e  s tu d y . P o ten tia l vo lu n tee rs  w o u ld  th e n  b e  s e n t d eta ils  o f th e  s tudy. 
A lte rn a tiv e ly  w e  w o u ld  p ro v id e  yo u  w ith  le tte rs  a b o u t th e  s tu d y  to  s e n d  to  p o te n tia l 
v o lu n te e rs  a lo n g  w ith  a  c o v e r in g  le tte r  fro m  y o u rs e lf. T h a t  w a y  w e  h a v e  no  
in fo rm atio n  a t  a ll a b o u t p o ten tia l v o lu n tee rs  until th e y  e x p re s s  an  in te res t in th e  s tu d y . 
A t no t im e  w o u ld  w e  h a v e  a c c e s s  to  th e ir  m e d ic a l reco rd s . A  s m all b lood  s a m p le  fo r  
s c re e n in g  p u rp o s e s  w o u ld  th e n  b e  ta k e n  fro m  th o s e  in te re s te d . W e  w o u ld  s u p p ly  you  
w ith  a ll b io c h e m ic a l d a ta  o b ta in e d  fro m  th e s e  p a tie n ts , inc lu d in g  a  L D L  p ro file  o n  
th o s e  s e le c te d . W e  w o u ld  a ls o  k e e p  y o u  in fo rm e d  o f  th e  re su lts  o f th e  tr ia l, its  
o u tc o m e  fo r  y o u r  p a tie n ts  a n d  p u b lica tio n s  a ris in g  fro m  it. If  yo u  a re  in te re s te d , w e  
w o u ld  b e  v e ry  g ra te fu l if yo u  cou ld  re tu rn  y o u r  n a m e  an d  c o n ta c t a d d re s s  on  th e  
e n c lo s ed  slip  in th e  F R E E P O S T  e n v e lo p e  o r a lte rn a tiv e ly  c o n tac t D r. A m e lia  F e re d a y  
a t  t h e  U n iv e r s i t y  o f  S u r r e y  ( T e l  /  F a x  0 1 4 8 3 - 8 7 9 7 3 5  o r  e - m a i l  
a .fe re d a y @ s u rre y .a c .u k ).
M a n y  th a n k s  in a d v a n c e  fo r y o u r help.
Y o u rs  s in ce re ly ,
1 w o u ld  b e  in te r e s te d  in  h e a r in g  m o re  a b o u t  t h e  d ie ta r y  in te r v e n t io n  tr ia l .
D o cto rs  n a m e :
C o n ta c t a d d re ss :
T e le p h o n e  n u m b er:
B e s t t im e  to  p h o n e : 
e -m a il:
P le a s e  re tu r n  in  t h e  S .A .E .
•  The Im p o rta n ce  o f  a -L ino len ic  A c id  (a-LA) a s  a S o u rc e  o f  Long-C hain  n-3
P o lyu n sa tu ra ted  F a tty  A c id s  (PUFA) a n d  its  In flu en ce  o n  R is k  F actors o f  C ardiovascular
D isea se .
Summary
D ie ta ry  long c h a in  n -3  P U F A  fro m  fis h -o ils  h a v e  b e n e fic ia l e ffe c ts  on c a rd io v a s c u la r  risk  fa c to rs . 
U n fo rtu n a te ly , e ffo rts  to  ta k e  a d v a n ta g e  o f  th e s e  e ffe c ts  h a v e  b e e n  h in d e re d  b y  re s is ta n c e  to  th e  
in c re a s e d  c o n su m p tio n  o f o ily  fish . T h e  sup p ly  o f th e  p re c u rs o r o f th e s e  oils, a -lin o ie n ic  acid  in enrich ed  
# fo o d s  o ffe rs  a n  a lte rn a t iv e  a n d  re a lis tic  w a y  o f a c h ie v in g  th e  s a m e  b e n e fits . T h e  e ffic a c y  o f th is  
a p p ro a c h  in h u m a n s  re m a in s  u n p ro v e n  b e c a u s e  h ig h  le v e ls  o f d ie ta ry  n -6  P U F A  in o u r d ie t fro m  
v e g e ta b le  oils p re v e n ts  co n v ers io n  o f  th e  a -L A  to its lo n g e r ch a in  a n d  b io log ica lly  a c tive  products . T h e re  
is e v id e n c e  to  s u g g e s t th a t d ie ts  e n ric h e d  w ith  a -L A  p ro d u c e  m ild  ‘f ish -o il’ like  e ffe c ts  on b lood clotting  
b y  d e c re a s in g  p la te le t  a g g re g a tio n , b u t no  c o n v in c in g  d a ta , a s  y e t, o f  e ffe c ts  on  s e ru m  lip ids or 
lip o p ro te in s . T h is  is e x p e c te d  s in c e  th e  fo rm  o f  th e s e  d ie ta ry  in te rv e n tio n s  a n d  n a tu re  o f  th e  
e x p e r im e n ta l s u b je c ts  h a v e  b e e n  in a p p ro p ria te  to d e m o n s tra te  such  a n  e ffec t.
• W e  p o stu la te  th a t  d e c re a s in g  th e  ratio  o f  d ie ta ry  n -6 : n -3  P U F A  a n d  in c reas in g  th e  s o u rc e  o f d ie ta ry  a -L A  
will in c re a s e  th e  c o n vers io n  o f a -L A  in th e  body an d  th u s  p ro m o te  ‘fish -o il’ like c h a n g e s  in card io v as cu la r  
risk fac to rs . S u b je c ts  e x p re s s in g  an  a th e ro g e n ic  lipopro te in  p h e n o ty p e  (A L P ) a re  u n iq u e ly  resp o n s ive  to  
f is h -o ils  a n d  a re  th u s  th e  m o s t a p p ro p r ia te  ta rg e t  g ro u p  fo r  th is  k in d  o f in te rv e n tio n . V o lu n te e rs  
e x p re s s in g  an  A L P  w ill b e  recru ited  th ro u g h  local G P  clin ics a n d  inv ited  to  ta k e  p a rt in a  12  w e e k  d ie ta ry  
in te rven tio n  tria l. S u b je c ts  w ill b e  ra n d o m ly  a llo ca ted  to  e ith e r  a  contro l d ie t, b a s e d  on m o n o u n s a tu ra te d  
fa t, a  te s t d ie t w ith  in c re a s e d  a -L A  o r a  fish -o il s u p p le m e n te d  d ie t (co n tro l d ie t +  fish -o il c a p s u le s ). W e  
will re p la c e  4 5  g ra m s  o f fa t  w ith  a  fa t  s u p p le m e n t su p p lied  in th e  fo rm  cooking  oils, s p re a d s  a n d 's a c h e ts  
# o f o il. O u r  e n d p o in ts  o f c a rd io v a s c u la r  risk a re  b a s e d  on th e  h igh risk fe a tu re s  o f  a n  A L P , and  will b e  
a s s e s s e d  b y  e x a m in in g  c h a n g e s  in s e ru m  lipoprotein  s u b c la s s e s , a  ra n g e  o f b lood  clo tting  fac to rs  and  
b lo o d  flo w  a n d  a r te r ia l d ia m e te r  b y  u ltras o u n d , a  n o n -in v a s iv e  m e a s u re  o f e n d o th e lia l d ys fu n c tio n . 
M e ta b o lic  t ra c e r  s tu d ie s  u s in g  s ta b le  iso to p es  w ill b e  c a rr ie d  o u t in a  s m a ll n u m b e r  o f s u b je c ts  to  
m e a s u re  th e  co n v ers io n  ra te  o f  a -L A  w ith in  th e  body.
B ru ce  A . Griffin
L e c tu re r in N utritiona l M e ta b o lis m
W e  h a v e  b e e n  a p p ro a c h e d  b y  D r B ru c e  G riffin  (R e a d e r  in N u tr itio n a l  
M e ta b o lis m ) a n d  P a u l W ilk in s o n  (R e s e a rc h  D ie tit ia n ) fro m  th e  S c h o o l o f  
B io lo g ica l S c ie n c e s  a t th e  U n ive rs ity  o f S u rre y  in G u ild fo rd . T h e y  a re  in th e  
f in a l y e a r  o f  a n  in te rv e n tio n  s tu d y  e x a m in in g  th e  e ffe c ts  o f  d ie t  on  
c a rd io v a s c u la r  risk  fac to rs . T h e  p ro ject, fu n d e d  b y  th e  M in istry  o f A g ric u ltu re , 
F is h e rie s  a n d  F o o d s , re q u ires  v o lu n te e rs  to  p a rtic ip a te  in a  3 -m o n th  d ie ta ry  
in terven tio n  p la n n e d  to  c o m m e n c e  in _  ■
W e  h a v e  c o n ta c te d  y o u  a s  you  m e e t  s o m e  o f th e  c rite ria  n e e d e d  fo r se lec tio n  
on th e  p ro je c t, w h ic h  is a im e d  p rim a rily  a t  n o n -s m o k in g , m id d le -a g e d  m e n  
w ith  m o d e ra te ly  ra is e d  s e ru m  ch o les te ro l.
If  y o u  th in k  y o u  m ig h t b e  in te re s te d  in tak in g  p art, an d  w o u ld  like  to  find  ou t 
m o re  a b o u t th e  p ro je c t, w it h o u t  a n y  o b l ig a t io n ,  p le a s e  return  th e  re p ly  slip  
a tta c h e d  w ith  th is  le tte r  d irec tly  to  P a u l W ilk in s o n  in th e  fre e p o s t e n v e lo p e  
p ro v ided .
If th e y  d o  not h e a r  fro m  yo u  w ith in  2  w e e k s  o f yo u  rece iv in g  th is  letter, yo u  will 
not b e  c o n ta c te d  a g a in  an d  th e y  w ill a s s u m e  you  d o  n o t w ish  to  p a rtic ip a te  in 
th e  s tu d y .
. Y o u rs  s in c e re ly
Appendix 3 
Volunteer Information & Dietary Instructions
VOLUNTEER INFORMATION SHEET
S tu d y  T itle  and S u m m ary
The Im p o rta n ce  o f  a -L in o le n ic  A c id  (a -LA ) ( lin s e e d  o i l  fro m  fla x ) as  a S o u rce  o f  L o n g -  
C ha in  n -3  P o ly u n s a tu ra te d  F a tty  A c id s  ( f is h  o ils )  a n d  its  In flu e n c e  o n  R is k  F a c to rs  o f  
C a rd io v a s c u la r D isease.
You have been asked to volunteer for a dietary intervention trial run jointly through the  
University of Surrey and the Royal Surrey County Hospital in Guildford. T h e  study will look at 
the effects of dietary fats on risk factors for coronary heart d isease in 60  m ale volunteers. It 
will involve changing your diet in your own hom e for 12 w eeks by eating a range of specially 
manufactured foods and oils, in place of som e of the foods which you normally eat. You may 
also be asked to take fish-oil supplements in the form of capsules. W e  will supply you with all 
of the foods and fish-oil supplem ents and provide regular d ietary advice and guidance  
throughout the trial. It is important that you do not lose or gain w eight on this diet and your 
calorie intake will be carefully controlled to ensure this does not happen. T h e  supplied foods & 
oils, which have been m anufactured by well known food com panies, have been m ade with 
different types of fat which when eaten will modify the fat in your blood in a way that should 
reduce your risk o f heart d isease. W e  will m onitor the effects of these dietary fats on risk 
factors for heart d isease by taking small blood sam ples at regular intervals (a total of 150m l 
~ 1 /4  of a pint over 12 w eeks), by m aking m easurem ents of blood flow by ultrasound (a 
procedure sim ilar to having your blood pressure taken), and by giving selected volunteers  
som e fat in the form of an oil capsule labelled with a harmless tracer so that w e can follow the  
w ay the fat is handled within the body. You will be paid for the inconvenience of taking part in 
the trial and for your travel expenses.
B ackg ro u n d  in fo rm atio n  on  th e  s tu d y
H eart disease rem ains the greatest cause of prem ature death in m iddle aged m en in the U.K. 
T he risk of dying from a  heart disease is largely determ ined by genetic factors (family history) 
but also by lifestyle factors such as diet. W e  know that raised levels of cholesterol in the  
blood increases the risk of heart d isease but this is not the w hole story. Cholesterol is 
transported in the blood circulation in different fractions som e of which deposit in the walls of 
coronary arteries. This eventually blocks the flow of blood to the heart which causes an often 
fatal heart attack. In contrast, other cholesterol fractions actively rem ove cholesterol from  
artery walls and prevent heart attacks. Fish oils are very effective in modifying the balance of 
these different cholesterol fractions in the blood in favour of the ‘good’ cholesterol. They also 
prevent blood from clotting in 'clogged’ arteries and protect the walls of coronary arteries from  
dam age caused by fa t and physical stress (high blood pressure). This is how fish-oils are 
thought to provide protection aga inst heart d isease, and w hy w e  are currently being 
encouraged to eat m ore oily fish such as herring, m ackerel and sardines. However, there is a 
problem  in that oily fish are  not eaten  in a quantity sufficient to provide the  necessary  
protection against d isease. An alternative w ay of acquiring this protection is by getting our 
own bodies to m ake the oils found naturally in fish. W e  can do this by supplying the building 
blocks for the biologically active constituents of fish oils in the form  of an oil from linseed  
known as a -L A . Unlike fish-oil, a -L A  can be easily incorporated into a w ide range of food 
products and can be eaten  in quantities which, w e  predict, will reduce the risk of developing 
heart d isease. It should be em phasised that fish oils and a -L A  are perfectly safe to eat and 
have been used in num erous human dietary intervention studies in the past.
W h a t do w e  h o p e  to  ach ie ve  in th is  s tu d y?
W e  aim to show that dietary a-LA , a product of linseed oil, can be converted in the body into 
the active constituents found in fish1 oil, and w hen incorporated into foods and consumed can 
produce ‘fish-oil’ like changes in the blood that will reduce the risk of heart disease.
W h y  have you been s e le c te d ?
You have been chosen primarily because you are m ale and middle aged (30 -60  years) and 
represent the group most likely to benefit from the experim ental diets. To be suitable for our 
study you must also be a healthy non-sm oker who is not taking any drug medication or dietary 
supplem ents which m ay adversely affect our results. W e  have been notified by your GP of 
your interest and potential suitability for this trial but must stress that w e do n o t have access 
to your medical records which remain confidential.
W h a t w ill happen o n ce  you  have  agreed to  take  p art in the  tria l?
If the level of fat in your blood is suitable for you to participate in the study you will be asked to 
provide written consent of your willingness to participate. This consent does not in any way  
infringe your right to discontinue the trial at any stage. Before you enter the trial w e need to 
obtain information on your norm al background diet. To  do this you will be given full 
instructions and guidance on how to com plete a 7 -day  food diary. This diary will provide 
information on the fat content of your normal diet and daily calorie intake and help us to 
design the experim ental diets. I t  is  v ita lly  im p o r ta n t th a t y o u  do  n o t  ch a n g e  y o u r  d ie t o r  
a n y  o th e r  l ife s ty le  h a b its  fro m  th is  p o in t  u n t i l  th e  s ta r t  o f  th e  d ie ta ry  in te rv e n t io n  
p e rio d .
W h e n  and  w h e re  w ill th e  d ie ta ry  in te rven tio n  tr ia l ta k e  p lace  and  w h a t s u p p o rt w ill be  
pro vided ?
T he dietary intervention period is planned to start in April/M ay 2001. T h e  period of tim e prior to 
this will allow us to study your background diet and recruit more volunteers for the dietary 
study. You will be notified well in advance of the  start date. Im m ediately before the trial 
com m ences you will be asked to attend the University of Surrey to provide a blood sam ple  
(35m l - 3 .5  dessert spoon full). A  small num ber of volunteers will be asked to undergo a  ‘non- 
invasive’ assessm ent of blood flow. This involves placing a blood pressure cuff around the  
upper arm and measuring blood flow by m eans of an ultrasound probe placed on the skin. 
This  m easurem ent will be m ade before and a fter a tab let of glyceryl trinitrate (G T N ), a 
harm less substance used to dilate blood vessels. A fter your hospital visit, which should take  
about 60  m inutes, you will visit the University to collect your food supplies /  fish-oil 
supplem ents and to receive dietary advice and information before starting your diet. T h e  12- 
w eek  intervention period will take place in your own hom e. A  dietitian will be on call at the 
University to provide dietary advice and counseling throughout the 12-w eek  period. The  
principal scientific investigators will also be available at the University to deal with your queries 
on any aspect of the trial. Telephone (01483) 879716  or 879724.
W h a t typ es  o f fo o d  w ill y o u  be exp ected  to eat?
W e  are aiming to replace approximately 50%  of your dietary fat by supplying you with cooking 
oils and spreads. All of our food products will have been m ade by well known food companies 
and must be acceptable and palatable to our volunteers if w e  are to maintain their interest and 
dietary com pliance throughout the  trial. If there is evidence of non-com pliance to the diet at 
any stage, the volunteer’s participation in the trial m ay be terminated.
in terim  blood sam p le  and  d ie ta ry  check
You will be asked to provide an interim blood sam ple after 6 w eeks on the diet. This will 
enable us to check on your dietary compliance and to m easure your blood fat level. It will also 
provide an opportunity for further food collection, though foods will be delivered directly to our 
volunteers throughout the trial on request.
W h a t w ill Happen a t th e  en d  o f  th e  12 w e ek  in terven tio n ?
A t the end of the 12 w eeks you will be asked to attend the University to provide a final blood 
sam ple  and repeat the  blood flow m easurem ents. In the sam e visit, a sm all num ber of 
volunteers will be asked to take  part in an additional study which involves swallowing a small 
capsule of oil (a-LA ) that has been labelled with a harm less tracer substance. This allows us 
to study the rate at which a -L A  from linseed is converted inside the body into the types of oils 
found in fish. A fter this you can go hom e and the next day (24  hours later) a final blood 
sample is taken. This com pletes your involvement in the study.
Participation in this trial is voluntary and subjects m ay withdraw at any time. All subjects who 
successfully complete the study will receive £150. In the case of subjects who withdraw prior 
to the end of the study, the level of remuneration m ay be reduced. Extra remuneration will be 
given to those who participate in the assessm ent of blood flow studies.
T h e  Local R esearch  E th ics  C o m m ittee  has ap p ro ved  th e  abo ve  s ta te m e n t
VOLUNTEER CONSENT FORM
? |e a s e  re a d  th is  fo r m  c a r e fu l ly  b e fo r e  s ig n in g . Y o u r  s ig n a tu r e  o n  th is  c o n s e n t  fo r m  is  ta k e n  a s  
e v id e n c e  t h a t  y o u  h a v e  re a d  a n d  u n d e r s ta n d  th e  s ta te m e n ts  o n  th e  V o lu n t e e r  In fo r m a t io n  S h e e t  
' m d  a re  w i l l in g  to  ta k e  p a r t  in  th e  r e s e a r c h  s tu d y .
fh e  Im p o r ta n ce  o f  a -L in o ten ic  A c id  (a-LA) ( lin se e d  o il from  flax) a s  a S o u rc e  o f  L ong-C hain  n-3  
P o lyu n sa tu ra ted  F a tty  A c id s  ( fish  o ils) a n d  i t s  In flu e n c e  o n  R is k  F a c to rs  o f  C a rd io va scu la r  
#  d isea se .
h a v e  re a d  a n d  u n d ers ta n d  th e  V o lu n te e r  In fo rm ation  S h e e t  an d  a c k n o w le d g e  th e  fo llow ing  points:
i . T h e  p u rp o s e  o f th e  re s e a rc h  s tu d y .
>. T h e  e x p e c te d  d u ra tio n  o f m y  p artic ip a tio n  in th e  s tudy.
T h e  n a tu re  o f th e  e x p e r im e n ta l p ro ce d u res  involved .
I. T h e  n a tu re  o f a n y  fo re s e e a b le  risks o r d iscom forts .
■
j. T h e  n a tu re  o f a n y  b en e fits  to  m e d ic a l s c ie n ce  o r th e  v o lu n te e r w h ic h  m a y  a rise  from  th is  re se arc h .
>. T h e  c irc u m s ta n c e s  u n d e r w h ic h  m y  partic ipation  in th e  s tu d y  m a y  b e  te rm in a te d .
T. T h e  fa c t th a t m y  p artic ip a tio n  in th is  s tudy  is vo lu n ta ry  an d  re fu sa l to  p a rtic ip a te  w ill not in vo lve  a n y  
p e n a lty  o r loss o f  b en e fits  to  w h ic h  I a m  o th erw ise  en titled .
5. T h a t  th e  in ves tig a to rs  o f  th is  s tu d y  d o  not h a v e  a c c e s s  to  m y  m e d ic a l reco rd s  w h ich  w ill re m a in  
co n fid en tia l.
i i  I, th e  u n d e rs ig n e d , h e re b y  a g r e e  to  p artic ip a te  as  a  v o lu n te e r in th e  a b o v e  re s e a rc h  study.
V o lu n te e r
S ig n a tu re  N a m e  (In  B L O C K  L E T T E R S )
In d e p e n d e n t  W itn e s s  to  C o n s e n t
S ig n a tu re  N a m e  (In  B L O C K  L E T T E R S )
T h a n k  Y o u  F o r  V o lu n te e r in g  to  T a k e  P a r t .
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